125
FEDERAL TRADE COMMISSION DECISIONS Findings , Opinions , and Orders 1:' THE MATTER OF NUTRITION 21 , ET AL. CONSE'\T ORDER , ETC. , IN REGARD TO ALLEGED VIOLATIO'\ OF SECS. 5 AND 12 OF THE FEDERAL TRADE COYlMISSION ACT Docket 3758. Complaint, July 11 , I997-- Decision , July 11 1997 This consent order prohibits , among other things , the two California-based companies and their officer from making unsubstantiated advertising claims for their weight loss and health care products containing chromium picolinate and requires competent and reliable scientific evidence to substantiate any representation concerning the benefits , performance , efficacy or safety of any food , dietary supplement or drg they advertise or sell. The consent order also prohibits misrepresentations of the results of any study, test or research. In addition , the consent order requires the company to send its customers a notice of the Corrssion s allegations and a request to stop using sales materials that make the challenged claims. Appearances For the Commission: Beth Grossman , Loren G. Thompson and Lee Peeler. For the respondents: Stephen McNamara , Hymans , Phelps & McNamara Washington , D. COMPLAINT The Federal Trade Commission , having reason to beJieve that Nutrition 21 , a limited partnership; Selene Systems , Inc. , a corporation and general partner of Nutrition 21; and Herbert H. Boynton , individually and as President of Selene Systems , Inc. , a corporation ("respondents ), have violated the provisions of the Federal Trade Commission Act , and it appearing to the Commission that this proceeding is in the pubJic interest , allegcs: 1. Respondent Nutrition 21 is a CaJifomia Jimited partnership with its principal offce or place of business at 1010 Turquoise St. Suite 335 , San Diego , CA. 2. Respondent Selene Systems , Inc. is a CaJifomia corporation and a general partner of Nutrition 21. Its principal offce or place of business is the same as that of Nutrition 21.

, ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Findings , Opinions , and Orders

1:' THE MATTER OF

NUTRITION 21 , ET AL.

CONSE'\T ORDER , ETC. , IN REGARD TO ALLEGED VIOLATIO'\ OFSECS. 5 AND 12 OF THE FEDERAL TRADE COYlMISSION ACT

Docket 3758. Complaint, July 11 , I997--Decision, July 11 1997

This consent order prohibits , among other things, the two California-basedcompanies and their officer from making unsubstantiated advertising claimsfor their weight loss and health care products containing chromium picolinateand requires competent and reliable scientific evidence to substantiate anyrepresentation concerning the benefits , performance , efficacy or safety of anyfood, dietary supplement or drg they advertise or sell. The consent order alsoprohibits misrepresentations of the results of any study, test or research. Inaddition , the consent order requires the company to send its customers a noticeof the Corrssion s allegations and a request to stop using sales materials thatmake the challenged claims.

Appearances

For the Commission: Beth Grossman, Loren G. Thompson andLee Peeler.For the respondents: Stephen McNamara, Hymans, Phelps &

McNamara Washington , D.

COMPLAINT

The Federal Trade Commission , having reason to beJieve thatNutrition 21 , a limited partnership; Selene Systems, Inc., acorporation and general partner of Nutrition 21; and Herbert H.Boynton , individually and as President of Selene Systems , Inc. , acorporation ("respondents ), have violated the provisions of theFederal Trade Commission Act, and it appearing to the Commissionthat this proceeding is in the pubJic interest , allegcs:

1. Respondent Nutrition 21 is a CaJifomia Jimited partnershipwith its principal offce or place of business at 1010 Turquoise St.Suite 335 , San Diego , CA.

2. Respondent Selene Systems , Inc. is a CaJifomia corporationand a general partner of Nutrition 21. Its principal offce or place ofbusiness is the same as that of Nutrition 21.

Page 2: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COM:'ISSION DECISIONS

Compiaint 124 FTC

3. Respondent Herbert H. Boynton is President of Selene

Systems , Inc. , a corporation. Individually or in concert with othershe formulates , directs , and controls the acts and practices of Nutrition21 and Selene Systems , Inc. , including the acts or practices allegedin this complaint. His principal offcc or place of business is thc sameas that of Nutrition 21.

4. Respondents have manufactured , advertised , offered for salesold, and distributed Chromium Picolinate for use in dietarysupplements. Chromium Picolinate is a product subject to theprovisions of Sections 12 and 15 of the Federal Tradc CommissionAct. The United States Deparment of Agriculture holds the patent onChromium Picolinatc , and Nutrition 21 holds the exclusive license tomanufacture and sell Chromium Picolinate.

5. The acts and practices ofrespondcnts alleged in this complainthave been in or affecting commerce , as "commerce" is defined inSection 4 of the Federal Trade Commission Act.

6. Respondents have disseminatcd or have caused to be

disseminated advertiscments and promolional matcrials forChromium Picolinate , including but not necessarily limited to theattached Exhibits A-G. These advertisements and promotionalmaterials contain the following statements:

A. Lose the Fat but Keep the Muscle .Chromium PicolinateAt last there is a safe nutritional supplement that helps you lose umvantcd fat moreeasily and quickly, while retaining vita! muscle tissue. ;\0\\1 you can have a

trimmer, firmer, leaner body.LOSE THE FAT Bt;T KEEP THE MUSCLEMost dieters who achieve significant weight loss lose far too much lean body mass(muscle and organ tissue). . . . Even worse , this lessened lean body mass lowersyour metabolic rate , making it that much harder to keep the fat off pelmanently -the yo-yo syndrome!

There is now excellent scientific evidence that Chromium Picolinate canaccelerate fat loss while helping to preserve or even increase muscle.CONVINCIlG :-EW EVIDENCE

Overweight adults were recmited by a prominent San Antonio weight lossclinic to participate in a \V'eight loss study. About half of the volunteers receivedsupplemental Chromium Picolinate (200 or 400 micrograms chromllm daily),while the others received placebos, Neither the partIcipants nor the doctorsevaluating them knew who was getting the chwmium (a I1 double- blind" study).The volunteers were not placed on any specific diet or exercise regimen , althoughmost of them were motivated to lose \\"Cight. After onJy 60 day' , these were theimpressive results:

Page 3: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

KUTRITJON 21 , ET AL

Complaint

The changes in the placebo group were negligible. But the ChromiumPicolinate group, on average , lost over 4 pounds of fat while gaining nearly apound and a half oflean muscle for a "let Physique Enhancement of 5. 6 pounds.

****

Another double blind-study was conducted in young off- season footballplayers participating in a six-week weight-n-aining program. The results were muchthe same: more muscle , less fat with Chromium Picolinate. Chromium Picolinatcmore than doubled the net benefits of exercise alone.

****

LEANER AND FIRMERBecause many people gain muscle with Chromium Picolinate , their weight loss inpounds doesn t accurately reflect the benefits of chromium. Most users repon thatevent lsicJ a modest weight loss as shown on the bathroom scale is accompaniedby lost inches and smaller clothing sizes. They look and are leaner and firmer.Chromium Picolinate promotes fat loss , while enhancing the muscle that assuresa trim athletic physique.HOW DOES CHROMIV'v PICOLINA TE WORK?Controls Hunger Many people report that Chromium Pieolinate helps to controlappetite , especially sugar cravings. It is believed that chromium sensitizes theglucostat" in the brain that monitors blood sugar availability and " tells " you when

you re hungry or not hungry.Spares " Protein. . . By " sensitizing " muscle to insulin, Chromium Picolinate

helps to preserve muscle in dieters so that they "burn " more fat and less muscle.Preservation of lean body mass has an important long-term positive effect onmetabolic rate , helping dieters keep off the fat they ve lost.Stimulates Metabolism It promotes efficient metabolism by aiding thethermogenic (heat producing) effects of insulin. Insulin levels serve as a roughindex of the availability of food calones , so it s not at all surprising that insulinstimulates metabolism.HOW MUCH CHRO'vIUM P1COL11ATE SH01.LD 1 TAKE FOR OPTIMALWEIGHT LOSS?

Clinical trials with 200 to 400 micrograms of chromium daily producedsignificant benefits. Larger mdividuals and those engaged in strenuous work orexercise may see better results with higher levels -- up to a maximum of 400micrograms daily.PUTTING IT ALL TOGETHER

The best thing about Chromium Picolinate is that it makes other sensibleweight control efforts more effective. YIany people report that they have tried dietand exercise before , but say that they didn t get good results until they addedChromium Picolinate. . . .

Chromium Picolinate , all by itself, isn t likely to make a fat person thin. Butit can be the decisive component of an overaJi strategy for long-tenn w'eight controland , in the bargain , make an important contribution to good health.

****

(Exhibit A) (refercnces omltted)B. WEIGHT LOSS , FAT LOSS A"ID 'vlJSCLE LOSS

or "How to Break the String of Yo-Yo DietsCLEARLY , THE KEY TO BREAKJG THIS DISCOLRAGI'!G CYCLE

EVER YlORL FAT, EVER LESS MUSCLE , IS LOSII\G FAT WHILEPRESERV1Mi--OR EVE'! NCREASf\G-- 'vlJSCLE.

Page 4: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Comp1aint 124 FTC.

This is precisely what Dr. Gilbert Kaats and his colleagues achieved in arecently completed study. . . .

One hundred fifty men and women were asked to join in a weight loss study.Roughly half were given supplemental Chromium Picolinate (200 or 400micrograms chromium daily), while the others got a placebo. They were not placedon any specific diet or exercise regimen, although most were tring to lose weight.

. After 72 days , these were the impressive results:

****

The changes in the placebo group were insignificant. However the ChromiumPicolinate group, on average , lost over 4 pounds of fat while gaining nearly apound and a half oflean muscle!

****

The review of clinical trials reported that supplementation with ChromiumPicolinate:

reduced total serum cholesterol and LDL , the "bad" cholesterolreduced elevated blood sugar levels and glycosylated hemoglobin in diabeticssignificantly reduced body fat and increased muscle in exercising individuals.

****

Chromium is an essential nutrent that is in short supply in 90% of tyical L.diets. . . .CHROMJU:v PICOLINA TE: Take daily, 200 to 400 micrograms to preservemuscle while you lose weight

****

Chromium Picolinate has other important attributes:

preserving or enhancing muscle; it maintains or increases the metabolic ratemaking weight loss easier.significantly lowering elevated serum cholesterolsignificantly lowering elevated blood sugarhelping to control appetite. A great many people report reduced appetiteespecially sugar cravings.

****

(Exhibit B)C. CHROMIUM PICOLlJ\ATE:

The yeast free BioActive Chromium with Important Clinically Proven Benefits

****

Chromium is vitally important to good heahh because it is essential to theefficient function of the hormone insulin. Poor responsiveness to insulin is verycommon and is linked with increased risk for overweight , heart disease , elevatedblood fat , high b100d pressure , and diabetes.

Yet chromium s nutritional status in the U. S. is very poor: 90% of Americandiets provide less than the minimal amount recommended by the 1\ ationalAcademy of Scjences , and most nutritional forms of chromium arc poorlyabsorbed.

Chromium Picolinate is well absorbed and highly bioactive. In clinical trialsat major hospitals and universities it has been shown to:

significantly reduce body fathelp build lean , strong muscleslower elevated cholesterolreduce elevated blood sugar in diabetics

****

Page 5: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

C\UTRITIOC\21 , ET AL.

Complaint

By mechanisms that are not yet fully understood nutTitionalchromium is absolutely essential to the function of insulin.

****

A great many L'. S. adults have poor insulin function. They produce normal oreven elevated amounts of insulin , but their body s tissues are relatively insensitiveto it. Indeed, recent studies show that at least one in four adults has reducedsensitivity to insulin.

The majority of these people don t become overtly diabetic because theirpancreas compensates by secreting increased amounts of insulin. In these peopleinsulin insensitivity is a "silent" problem that can be diagnosed only by observingincreased blood insulin levels and/or modest impairments of glucose tolerance.

There is increasing evidence that this "silent" insulin insensitivity is in fact aserious medical problem.

(trivalent)

****

But there is now evidence that insulin insensitivity may itself lead to weight gainowing to an impairment of "dietary thennogenesis. . . .

Insulin insensitivity almost certainly also impairs the development of muscle.

****

Diabetes As noted, most people can compensate for modest impainents of insulinsensitivity by producing more insulin. But in some people , as insulin sensitivitycontinues to decline , the pancreas is unable to keep up with the increased need forjnsulin , and " adult-onset" (Type II) diabetes results. In this syndrome , there is asignificant net reduction in insulin activity, resulting in persistent elevatIOns ofblood sugar even after an overnght fast. Adult-onset diabetes. . . is responsible fora tremendous toll in premature death and disability. Long-term diabetes can leadto heart disease , arterial disease (often requiring leg amputation), blindness , kidneyfailure , and nerve damage.

****

POOR CIIROMIJ.Yr NVTRlTIOC\ AND METABOLISMDiets that are too high in fats and too low in fiber-rich unrefined foods

inadequate exercise , as well as overweight, are all major factors contributing topoor insulin responsiveness. Poor chromium nutrtion also plays a vitally importantrole.

Refined American diets are very poor sources of chromium. The KationalAcademy of Sciences has recommended a daily chromium intake of 50 to 200micrograms. Yet studies by the D. S. Departent of Agriculture indicate that 90%of Americans receive less than 50 micrograms daily--and 25% receive less than 20micrograms!

This problem is compounded because most sources of chrorrum are notefficiently absorbed. . . .

In addition, there is evidence that many people may have defective chromiummetabolism. . . . Diabetics also tend to have lower chromium levels.

In brief, impaired insulin sensitivity is very prevalent and lS associated withincreased risk for overweight, heart disease , diabetes , and high blood pressure.

Chromium , which is crucial for proper insulin function , is in short supply inmost American diets , is often inefficiently absorbed, and may not be efficientlymetabolized by many people.

Page 6: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Complaint 124 FTC

THE SOLUTION: BIOACTIVE CHROMIL'MThese considerations emphatically suggest the desirability of dietary chromium

supplementation. But not all chromium supplements are equally effective. Inclinical studies, inorganic cluomium (e.

g.

chromic chloride) has been beneficial formild impaiIlents of glucose tolerance, but has not proven useful in overt diabetesor for lowering elevated cholesterol. In contrast, large intakes of brewer s yeast , arich source of organically bound chromium , have been found useful for treatingdiabetes and high cholesterol. .The most likely explanation is that some organic chromium complexes are morereadily taken up by cells than is inorganic chromium.

****

CHRO:vIUM PICOLINATEScientists at the U. S. Departent of Agriculture have developed an excellent

perhaps an ideal organic complex of chromium. . . . Chromium Picolinate thusproves exceptionally effective for achieving intestinal absorption and intracellularuptake of chromium.

****

(Exhibit C) (refcrenccs omitted)D. CHRO:v1UM PICOLINA TE -- THE CLINICAL PROOF. . .

The initial studies with Chromium Picolinate have yielded exciting results:Physiquc Enhanccrncnt for Athlctcs

Young male athletes engaged in an exercise program at Bemidji StateUniversity (:vinnesota) received daily doses of Chromium Pico1inate (200micrograms chromium) or a matching placebo. After 6 weeks , the chromium groupgained 44% more lean body mass than the placebo group. Even more striking, thechromium group lost 23% of its body fat as compared to only 7% in the placebogroup. These differences were highly statistically significant.

A similar study has been conducted at Louisiana State University with menand women beging weight-traing students. A preliminary report indicates thatChromium Picolinate accelerated the increase in muscle size in both men andwomen , and, in the women, nearly doubled the increase in lean body mass.

****

Cholesterol Reduction In a double-blind crossover study conducted by themedical staff of San Diego s Mercy Hospital , people with elevated cholesterolreceived a daily dose of Chromium Picolinate providing 200 microgramschromium, alternatig with a matchig placebo. After 6 weeks of chromium, LDLcholesterol. . . had dropped 10%. .. Inorganic chromium has not been reportedto lower elevated cholesterol.

****

Adult-Onset Diabetes A similar double-blind crossover trial was conductedat Mercy Hospital with Type II (adult-onset) diabetics. After 6 weeks of ChromiumPicolinate (200 micrograms of chromium), fasting blood sugar was lowered by18%.. .This is the first time that a nutrtional intake of chromium per se has been reportedto llprove glucose metabolism in overt diabetes. (Exhb1 D) (references onltted)

E. Chromium Picolinate --The Results Speak For ThemselvesTwo well designed, well executed studies prove that Chromium Picolinateaccelerates muscle growth and reduces body fat. Such a statement cannot be madefor any other chromium compound.

A recent issue of MUSCLE & FIT:SS presented an artIcle calling attentionto the newly proven anabolic role of chromium. Body builders have believed for

Page 7: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

NUTRlTION 21 , ET AL.

Complaint

a long time that chromium helps build muscle. What is new is that scientists nowhave measured, during a clinical study, the actual gains that chromium produces.

It no longer makes any difference what people " think" about chromium orabout the different form of chromium because the facts are in -- facts detennnedby clinical tests conducted according to acceptable scientific standards. And theyhave shown that one form of chromium --Chromium Picolinate--does acceleratemuscle growth. (Exhibit E)

F. Lose The Fat; Keep The Muscle With Chromium Picolinate.Here s Why You Need Chromium Picolinate.Like iron , ca1cium , and zinc , chromium is a nutritionally essential mieral. Its mostbiologically available form , Chromium Pico1inate, can have nutritionally helpfuleffects on your health and fitness. Combining it with a lifestyle aflaw- fat eatingand everyday exercise can improve both health and fitness.Lose Fat and Keep Muscle with Chromium Picolinate.Kine confinning scientific studies with humans and animals demonstrate asignificant reduction in body fat when Chromium Picolinate is added to the diet.These studies also show a consistent trend toward increased lean muscle. Musclebums calories , fat merely stores calories.Chromium Picolinate Helps Maintain A Normal Healthy Metabolism.Insulin has very important functions: 't maintains the nonnal nutritionalmetabolism of protein (muscle building), carbohydrate (major energy source), andfat (energy storage). It also inuences appetite control and calorie-burning. Insulinsimply can t perfonn nonnally without an adequate supply of chromium.Chromium is UndersuppIied in 90 /0 of Adult Diets.The National Academy of Sciences recommends 50 to 200 micrograms ofchromium daily. U. S. Departent of Agriculture studies show that men get only33 micrograms and women get only 25 micrograms , on average , from their food.

, help yourself stay lean and healthy. Choose low-fat meals; choose exercise thatyou enjoy; and choose Chromium Picolinate to supplement your daily diet. Do itfor the healthy edge. Do It for life

****

(Exhibit F)

G. "Lose the Fat; Keep the Muscle " with Chromium Picolinate. Milions ofAmericans are trying to lose weight and many succeed -- but only temporarily.

Typically, up to 30% of lost weight is muscle. This lowers your metabolic rateand slows calorie burning. Muscles burn calories even while you sleep; fat merelystores calories. This lowered metabolic rate makes it hard to keep lost pounds fromcreeping back. Result the "yo- " syndrome in which weight is repeatedly lost andthen regained. After each lose-gain cycle the proportion of fat increases. This canresult il a permanently depressed metabolic rate , persistent overweight. . and utterfrustration.

To break this vicious cycle it is important to lose only fat while maintaining,or even increasing muscle.

Most diet plans not only don t work , they re counterproductive. Permanentweight loss requires a permanent commtment. Steps 1 , 2, and 3 in the box Lbelow J

are endorsed by nearly all weight loss experts. Studies show that optimal chromiumnutrtion , Step 4 , is also an effective part oflong-term fat loss prograIT'I. Chromiumis in short supply in 9 out of 10 American diets and it s absolutely essential fornormal insulin function. Normal insulin activity is crucial for hunger control and

Page 8: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Complaint 124 FTC.

calorie-burning. Studies show that 200-400 micrograms of chromium daily, asChromium Picolinate , results in significant fat loss while muscle tissue ismaintained or even increased. Dr. Gil Kaats of San Antonio reports

, "

During sixweeks on Chromium Picolinate, ovenveight volunteers lost more than four poundsof fat, while muscle increased by nearly a pound and a half."FOL'R STEPS TO A LEANER FIRMER BODY1. Reduce Dietary Fat Consumption to 1'0 More Than 20% of Calories-- Eating

Fat Makes You Fat2. Increase Dietary FibernLow in Calories; High in Nun-ients3. Get Regular Aerobic Excrcisenand Burn Fat Calories!4. Take Chromium Picolinate Daily--Lose the Fat; Keep the Muscle(Exhibit G)

7. Through the means described in paragraph six , respondentshave represented , expressly or by implication , that:

A. Chromium Picolinate significantly reduces body fat.B. Chromium Picolinate causes significant weight loss.e. Chromium Picolinate causes significant weight loss without

dieting or exercise.

D. Chromium Picolinate causes 10ng- teD1 or peD1anent weightloss.

E. Chromium Picolinate increases lean body mass and buildsmuscle.

F. Chromium Picolinate significantly mcreases humanmetabolism. G. Chromium Picolinate controls appetite and cdving for sugar.H. Chromium Picolinate significantly reduces total and LDL

serum cholesterol.1. Chromium Picolinate significantly lowers elevated blood

sugar levels.J. Chromium Picolinate is effective in thc treatment and

prevention of diabetes.K. Ninety percent of U. S. adults do not consume diets with

suffcient chromium to support nOD1al insulin functionresuhing in increased risk of overweight , heart disease

elevated blood fat , high blood pressure , and diabetes.

8. Through the means described in paragraph six , respondentshave represented , expressly or by implication , that they possessed andrelied upon a reasonable basis that substantiated the representationsset forth in paragraph seven , at the time the representations weremade.

Page 9: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

I'LJTRlTION 21 , ET AL.

Complaint

9. In truth and in fact, respondents did not possess and rely upona reasonable basis that substantiated the representations set forth inparagraph seven, at the time the representations were made.Therefore , the representation set forth in paragraph eight was , and isfalse and misleading.

10. Through thc means described in paragraph six , respondentshave represented , expressly or by imphcation , that scientific studiesdemonstrate that Chromium Picohnate:

A. Significantly reduces body fat.B. Causes significant weight loss.e. Causes significant weight loss without dieting or exercise.D. Causcs long-tenn or pennanent weight loss.E. Increases lean body mass and builds muscle.F. Significantly reduces total and LDL serum cholesterol.G. Significantly lowers elcvated blood sugar levels.H. Is effective in the treatment and prevention of diabetes.

11. In truth and in fact , scientific studies do not demonstrate thatChromium Picolinate:

A Significantly reduces body fat.B. Causes significant weight loss.e. Causes significant weight loss without dieting or exercise,D. Causes long-tenn or pennanent weight loss.E. Increases lean body mass and builds muscle.F. Significantly reduces total and LDL serum cholestcrol.G. Significantly lowers elevated blood sugar levels.H. Is effective in the treatment and prevention of diabetes.

Therefore, the representations set forth in paragraph ten were , and arefalse or misleading.

12. The acts and practices of respondents as alleged in thiscomplaint constitute unfair or deceptive acts or practices , and themaking of false advertisements , in or affecting commerce in violationof Sections Sea) and 12 of the Federal Trade Commission Act.

Page 10: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIOJ\S

124 F.

NLTRTIO\21lJ!CT' Jrql!OI:.S ISUltf35';

iF C:'o ,:: ::()b! i8S' r\\t:' :"88-

V " S7dJ19

Complain!

EXHIBIT A

lo the Fat

but /(ep the

Musle.

. .

hromzumlinate

AJ/a tr a sae

rnti wpplIhheYJI=umm 1m

e= an quid. wbi

ntr; vita

1I. YJ co

a fnmmerJirm

/eto

S70U1;2

Page 11: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

NUTRlT10N 21 , ET AL

CompJaint

EXHIBTT A

lO II FAT IU ."mU8/a.

. .. . ' "

Wgd.. +X'r. 5IgJl1 1 'oeg:,1 ffk:(l1:W'X;:T1:!:r:I\lie;lOl tm! Tt.:'1Of cJ.:.5O1! .11:\:.I13:.a: ..'X\O

rrLlIe, ie1f C'L Si..lI.m Ie ,sp,cr f bntJ' f".J \Dlrr r.!, m:ag I alaJ mLX

..;.

iaJ r:l!Ij\uf\\\lki

:'f' a'!R, I;h( tnd.O'JDJLlP'aH Jlc:1.kier:ix 'C&";'Jk.

~~~

t"JrI:lIr.,LKJe

: JC, I1 rK:t/D- .pro", : SJ \.too.gh( :iL1JiIpa!'JOpatrrj"'W": sr' '\i!.d:i \\)ILi:t'1 11r. - !. C'.rorn:L: mll:l I.:Jf.; IigTcIt'1ml!fd:\I wf:i:)(; \td

\e:.''. '.Jp:. rtr(h

''''

grhgtgL"e::' J1)TJW':. 1 7h

W'Il l)plarOOOT\ cZr:gtrrdtt "U: gfl, ant:

~~~~~

dugllltcpinr

BiINQ-.lJ f"l1..gr,

4fDrif;u..ru re' a

1"J,'tdmlri()l

~~~~~~ ,,,,,--.

b I

_..'',

c..

57U('

i!ec;J'n. ;T(stlc..nIl"'t1.1,

x;ad" px'U :r1lr& Jr)(p

r.l crrnt\lt mz;w::; rr :h:m;(b tt

..i1 :lre X":i:TLfie..tJieQ.g;.;;ori"a.i\ J;r".. r;c't(;:."de poo ik!J'1

.;,

IOCDU."..- lJ.aJl' goifO':u , JIN' p.1rlrc~,~ J ;L\- ""I

':-

;rD'tI;1 t"'''cX

!.';

"'.ff1u'd

/JJ \IlL' C"JD"LJ mur.al c.1r'J..m ;"QJL Jl 101f 'JU"

WIOth:t=:lCO

'irI11:;1'1

',,,.

iN;mcl

=a.

,..,..

:':CL! :;Lx; Ia.

::''1IL\.r:n:l'lgplg'

="r,gc.l.'mJJlL

'nn' c:LK w:rr.

:'\

c.rbol1::i..ij:r

.:.:ro:C?Ig"crOCkgiJJ ':'T

IJ:

-"""",,.-"".

5h' 1'1-1

Page 12: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Complaint 124 FTC.

_AN FI.M

Be'1.1' p:mU',,' C'JLJmf'.aimx;nJ:::u i'Ir:tur,1ttl 1I!t ial!

sirn/h!X'C

~~~

lal1an;mctg.2 TImuwmieuw,OuumPm Im!atlm \\ll('.harcng!t

..!1''''TaI;t15

WHTISCH__",mC1umF"I5"l"'IJ,JiI\bwa:::J'I''.ri

:/

c.J rrOld1um Guum ,JlTl.i rolt if

jfl1g l1tar" I/!t. j;'15tJ!n 'ieighi:ml!fodr mlJ I7r.tOlf!marmt:

I(.j)

'..

:1 .

'''.

'7.. rw: 1o2!

~~~

I"rjiI!I::l1lUrrllum

I', :.\Ig3CT gs!!15.\d1'Htn 'gil. If:atr&..r.bI &I1f".o..w'IhunCf"dhlI

IL.

-.. ,,;-

lrd:wn pr,;nmW i1, 61 TI.o pr-

e:r:ImIm oojL,gK!-oLrN

~~~

:adml..:aj

""-

I'IJ!tD1urI"I!IId.SJaw&r"

::'

r;I'I;!.."ICmid rib1!xr:.a h25.1

-:

'epElM

~~~

, t"d.'g riih!j.

,-",

St_la Meli- .!In:.Jlsb1' .ag

~~~

eifCci WI10ir: .J J1 , nh r: ,,:.I:idJ

r ':.oo I''-J.Jl

,gj-,

.1" 0'. ,.J- i\. S70 ,)1.s

EXHIBIT A

,"'

,Ji '00&, :t 1o.( . ' c,r,ICV7l;L!:i;rcLC 11g:,J!OI, l:ts Jr W -np11

~~~ ()

CXex.'m. t5'''1L' "ug,

U;lDarr. UJnuma'.J'T ..d:MTDlAD .

Lm-LII C...um ,1UtnD ;j aJ 1 ri

1Ig. :CO,tr rm:J'f 'td \tJ !7'. .'XJ\

':-I" r:T/"" ;'la.r:tr ()f;a. h:! :iI()nc.

"'Ct fO."""Ig.1)1 'D1 :::1 \ nc:: c,".':J ne;

sp" wi/l Mri Iq :0:

'\',,

1;

u:mu,l:1;pJ 1!2I, C'mJ&1:e' pr::"'oc :rnD ::tJ11O " "X:.o ")"\ y"llg.'1aJi I!S'ldi''\lI J!i.:!l" '';JLJ:'"ir:,'Jb,

':,

\'i'I' J.'\c.\C.l:yprrP'!1" ;;'WC' l :SUJ.!I1 1:! Tlec'jJnSJ?:r prxL

c+- oITi;;1.l." II'

ratJlx;;lr'::t. :.1II' :u:,:1;ar i p/t1a-

' ,

fra:()5tuLa!;l1g 1I Ttlx:' "Ilwr.s fro:

mM.atr, 1Um Pr-rFm t\, Ut.."\:a. bd . 71 C)Dt c:or:

urs q.:x, .r,1\".f:m\h;g, Jlfal rTCi coWri"w;aJ

.Jlt i:e law fOJ.."I:m pr..f,:; 'lg1".T..iea .tu:e ,'r :P:tr ID -t, pr'0rJ'h-'1rg' :' m gc J5.U.'n- !ai wb-i;;'

-q..

.L'irn

'.T. a.-,I'\IT"lJ.")"'..t" .Q,,; J.;.,TLS laDe, CB, r. 'V';" 'I'"

.,

\!CS o:'!t:--

''-

::,a::.'''

. .

ci oW'1lS "UI: rT'' ' :VC ,:, :L.

..: "- ';;",:y

T. \e":;. n.. '-::A '1:: '

J7';U16

Page 13: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

NUTRITION , ET AL.

EXHIBIT A

IQ mt'.."C::l1J; ,JJ'E''T.p.. J.r!rc' Ig.'':.:

121 Ol'0umf"il,

~~~

;fed If'PIlVlf,lIrrc;"L. gL" iJr:,I:IRl'IOJ

ml' re:or!,.\t\J;X'" grrJrtwgr.1""Jk' lungr. ;!1 ;UtMoo INTtr

mg mLKIe rJ2S\ILKJe CJI. !' ' f;j a'L f1,

,,,'"

'I.

3\ NJKl.gf;u lco pg . Jr5I r.gIIlih G'uum f'hI . 'D'( Ie CJ k1 fa! Jr

l!rl crph"IQU. t""1\hol'I:l sp.Jdfcw11l!ca l.. ,,;-o o".1! to Ic

't. 1qu or",t.hz,laciflllOio. cr,"ooh:M

m;",y:CX!

~~~

t-' rIgttC2inl.II.O, gogCf'dw:' (f'Q005:t!tal/lm:La'OC;-olI:: 'OI'!t, lI\Ol J.'1oepr' J1tr

LrjLl

;';/'

;HT)i",

""-

roclll, ru,sL'f!Ui:Jo ? "1 ' GWnurr "'um. lt for 'TJlUrrall,g I rJ ml,!e j

r. aJrefor lJ311'T. Jdx!\SU,!;, c.JR .m:t' qudf.. :1:l:l1' \QVT lgc \\X!ow-up..thafabU1go:'T !kJbwlIfoc

PUG If All TOPtn-b!:h:ngotO'JmumP';15rhll

-rll(Droei

~~~~~

thMhrtndi:i=:t5or1, tu!SlIIWdl WI px re l: tI ;I OJum

- ,

tlr1 &1l&.N3lio-!a!Otgplllru.t.JM'rJ1h D:' \orefo

1'.mt;gc :s\W

~~~

II:O r!mg.

ChlJfYll.J1tI IMS1tIW 1Dr"!\4ktlfaJ

thBuIII::,

~~~

Ir:1J

for \op gb rotnr.l l. r.h aJ m* l(,I':r:., boU() pXh?

570017

Complaint

IE I:

::" ' . ' : . -::; ). :(,

';-1';

I I\GR.Ft' K 7ht!tnciduum ICUn

SU6o1. CJ :o a:iDCt ;r d.er1 -''JI"-li. \sJ.OO . :1S1 u. ,\b'g. w,-e1:tf1

2. EI-GII TIefOCciC'JTump.rl:..oolllQ:tr!k lIhlJ.1 In()Bua\'eRes I . II

lo,. 11:

, Pw:C\lar T',- SJUL L.fJoc'iC!.rJll": ICWl.1

::rC:2'= dlJrrJ!I. ri mg.f\'1g pigs J

'rJ. i1tiSUlI: 'X;j-1 'eli iorrJ!rr:ra'" lzr

ISlf. l'U.l() L':

J(()Ed a;L btJles1Dn- l.riClPbwl:CE,Y:

,)aUSR. , c.UlhI aIir"JI U'lh

r!ol'iJJ()r;r-iiLc"TlJ!EL\O: l' \1..;Rt".j

b :L:O'\1; \1. anrQR "Ie!aL 1rll,.rrej;;ur:\lJt(xDruU'b T\,JGu1r\e

fdJ, "tF P lmiI.o;1 snuJatOlr:1\3 Ji.

:. ,

TIl'rJ.I XH'lr.'r.U1 wta .

";,

Bf::Hhm: +lgl981

P1rtCis.IJ01;oJB. R2Gf W83,trJfI j;rUCiIdJ pa. 4ei.:.m19:-g ()oM.E.;r OI.JOtlfl . jOl\IJ i 113. :98'i

10 1\c\.~:Juqt ci..JO--dJfoI gt\tri\./fp:_'V1B3,

, 5O'li R. ur; 1 t'ult E :T.Jl: Jug:"J., , 'GI, "Lm &9, 198

1:\ c:)c.h::a."Jr,- 8JJon-:u HP. .J, \1\

Pr(\' \erci. nJl '1 ,.f'ri :;, ::lrto "'-a!o:1\e'Jbjl! " !0- .

::70015

Page 14: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSJO!\ DEC1SIO!\S

Complaint 124 FTC.

EXHIBIT B

Nutrition 21 1010 Turquoise' SoU Diego, Dliforn41 92109 . (619) 48&1021

Decl.mber 1991

WEIGHT LOSS, FAT LOSS AND MUSCLE LOSS

How to Break the String of Yo- Yo !Jietsrn \yndk tf' rolum NlJlnliorr Nno dated

OIobe '6, 1991. the ement nutrtionit Dr. JeaMayerstate5.

"'videTcrsho that the a.OUIt of fatSlorec in the boy iIcrea with t"d, cydeof ' p-iU.d-dc'W dJetig. YVen a pelos weight. bolh far and C".use tisue areshe- \-nen rhe weight i5 put back. however.

it te!\d. to be made up of a gTf'ater propor-tion of fat and Jes musle, leavig the pe-wn '!after' th"It'ver

Cor.ider 5-fool-5 woman weigrug 145pOll.!1ds . of which 51 pods ue filt, or J5pecent of her tota boy weigh!. Afler diet-ing lor a few monW. she k e5 20 pol.d.

13 11 the for. of fat,id the re51 "- IDll!e

t:\W aId water. She nOW weigNi 125pour,ci. irduding .3 p':Hmds /30 ,?,cent) offat. D\rig th flex! sb: monW, however!.e losl weight CTt"p. bad. But Ll-e rega.edweighl is compo of i7 poUJds of fat afldoNY wee fXumi of UHlscJe t'.sue afld

water, Thw, 110' woman weighs w!\t shedid ongmaly, but he' cag more fat-55 PJW'ds , or 3S perCeflf, Each time u,e cycleis rl?a! , she' s lihJy!o beome ' (aMer"

CLV Y, nI KEY TO BREKIG TH5 DIS-

COVRGrNG CYCLE OF EVE ORE FATEV LES Ml...SCLE, IS LOrJ'G FAT WH!LEPREER\'L' G-R fVfN f!'CREASIJ'fVSCLE. (A mott' aC(1ale term is leafl \xv

r.a ,,'rjch includes flot ol\y IDllcle , but aLs

crgar' ..5Ue s'u,r. as hearl . liver, kidney, etc.)nus is pr(' y wh.t Dr Cilberl Kaat' anc rus

c;);te"b- I. ac jeveo T! a rpcenuy compJI'!l" srudya! ,,'d. r:.. on October 1; at !hl' a n., ua I

:T!. ,r;; of lhe AmE'rican Aging Assoc:atlor,Orw ' u"dred furv mt'D ard w"mc'r w!.re Jsk..

C' /C'Lr, cr, a weigJ1 loss chJ .1V ROU\!,hJV:W Ii ""' ere

given supplem 1. Chomium Pico!ile (2 Of40 tnaO'gra.r chor:u. daiy), whie th othergO( do placebo. n.y were no pl.ced- on iUyspec die! or exercise reg:men, although mostwere trng to la wrght. I\either the volW'r

nor tieir docol" knew who was gettg L'Ie

chrrum wh.ch IJde it a " double-blid studyNte! 72 dar:, were the impres:vt' reults.

k,",,"

H be

11, cnatges In the placebo gro,-p were lI..ig-nic,ml However 111' Chrorr, ium Picour.te 8'OIJp.

or. Jge, !05t over 4 pcl.nd5 of jar wh.Je ga.:_I"J.'g

near::- a pound a.'d a :-,all 01 leaD

!,,

5c1e A ,Phv51Jue E.'1, ar, emer, : 0:' 3 6 ;)l:ncs

n,, ' o;Jc r peoFie If' :). 15 SI:.d:v ':n erag'e d e 5

d t'v":,, r1er I.;"ar :1.. .vounger ;:e''' F't' ,a'aogeC,JfI:n'.I d 0" pagr

,1 "W-

5701C'S

Page 15: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

NGTRlTION 21 , ET AL.

J 5 'B O.j J.. - -i L j

Complaint

EXHIBIT B

Tl.,\,_ o: c'--- ;:E, ::R_ ;:',1);:

Chromium Picolinate 'l1d Diabetes I Journal ReviEs Studies I Pigs Slim DoW1

NOTED PHYSICIANRECOM."'ENDS CHROMIUMPIC OLIN ATE FOR DIABETIC

PATIENTSoq advi tny dibebc patif1 to supplemenl

ttAr diet witl . 200 miaog a d.y taJI" ofWomJwn pirolite, .1 supplement avaable .t

'" lcx slaTes and ph.aci It m., C:I"

mJe if easier 10 contrl sugar 1 1!1s.

t-th th05 word. I5don crJeJd. M.joined the growig w:1 of rnedca authorities whoendor'!! the heaJt. ben.efits of ChmiumPiC'lina!e. The guole is from hi new bok., BES TRTM (Simon ok 5cwtl. - 1991).

Dr. Rosenfeld is ii clca pro!(5r of medciNew YOIk HosiW-Come Medca Cen

Wa. CCt'tator on th Jong-l'ng, natiorW Syndjc:ared tdevion .seo: M.gi oI 3ut.or 0/ ller tDp-

orfnut:on aM heath

-"'

l.uthrs whD endoI' IM supeores-o( biologc.y .n:tive ChomilJfe: rndude Jeffey f1, M.D., THMJ PROCRA &: Row Pub-Il . 199); SN!ldon SaUl Hendler, M.

P\p.

, "

. DORS' VJ AM A.JtL "i.ENCYC1PEDLA , (Simon l99;"fEJ'N ' Hel:u M. , TH

PRICITN -PU- 1St.'" Ma' s Pre199);R.d Hoffu M.D., TH DORS BOK

ME KEDfE (R&l Press-I59J;r\m M. ' \ltir, M.D.. HOW TO LeEIIGm wrOll DIFG oM 99 SECRE

,). LONGER HEL THR Ll (Pips

ter

~~~,.. .

NUON JOURAL9fIrPf- MJON, m !'ew, 01 th claJ

. .

witR Jt5 o1. l!Q. wjh.ThJaw Ls the cl:-nanooof terrJON A y of

r:- ye MI'\.bUC! tlon ' !t?';(speaJ tmportC' te

lnw.!: u. it iath R. .ca'tifkdedC3te tD tM ro !.\.t ireadJet J'ta.es of nut": or,aJ far.rs are !!ffiC"J:::Cu:;

n'-:T,

.: ''::,

l.'' "c'

Dr. Br Leibovitz , edHor, says, ru f=of TI JOURI\AL OF APPUED 1.ON 011 rupplemta rnc: ar rncrnutrent5 irthe pr vcncon .md b-atIen of lia. il weLl .Jin the rntcC' of optim.u health An eTor-

mow, a. ever-iTcra.ing vO!WIe of data support th C"pt.

The r of clca tr rerted rup-pleIC1tat:on with Ovomium rwlite- rvua to se d101eter! and LDL

chole5terol

- redua eJevated blOC suga If"els a.'1g1ycmted oglobi.., iI dibebcs

- 5J tJy reuC1 bay fat aId mus in exering individua

Bewe of its abity to the actvity of

Lrul the olde In the Jou. Sl.es th1 ad-dition di applitioN fm O\u.,PiC"olitP aUt bo EC1d, IO.lch :u

- lmprnved ou heag- imprvN U:unc - i.prnd 1m fuon

. reuC rik"ofhea' c- - : c

:.

PIGS ON O-OMWM

PICOLINAn: LOSE FAT GA, MUSCLE

0u1. PIte ruPP!emte pig h.d21'11e Gl fat an i% more muse th unauppJe: pi Krg to 4 repcrt de!V'to tN Amer tion of A. Scen in

.A Ucon 'Wen th saL_e..of pfp: Sae ft. Sae livig condoons

An ye. tt aD are lie pip. Th O\umPilite suppemente pigJet al h.ad Jowe:c.les!erlev th ctmtTl.. GoU1 of.ASCen, VoL 69, Supp. 1)

IA. !. Soth Ti P;lge, a. T.L War

ducU th sty of Gl ctertk:: -I tbJ:en cl A. 5ce" ;ot Loui Sbt.l:rJvenity. In _th tr t!cNorlde, pirli aci, ar Chrou-Jur I:

ON)' I\lcm. ted wi!. O\um ::

?'.

co!ite SMwe f.!VQb!e re\O

.. ,

"" '1

- .' . .: - -"--

J1 amy CDtr . fwY'

00"" be couced wit. plgJct, two IJ .Stile Uruvety an ON it Or 5attsHy, /t ls reg ro bow L"'t vi.r the

bt:-, f.c.J eJ!ec C:e.'Jor'.stT l' for

.:.."\::-

r- ;:" l.- -.l ;

;":

o,"

Page 16: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Complaint 124 FTC.

EXHJBIT B

Diabetes: Chippe'tva Ir1diCI/S Benefit from Chromium Picoli"o.tt

DRAMATIC IMPROVEMENT IN TYE II DIABETICSAme.'l' C& !1djd. U" e5pealy vulI'd!.uble to

Typ D di Il'. Th lnCe. C1 of the CLSa5 hai.rK'TI'.ldraratc.ydu.:ng llJep,l:50yun

Bea:. G.rmium Pk'oli!l' J"u' eJeya:edbloo sugu in claJ st'Jdies lot Mere)' H05pita i1Sa Diego, Dr G. EYaN CQ!'ducted U1 irormtral with Eve cr'pptd fn :. nortem .Mesta . ormaJ non-dbec bloo sugu rudiIpl1ge bttwee!1 t( U1 120 migams/dt'la

Supplem lation with 200 microgr.u a doy ofc.om.wn frm Chmium Pico1ile proouced

impre5jvl'reu1t5

11. 1' potmtiaJ hea.t. beneF. so 5trJd thta fu $Ue srucy w\ be 'J."\dO'.. il jaT1\wyThe !"wt: of t!l' preli.i'1.H)' srudy a.e edu1edlor p'.JoLiCJton i. \-'ERV IOL'R.",' AL

MillCL'"Ei., '.cvembe.

rMRT At"'! "iOTE. Si.Cl' ChcmiwnPicoli.a l' m y 'eCuce the rt'Guiement for in-swir or diabetic d."'g'. aU diabecs, wheU\erTyp I or Typ U. sl'ouJd ta ChomlumPirolile O"'1.Y u.cer til' direcon of thirici

8LOOO SUGAR (mo 8E.NEFICtL , PERCENT;START CHANGE CHANCiE:

Mo.

'''

19' ;9.5;.':lFerra

"'-

. 1Fem.e' 22' 61.6%

Fam.e

,,.

30,

FamaJ 280'..)n. 11C!a nrU DI"'r., '" and 251Jn.ts '=l.lll61t1d., HII

irlo in hal bo &dUtIJ down..

b) Th h& . o'kloc dru wNl' "U ro be tiue,) 1M dtow Ie 1.j1 ar. .r week. SI' ?fodad ra"l wooldbe "-;"

Nt.JooI

. -

BREAKING THE STRlNG OF YO-YO DIETING(contiued frorn pilge 1)

age 361 which i. wl'y tJ study was repor1ed atth Americar Ag'. ng Asation meeting

Chomium L. Ul .sbaJ numen! that i. l."'

short supply in 90% of tyicaJ L'S d;e!: So t:

thes silple rue\ 10 brw rne yo-yo syr,drome

CHJOMIUM PICOLINATI Take daily, 200 1040 m.aog0U to presO:rve muscie wh.i.e you

wei

FAT: SlOp JtOMg it C'.:t1ng da:.y ccn'su.ptJon:o :eH than ;c oi daiiy caior.

FA T: SUr1 bumi.g it by e:re irg al :eal

m;T"":! por d"y a ie"si lotU day.s ,';r "'MC4,RBOr;YDR.J.IT E..: fresl1 :

..;:

'e:;e a:-:dand "'nele gra,... p,odL;C rugh l!, c,e:ar:fiber Cui wav Go...n on fC0CS :I', onIJI:',

sugar

PROTEIN: E.t moderale olcurHS bu! make SI..IH'

very Jow fat or !'o fat as in ski mi ornon. r..IYOg'..

Although pre5rvng !Ju.le i. of oV!.diJg im.portace I. sol.ing e yrryo diet prob!

ChOlI. PiCOL;n.ale h. oL'1er imporu'1t -at..

tnb..h'5

--rt'r.-:ng or en!1a: cng mu.e, it main!.or :,..crease tiw melabc c rale rr,akig weigh( 105eilleI

-5ign'lCaILyc;'ol te:ol

10",. e1"-..'18 e.!evare- ser'.i

--,gr:icanl:.. !o' '5 J:",j s:.ga!

e:?ing 10 cor, tTol "pre::le A pea aJ,Y

r:e rexr: rE" "Fr"t::e aLY sugaICTa."Ugs ll10

Page 17: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

NuTRITIO"l21 , ET AL.

Complaint

EXHIBIT B

--- ----

ProtrohoTlal ,\1atmals Aradab!t

--- --- ---

CHROMI PICOLINATELose the Fat;

Keep the Muscle

"T r1""

- .

"v"

--" " y,..,.

,ODor.a

Fie ue rc..' ava.blf to distr:bul:)r' a.'1reter of Ovom.'.l Pillre produc.

1. A vivi w-a-bl. WL thtpr G-0M..'M P A TE-'"t.FatKnthMus"2. A ..eight Lo folcIT W! pick- up th

r: '1 tr. Fat but Ker thMuse" I:igned to fH into a r.-buires e1'.e!o or h e:tu rack thefolder C9L1'1 how Cvorr:., ?co!i'1t'work. to heJp re\J bcy fat whiJe r

in a.d muse-

3. A "'usle lolder Ce5aibe t.e SCeT-

tie tests that hcw signficant ga1r.s i.muse m.l re JJI from 5LFp!e ent oT1

with Chomium PiCOu.l\o:lte. W:t" the con.

tiuig conce aboul l-,eah.'1 n.urds 01a.bouc sll'oids. a we MId effKtvenutrent is an importt to athetesor a..,yone irlen red iz mal, tair\g iIstrns, lea1 ph)"ique The folders .udsheLfer ue avaible i. rea.n.bleqUaItities fret frm Sutntion 21

OuOIDIU! PicoUnate is a bio:og', caJ

ilctVt' form 01 trvaler, 1 chrom!' .;m 1.\"..: IS

p..tt'rlr.- by tie US Dopanmerll ofAgrC\Nr It l5 licer\ exclusIvely to

SutTtion21

NURITION 211010 Turquoise , Suite 335S.a Diego, CA 92109

C " 1"-' . C ,, C,,

. :

lL /h Fa:

. _

Jm KRHusk,

ChiVmlliJnPi!lnfle

"""J--o-

--"",

,aDr..,,-"io-

,J""

""''-'';-. !._- -

r""Jl;!

",IJ''tuJJ:r"-,r!,

"t-;b;:

""J1itl- Io.

.:..

t.fllr..1

-"". :."","".'

ODI.,;. "on....":'i..PI"",..pi ::1J

:.,:=,

""w.L ", i

Jl11

Page 18: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIO'\S

Complaint124F.TC.

EXHIBIT C

'I"J' i"

"''

:C (.'L ,

6X, J.' :f. r .1.n:.::;'Jr: 0/ 'h -...Yt c"S"

?:,,

Ie ""1",- 0 ,r .Ir.-.c 1"' c' :;, ,t; - :,1 ...e

", ;"'L. J.' L'l' '\JJC

"'.

" J.": .:"t'

!',

""-w

\ '" ;"

- '.'7 .

' - .- ;.' ;;.'::,

,.: 11

y . " "_..- j/"-

i.' .:JL' LvG"' - 'i.;.r

")d,.c. ,u.'i' , ""'r "1':;"1.'': ':")%3 ""'-:c.rl .v -

t'--:0 :.rrl;-

":, ':': '':'

, .L.-;r.

,:' "".

e""JIr Ir "& r, -0 'C. -

-"''::, "": '- ":':.

::e:- ;J.'7

dxc'

":-

0; -:..2" '"t - :.i Jr. c -'

. -. -

""u'

1,.0-' t.;:\ o. -.

~~~~~ - . -'

",,,"C

'; ..- .;' ;,':'- '-::'

l;

rr.JJ,;.L- '.i'\

-,""--rt.:-

--

:".c -

'':. -

7'- :'''o_

c: 0-.

-.-

,r.

.. ..

c-' :l"' -

..,-" ' ..

"X "c..

-:- .. '. - -" -:' ''. .., '-- :' , -

x.;"

:-;- -

..10

' .. - - -"

"i''0-,

, . ;--" : - - """ -', '

.i' ,,'J''' 'L'-c- J.""

",.

,-'l 'k' 1.'

' . .. -p.,-

eo.

-=. :. -;

":.;-:... I.

....

J:, 0,_

""-'

:-\J", l'r:

..,.

, C' .1: :r: \f;:r :r. cccT, C LL,;

;r "''r,,-

",,..

l!: 1e:.-

)...

, ,5-

-Y- ...x "?1'

,,, .;

i; O" ,")'k J.

' - ..:' - -.- ,,,

-,l:'

.. "' , '", '," ,(" ::"

:r".

-: . : .;,,

,'X: -

h0r"-

...",- - ,"$.-' '

Y:'

._.._ ,:... '" -

":r)-' '- lcL'

?:: :,!:

:;:c

ll."

,-- ,"' '':;

'J:,

,, ' -,, ""..

rr' S..

,.,-- "

e-.r

""'-'=--- . :- ",::,

Jt C "",

,,; , "..

" 1': j; ' J.

,-...,

.c,

':' ,,,, , ,'"

1.C'': .

(-' '"'' ",.

..r :"''k' ' "::a

.. :;, ' "-":- -' _ ':\'

:; Co

- .. ' ;'" " , ...

2; -

.' - ! _

''Tt: .:

, - ... ,.

c;-

y..:'.

.:c-..

, - -:-" -". " ' . '-

't:

. , :.

c,",,

=.-

)c

-.- ..",.,.:, ---- ", -,"

"'r--

. ", ' .: -'-- -.,. ,---. '

.x:

", ' . "., '-

0.' -

' - , .:-"'. -:.=:

;J'i.:

, '- .,-:-" , :.-::', :,

- -c

' - - ,

, c

, -

.1" .

; '- . , -

:1",

-,,,' ..,, ,: " - ' ,,,' ., (- .--,-'", . - '- ', - - .

c ':..

S7:"IN C/"'--

Page 19: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

NUTRITI01' 21 , ET AL

EXHIBIT C

LI1I!I

~~~

r,"-J, ih:. :sc

'TlJ Ef.c. I..

": '

r:" T...J"nr."e.ii' ;"D

:r, 'J"'': ''J.-cCl'' :s.c \1l.1t "1ng l),

hll"ddiJi\2

-'

oel.fI .'.;"CQ" ,

,";

-cr.."

1.:"U;oIx:

.:'"1' , I.,:.!'i ';.J. mpa., lIl!Itr1r1

,:' :'

i,:,

::,:

.JS:;1). '"'1.

.aL" :r)

~~~~

.i11.)

''),

1 !rc" l,, :c.o'i(I

':.

:J,J:w \I:rt, ;:'x6f1 !ai "E (' ) If.:

' "'~~~

.L"i'1;g, Dhx? IRe:j\ 'l If, :1"UJ Su')ll.b : ;1 ia:c ,t'GJ.J"" ,: 5 rrt\ lllkni

1...",=:-a !eGn tI(orrllcdes:..T.:Jrm'ni:

oj 1:1,1,;1..'1 S!'

, :-

c... rt c

,,;

n fur",)( '(Ie ;r ;rK.'!!

=trl u:U Je :. -Y.

'"

"' DJ'\ ..;;i r \oWl

rf(o"

"$-

. In:: .IL' iT\pe ' 1 1:n:l n ttLr

,,:-

:trl J ;:C".: . 'tLC ,'1 1 rJ\ r':t;g ,1

:eJt"J'f:i) ICU"'1.. i"i'.r(M~'

!'~:"

IrUII..1l

fiJL", 'frttd;! :JL

"")

,jlJ''Ie ref) C,p J."th", l. L':-

J.:i OI

:'":"

lIJ', ;; 6e lci I""

t.), b!Jdre-."":liLml'

-''

LJ, .

,,'

,ttI\OCIthm:G)JT

'p?, ;j,

cgt,

;=m:' '',ti LIlu tllji!II:!5XJ "e:I1\:Ir8 1t!1:1 1I ;;r, txtJg::rin- BUI'i "",r1g .D'" a1T:' 1T, 6"tu LfIfUr. 'f!!1' --'IJ , n h.

jj,

- We i/iD

e1-:biiX

Complain!

.t-1"":O"Jiilfrl..i:o,i(!", t:,'L'U't.: ::,

\!:,.'

I Z, X-.o' , J1 .1 :::lI,r x:r, :J, :'C:"- ;' L

L:, ;'L""-- ?ac. ,J"" LLY:ti;iJ'

, ,

COx:ro",

R"f,"J, :L"! rc'-'ic:" S'- ".:c\ :i).If, -r"iJ'::' , ::vr.(ra;r: ;I:":':-X

:;--...

"5 )(' :.:h S CI";-1 :;i ,.."

":.

,,'''LJ :,,

;r" jVa'" l!tiI.1J '- '".1' J!": 'K:,

ie

;,,

~J,"c-vi""'

-:' : :"

7'..' V.:

.:.p

lb ma: ;('J,j:r,JJc.T 1

!;" :.";,

Ic-"'1rrJ () or,

,~,

.:,crJ::c , Cor,

.y:

0,;-, 1: 'c ': Jr;, .:",ura I:t , I ,11."; .)r. .r;' , -c-' .. ,-T

l"C(' c.J

.' ,

J ,;,:r.'q;:'L'

"'_

:.i:::J:?-:

'::,

le;' ,1'-':'

l" ,-c f"Cl t': L,"' rl"Y': ".- :i

:':. :''-,,:,

":":"" or,' J1I L, :i :'\ci.:Jurr,, "G, -'.J

. -

C-..'J

'::

:.;ln'. .:'',,'C:005?-X:'

,:U' (11 ,,1J T1.l\ n,e (r)1 , T- ---' -:\f

-:"irr","'!1 , 'T, ilS. 'h Ii,l: 91t o'L' .;,.( J. :.

JI" ,

\ ,

ieJ;T :_ IT"'J'; k c ' J.- :,-- . . -cc'

, ;-:-

-I :i

'. 'j)' ::':-:' - '- -:;;-' ' :.",.."

..c ":cPL J:1... J1o""".l" .s X:""

-:"'

;e" - :: L"-.: 0 :1 J,)'- , J.'

,,"

;,L,:rJ.

0' C"!L:l.' :n,= r:iC'roJ

';'

''JUO, lK,:e:.

..,

'1'L.

::; ..

; i)'

In brief L 5f-j ;r. i. '1;1" DI':ur G L' :l

'L' \" :or

~~~

he: dJ QJ. "".t 11

o\o rereDlr;Li d-. a; lor prtpt iJ,s; fu,1(:O L' en ;.

",pp

C'- \rr,fOJ 6t" t' :f n 'no.m

~~~

.w" J."1C :'.;\

rOI De ;-\ t',

':(",

;U)(N.lt" J: 'fX, ple

, U,IO ;'

~~~-- -

Carond

')

,. J Pdb

')

nC' H n15 ""u-

' .

Il D,,

--.:. ~~~~""' ..-:"""- ,:-

S70U-;J

- -

't''

::-

- .J -

"" - --- '-' -,- --, -'- --'._----------. --"' .._- . - - -"- ,. -.--------

w_-

--., --'-. -,-,-,-- ------ ----- - -.--- --- , . - ..'- -

Page 20: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSIOK DECISI00lS

- "".:'''Cr' !.rL' .1.,

- - : "-

,r' :':;cW

., --"". ' :.- ,

r", ,,c..' "uW,,. ".J

' - ,;. :!" - ,

:o: ,j Oc . ,,11plJl'1r' ,;.. " - c

"" :

'i:'::.1 jrfGr:L""

'': ' '"'":-

,.1-: :.a'

..

111, '",1 :' .J.. "-'L"":, rc.',

rJ\t W"10L'rtLM !IOr

.:.:.. ''-

,;rdx&.":;':'-~C1 'j"rrJ' 1e'J JJ..:.

;..-:;,,

r:..

.:. ,,..;,,

J.;'

,::..

10"':",

,;

\ .1

: , .:..

J.' .

;"'.. -

1r.

--':

.L'C ,

..". ' . - , . "-

t\'.Ii'o

. , ( ,.- .

.1" . - 2."f

-.- : - \-...... :... -:_'"

f .:..1f :.'t V";L;

- -'':.., -'

":,I:O

":- , -

'i Jm,-;,:

.;

rw- J .

" .:.

-:o

-,-:

'.r", ..,.J "":1r.r

.:-:.

r,;-:J::.;,

,,,. ',*,

ce 1ri1 d'i' JW i.r, .",

-,", "

"7,= 1"

"""

c .

:: I

."

'i.':

.- :.?,

L( ,"-'';:'t .l.

: - .;, ::..

TI';"J'- ; 1\' J?' """

;'- ,?,

":c- ":l.no\\ l'",,,,;'': -, ,"c

"",;.-

i' ("

e'$ .ntuLHriW

""' :'

7C.J''; \.L'

efJ i: "".1I',dL'!li

.:,",

il J." f ii .J'

s.-.r..1:tl 5 !) I?C'J r.. ro 11 e. L",,

1" li' 'Jrtr.x c:.p

' ' ' :"

":r"'

,. ,

::V,(rJe.'" P,CCL

, J. - . ' J(C J - J.' r-..,i':! '.

":'

.A . "J r. c '

'': ","

,-c...:i, u.J':""' "'''.i;:_.::_

.,.,

X;-'&

..\i

':,

;,rX:,'rl !-l;6' If '\'tJuml::' Irri:

"-' ;\p,

'1e

~~~

JCw.g.-C:U,0' .

.."'

JJI' c'e p1i;, jL/ ;c(", \ rJ' , le ;;,

:',

.;"? 1 r.1 'i, ie ;)rh :T

.. .;: " .:"

, rn ",c' ?" :1,

""i!oo. ::\rJI':: i",

':'

:::"00Y.-"J", ::::"u,

';"".:=

.. :J: :Clr,

, .~~~

.1 Jh,:1'

CompJaint

EXHIBIT C

124F.TC.

"- ( .. . "

J'

''-

r ,"C,n(:

':"\ - '. ':' ' "-'-' ' - ,:.: ' , ..

.:~:t' :i

"--

"1.', ::x

j)' -:

(:J.

, ..

. r

::,:;

.::,:J;;

'" ,

c't"'r

,, ':'

;):c

-.~~ . --, - : . . --.: .. ",--

';iA-Y -

- -

6':": "-?

..("

,)\1

,-,;:.' " ,

I :-

;'; ,

c. ' '?JL."'

\. '- -'

c '

-,, ::\""":,,:"'' ,

.L

:". '-,",' ,-, ,

2:':,

;.' , :-""' . - :.--- '"" :.

..o -

"': :..

..:'t:"\.,"

"bc ::.0,

,;-:- .. , : :.'

'-";..:t .:

"";

rv,

:.

\.l

.:

'Cc-

"e; -: ' ';i: -

:"-

-:..t3 . :', :L":' '

:: ""'- -

.: .1- .i"-'

'':

-:r: - " 0

.: . --..;; -.. . " ,

X:1c.. r:--

"-" .).:'?~~~

, j nc:

-:-, ''-,(',

l":,,;N'

\.

..,,:( 't e"'''

;.

.1'- (.l-cc

- - - , ,,:

,:w.

::c 't :J,:O:

,::-

?'C

- _

=UT"fC ,.:; ' WNC; ,,;:1. -Da- J.-

";

.3 ::x'

,,;..:"

J.- :o'

-; ;:".. ''-

II

i.ol1""""' ", ;,i b.

.. , "",

'" in ;

".. ",. ,-.,"-,_..

A"",,.."o'o"oc o..,

Iod,..

,;..",

:-.z: 'O" '-= ,..

..,

r' ,..,,,,- 1"1

Page 21: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

NUTRITION 21 , ET AL.

Complaint

EXHIBIT D

!o i;

.' "..

. J."'..: ':- "0l!; ..LS: Jf

-"....r.l Jr- ..Ju.'T5i;1 :'7

, ;:

oo.J.(!t'ifJ:,"

' );,: ...-:.

ii J\f jt. ,

w-,..\OOg .wkl

e,,-...

,,,

1,,,-!!;l,,,.- ""iI-OC.l 'L1 l rf\

""- .-.-

1\t;" :J'

~~~~ ' -

iQ-'r:

:.,

r.::ni..w, jX-

;;':', ~~~

1rJ r J

...

,1ut.."'.i.:tI c-.'OWi

~~~

roortbn1x'

.." :;"

p:Ja.:-pE-:k.'1 J.I;r.'5',.;"!:OT"

. ,

r. .: SUCl

11-""..c... Ib"

""--'",,,,,

'"gr.., rl,:'

':'

crlI .JJSI(:I' &rrIDt:.rg "t!/, tn,,

\ p

.:!n:r.J

:iJ10Jum

-"",.;q..""''..

r...

;;

It:h' 11 rcLHItSLJ , IX'""m:i j:ui,

~~~

.!iFc:u=

.. .- ..

C'.

=-

"",,..,,0.

"" ,

""0 ",9'-"'_"

. r7 :s J, -

"-

re, .a:.:: ::--

- "'

,:i

ttc;e:o:i f'"" gr!

:' : =-_ - ,

OY ..

"'" =:".

::J.'\::"-'-::t'''

:,- "-"':'-. _

o:"7'& :'7"

. '

-a '

;-'- " -- ;"

":'.c ' i:::

:-- .... '

"' lo ,-r

- -"""--"

Q -

U7'J

::'

Page 22: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

..:-

:0' ;; I if l-Ll.t.f lJ

;;. '::

:o.:kca: 7'

'-.l. r:..' 6c-.::j"::J("'.rf"..

:::hrommn

~~~

.'lr.; "="'lDd1le' :"":1 117 VJl1iX:f"~E (J

lci '.I'

.:': \. ", ,;" :"

r'lj:;:qn n \J'

'! "Y - :;, 'f B(U...'

~~~

1'..te ,"C"" J;, n ..

=:

.,t

rith C"Jr jie.. k:rr !r",'1.Jxd'JUT1lIlt,..a :c,bo..-w

r_I,...s...-o ,,. r.--

---.,.

J.. Jv fj'-pJ.... ""..b7

.,...", p;'''-

__n,., Th ..1--

-""_"'""."",/"_

'''a,.'',,;,

.""....

WI """01.... r1 .!_I ... ,I....Uj..,,..,,fwlo--,n,;rip,._ 1.do.,.,,oN/.,"n;"""""""''k_''

~~~

rr..:R:io-.rA7"".;P-1. .TJ.V1,'8trd5t'

g"'

=tl

\ -

"I"".leoJurnITn'J d7C,W) Cxf- rr r( 'q:H':'

I'th :''qI,,g' tt ih

ff ;=w2\ljilC1 c1;

~~~

!.1g lhr;v!7.J:m u11.th fu rii'

!:\=-

I"",

='""

!Jzl.ng.nciC.h:"..rP=.J 1m WJ ta If re ru'b rw r;,r.10 O'li J.

;m- ,T_'j';; "'1:r c.':J= JJ. IfRjn\! qLJ ci

..11(! J:runo xU J'i :.cJ. :HJC:!Jr, ;r JX r,

";: - - ':!.

"'lIl1':li1Jf"JLC:

'':':'

Jr-: I(.:

.:' '''-

'IX:L (;Jer,cld"0rL, "..i;r:"- r:t1

""; ,,

Co"'-...

"'"" --.

"'..,J '0:.

",=

R.io:m!CP\11

",. -,- :,' ..'

Lcc..

'=::,

'-7...

:":' : ::': .

,",, (o ",", ..'u'"

Tn'- I"r-;c' ".J"C " ,,I n , 0'1-1

Comp1aint124F. TC.

EXHIBIT D

:. ,

:1' ; ;w \;I

.:$

J'.."

7'.';lIi.tI-m) Jf6

::'"

-:JL: 1' C:m. dd-Jr:JS g;'O I8\iI?:-c. .w' iJ r:dlmg-e

!''

=(J::i IO\Z3)

-;,;

:t 5r CU rI j IU 1lW;j;t" JlJi: h.!mJ:+'rvg!l., 110i

If.. . . . . B

..

i.,

--.-.-"."

../o",;."'

Fa"''' I* f/- J.. .. d""',up

....,- ,.""..

O""p"-

::- ..,

JQ"G""--""i,.

"._""' p"'

''- i(r

~~~~

urg or 1T,J'TWJ SI \01:', J= i"-gcn:JJ.'T('C3.e Of

:-:"

, '5!:sd:.Slr1tI 'i, r;a. :.Qj'hQD

~~~

7JU7G

Page 23: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

"ITRITION 21 , ET AL

Comp1aint

EXHIBIT D

Tb

," -

:.' JL.. C-.

-:: ' :.'.

iL' ,:h :'r ":::. I ?

;. ,,

t.'ru1tft'

'''

rl/:):))

--1EIN"''''' O,:t;,., . '

. . . . . .. . . ' . )\:':

cr. "

1:'

''' .

G", '

'; - ,.- .. '-,'"", ,-.

";.J

" ' . ' ' ,

Tb ()1O , J.":;

,,,.j

rr- ..;(tr.,9'Ki5., Ft:;. ' n."1&i L!'".er'

Tbt1II."I , tlm

- -

\ ,r",,,,

Pr'k

;:" :.'

.",Ht"",.R

:.I , fl;lI,. .i

.. ,

1bltS. ,'fr'. t";",I:.'

CJ.illil-J'\IJ,R:0Ih': , 7"f(

"',

Sf\:s.:. \trF'::, \.r' :'.i'T''I, .5!':

\WI.

RxJ. :J 15L"O&' l.-.

..._

8-"

" "

:!:""r:JliJO, '1.ur'ci ""4'" ,,m:\I.; "Oli"G': JIJ'T,Pci ;\1J.K J:f" :'J

~~~~ ..,.. ;::' :. ~~~ :;..;;

.o:-

-.- ...:

Ie.

\\)

d'Bl ;WlJ, gdiJ': I'JrTL.

:;-,

r."l

.,

tbeor' ",-zrughghIeLf, i.kihcrr"" Ic"':"i.iL.':?"1/lurr..-c , uI ' ",ne DR-'O1umPxL.1:! lo;Al1t;l;t:CJl:it.5:rod,.-v.r ; \(bo -.\)t ta - CJ (Du. \S\De ""r.asilJ.1/ t'l \"'-"r!f'I''':i:'"in ~:'r " to ).., '9ro

\, ~~~""' \

rr; r;n ':r;rJW \"''' UII.

:-..-= :':"-. ,

:I ..

-;.-- - -.:=:. ::;-

1'frI!UIHrt)lemOwJIJf\1J!. ,"CLG g.Fmt"i,

'; ;" :?:

IfFxTcds!.mrT /U;".rif !!ioSH

::;:'

Ru"nej'Tar;:IM\.-S

;:-

oi --

=.-:.:~~~~

\I " "hf,J' r1l\ma ,.ar""'ttJW -1 1t J. ...e 0: G'.lllf ?1 J. JX

.."

"l_I'.E,r ..zr."\lJ-;\ pc "

:y

cc,

:"\ :';::

.c

':'\

GO T?IBl"\l. ".\ 'K1.\CV1cr:!C\lU )t-: cr: D'IIC'E-" l.C( t-C:

-:,,

:t:i

~~~

r,

..'

" :':f"W' l!:C :::L' .I :l ;r:",

:._ :"-

Z:l.":;'-c:"

:, ':'' " .:' ""..; :,,(',

e,J :r:, 'f :-':.l II 1:1"-,

. ; -

"".c

:,-,":, - '\: -

"":rL..

S7,)0'

Page 24: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Complaint124 FTC.

EXHIBIT D

--,,-- . "

C1SO 1k' crr,\\pIlC:"\ :"I"" .'"\' n:L," Cf

"-\:

r:i,I( c.

'';' :: ':

" 1.-: .L -o:'

-:.

..7: \'lCi('CCL

dk -,r J'.A -:J\:r; .:OO

,,-'

; 1'.J, . ttr. hN'GT! r_ t. f.: ,".2 ,'r Vt rx 6' 11lh,

&JI",'f, cr. r,,""'1 ' i JI'!J"T-trr. lIL- dlf L,i.gx:r IJ.J.r:or, ::J~"a:,(J,n;u=r.; i1 eIT

OIr.lI, ((l\cid(I/-..,(f-;pre ",!rieriDChJuJ f'1

.j

8.c:. 1t C

Ir :i 1J", ':N f, ;",(t J'.. !N j \ J! , PICW rx i'. ",'1plOUn r. .J! 'j t-J;:hjl

, .

..::J'f .:'u. IW' JYflf\J

1CUllblt;

G1r,:rlQ'L "J.'::O\,(

.J"''' J.':i \t. ,'Lg.

" ;, :.

", l"":-:.l,ldlTc'(.;P" .ic:l f:f :D\!l ;ft'_ lI! J ,;:1- ' .lLl"' 8."

') rlk'J.. l .

.;,' , ::

\ .i

(,-

'C: J'''

.:.

",\t!""l1 rLJl,:X.. l ci - ?fa:' ..r

' ,

-iI (T:,-

l"imdl p T':,: .'C/

..

-' :;C;.,ler :c (' rTr;WJ r: .::;n, J.

" -

, 4:t

.:

l:..1"- : ":.t

",,., ,

-,;"O o' ' ;:C:UrJ( l' J r J!_:-..;t l'.J. L:c ,-JJla '"lh, um.1, 1"iWi fo I1;!ct :.:.ihc..v.er'.1'O ;.f\\II)Icp j 1".lcr -:.J".J.D,pie\d.lr t/'iU"poUr": vi .

~~~

:u ..-'

,,:.-;: ,

:eu:th lH ri ICU."lC X1:I J , :.:cm St

L'1p1dJu:",'O XI r.J rc 'rJ. ::r' ...I.. "tf9dttl1 .nLmJ-e::J l.'rI Bu!:: :-'.JJJr.J.-. .Jlrj\'X I( (f h5 1Qc: ' !D CC f)' \.!" d UOl;U

C"""!JL; '1\;, J. ;"r

" '.

.. J'c .: r :,

""-'

Wo, j,cbJ , :N "(

.."',

;r, oj ', o' d. ut; or.; JI (.' .In"

\;:.

1:: "!he.J; ,('1

-;,

:il "Jn Ir iC\X J:CJ1l.'ou

C.\'DJ\., Px:

D Ke\,J\Li: .r.'r;,' 1"

""'

.-:.101 r(rc,;i "CC

":,

.l

\ Jr' l' -'

.:.

:;r 5;f :i.

""-'..'

,-,c. r1:XTJ'

2"" D\'1'\

--\

-:r-

",:,-:

:;t'. : chr:r

';''-;" "

X":U :, r. j

-'\

",r

.'.: - - ':-

:.1 :\ ,,,: Ji -

.:. "-

. l. -:

, - " -' , ' , "": . .: :.

:i

::,

".-r" f'ill,

.: ,..

:C ::d. ('lc 'T,;':ct: .l- LL-:-.:t' ii..

-:, :"'

if'

G:'\ \fr, : "! "e -:( 1 ;, r:,,;,:c

r::: I'J .':"f':i

-. ,

"n" t; , rli.J'1r.'C"( j,JC "''/'1:D:' UJ1: 1;,,(S- LJ':: ::i::. .JL:'7 :!i, -1(-.";.1"-

, '

I; J. .r.(r.JI.I ,"X .ll:: CI

':;

'1 01 lfr %' l'Yl.')

''-

J:.

.:

rl" iiU

' ';.

-:i!l -:rJ.. - t ..!J C -:..:lJi':u.: ';!'JL.s'-: If. W. ';''' :L:.

,, '

.!lI'::..CD,:r.i lI:i .J:..r. ":,L"'. "l

.'.

:'X"-'\e ",;'- ""l'

,"" ,

o';' J ;CI .l"'\,'

: .;,'""- ' ,

;;:Jr"

...

rof':'r:lI

:,, ;:jj ":.. :!,,:,

l:' c.. .:L

:"'; ,,-- , ;' --

l.": .J ' lor ,,

-',

:; ;J:i

- -

:;J:.- iJ:, ' 0:,: 6' -."J

''' .-:,')

-- i'

.'':

':)f

' _.

.l''':" ''JC:.

':"'

'W/ \'l;, :' ?.J!\ -l'X':- 0 'o

--" - ,

,:,,i,I",,

': :-:,..

'u;-, \rTl."..;UlTl."E1, rJr:o .lr:'r'I. ri;

,-,

.rr

~~~

,l 'fci'rr",:- " WJ

;"'';

L'OC

::j.

1m,; c,Q '.r-" ,if:f.u,l\0'.

'"(;,

n;, I' tJ m:w' ;.'.:h. , ?/!w-. '7:,i

"""';";'

-:J.'1-1,;a .t:. J',;

: ,

?r;""'

;,j . -.

""..",1J:d)"-

- '

''dI.r.c'!G' ::Ji,'', :.. .ire,"i,

-,' ;:'.: ' ,-,.",

Ii

;:''''

' (:(J J..

,.:

Ii,

""";, :",

.0'-"n.'0k I/.CJ 0""'" ..;n:;"n: . .'I.II

NlTRI1l0\ 21

- -- -- --

,"'ji! Sw", ;

. ') . . , ,, .. -

57:);)7S

Page 25: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

NVTRlTIO:-21 , ET AL

EXHIBIT D

.: 1 I:; .

""" =-.=,...

:11 o..

,. ;

:'C. -:..::r.:","

""";' -...

J.-.""...J

,..; ",,! ...

J"";I n:T"....:rL' J.=- 'U";"'

";"

"IIjlI., ::,,'t' ''Jtn,, 4!"" ::"-.J'

w,""""' -ol

"","",frn-

...

ur.J-;oo

..." "".

.Tt

""'',

..Ci''

'''' ''' "'' ''''''

.r"'

.. "" ,...,", "" .

'"0.'

'"

L ''';J.' ..ri,:J:a\I't'J:

. ;o'

'"'. \ ".:"' .. ..

-U -. ;,S-j .

' - . '"

,c.r"CD,J."

.: =: '

rr - :o-

;..

.-... r.

' - ;; -

-," J? :''':'II-

& J..'C..

' '.- ..,- ' ;.. -: '

.l:; 0_,,

,;.-.:..,:._

.i:,,'.. .:c;,, \C::

:.- .:..""

vuoJ""'.. M. """,;..y, ;Al,""',

"):.....' -,,.:..... '''" ..:;.:.

.J -

:.. ,,

'n-

..:_..=..-.. .-,- -:,,

, l- 't- ...3d.

""'' :'''.'

'1' "".

L-"''''

0 " .:0" " ''''

:""",- ""'

'''C-"' "'.lC

-W";. .o'='C' ..,I

'', ,,, ,,''' ",,

;:Sit,-.o

, .. , ", """"

. "' S ..

,;-,

"".."I, c. y.. .""x-=;;'=L"..: .r ;j,

..:

I:

..\

I. C'.u.""!l ..r;cc""o jlU"""'"n, "" Ck \cU I,,' ,; 11

- ,

""'1Z, .r

,'.'"

:T.r'

'''

''=O;,

="

C1l,

, "

:. c.,

LTRO

' " ,"". '

c .

Complaint

. ;

,--J" Z:' ""-o;....

' :":=-

::r:J' fl,

"'.."-'

Plf'

''.

J.'''=.

".'

J",, i \.1"'"'

. ""'" .

':""J')(.. -"""J',

::.

..'\i.--""";"L''' 'r;i:' ::;.r

:*. '':' ;'-:':-= '

\0.--,:a1 \J' ,Y, =",';J;.,v =n:.n

.,=,"".

=E:""!l

"(:""

S*'" "(r;t '

()::''''': ' '" .",, :;;..!:

(I!o. O:tfd

::=""""'''

''''CTI/J:

= "",,",'(. ,"'

I': \r.l::\"

:, ; ''

'c,

--'' '''':'

5L. ' !:.oi: tr:x

",'

"":'=iC . :\\!J

):,-

;:c;L,

"--

"" "l r-ie"= ,j ::.rr. c.'7-C, "",Y

'--=!,.-_

-o

-.

"YL ' c"'!l". ,-OQ ,-Y,, 'N , " ,1'"';'

- .

"\' C,"..- .A ,

.." :.. -. ",..-"

"'5. r:h

="" -":"" :" ;, ..'""-, ,-"

:-''-'J'i

"""-"" :- j-":. ' " - , :() ,,-: . ="

1.-,, u;, O""::

. -: '- : '" ,=, '.: ..' ':"="

C-

"' ""

i ::::r: ' - :2,

'"

J'_ ' "T'

"",;" ;;'''' ,

"c."'. ""r_",;

,'-

, ,,. :c 1

:-- ",-.

ec "CJu.'7 ;C-:;-.J Y'

"- :;-::-,

--"'C" 1V..-f_ ":.I!,,P '

,,-' "': '" "'

' , ...."" '0 199

' ,,,

c:J l,.r" ""ci:.-;",,-C """"i!=

~~~

iI",, I'-; 'I""

): ".:"

CO .r. :coi,c,U

'-,

""'L"'

"''"

o:"""iJ,..,.. s.-

""'

();.UI(T"

, B '"'

, '

!'JS;::,,-PAIDE:.

. .

' I

,-,- ,-.

Page 26: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COM\,ISSIO" DECISIONS

124 FTC

EXIIB IT E

Complaint

Nutrition 21Februny 1990

10lD Turquoise. S:J1l Diegu. CtiirorniJ 9::10:1 . IG J 9) .J8S- JO': J

Chromium Picolinate-The Results. Speak for Themselves

T'lo 'WeD designed, well aecuJed studies prow! thaI Chromium Picolinale accelerales musclegrowth ond reduces body fOL Such a s14lemenJ cannol be mack for any olher chromium compound.

v RichJrd P:Js.w;)!er , Ph.

A recent is.ue 01 :vUSCLE & FiT.'\iESSpresnted an ",tide calUr,g attention to tJ1(,

newly proven ar\boLic foie or Jor., i:JmBoy budders have beljeved for a long timethat chomium heJps build mLlcle Wr..c isnew is that scientists now have measured,during a cliniGil study, the actual gains (.'tchomium produces.

It no Jonger makes any difference wr..tpeple " thnk" about chomium or aoout tr.diferent forms of chromium becuse lhe factsan in- facts detennined by clinicaJ tests cor.ducted according to ac ptable seentdle

standards. And they have shown that oneform of ehromium ..hromium Picolir..te-doe accelerate muscle growth

11 article will discuss the srudjes showi."lgthat Chromium Pieo:ina:e is sped:cally eflee.tlve for building musee and promotir,g fae

loss.

THE FIRST STUDYTwo clinical studies exa:nined the elfeels of

Chromium Picoijr..te on body composjtion inyoung male athle!es. They were conductedrecntly at Bemidji Cvirmesol.) State UrJvrr.

sity U:lcer the direction of Dr, :v1uriel Cii:-.and GUY Otte Ten r"ale studen!s emoUed ina weight trai;c;"g col.rse were rJndom!:divided into two groups of five eacr. All

them workec out ier o m:r,utes twice a w(',,One gro'Jp rl' Cc' t'd c.l. ,)ITU,';:7, :':, 0:;,--1,

(:00 m;c-ograrr, s 0: J.).

-:,

J:r, c!aii:, wl":t' '

oL'"er get a ;:lacebo , J sirr, i:Jr looK: g C2pU:-

bu: wlt;,cut ar, \' Je cln' .ngi("':It'r, ls I: A..,. .:doubll biJ;'

':j' . , :.

Jt :S o' SC:;::',

nle ts were cOded so nelther t:'ie slude ts

II;e sccntists evaluating I em ;'ew who wasgethng Ihe c:-,:o:-lum. Body ccr.:erlt of f,,(ami \.sc:e . as ,..ei: as bice?s and calf cj,cum-ferences

",'

ere recorded a : tr,e start of l:'Le

study iJnd agaJr. aHer two weeks and SIXweeKs of supplement.tior..

At the e:lG of ehe s:"Jdy the ct-.Jnges in thestudents ' mc;scJe size and body fat wererneiJSLiree, The:l t)-.e code was broken and thesc:ent;sls learned for the first !:me which ofthe studenls had been taking ChromiumPicoiinate ane which ad received piacebos.

In six weex., the Ovomjum' Picolinate

group gained ar'. ave:-age of 3.5 pounds of leanbody mass, compared to oruv: 110 of a pour,in :he pliJcebo group Tru s cifierenc washig:1!Y sta' :Jst:caliy sign:heiJr'.

Wilen th researchrs analYZed all the dif-ferences between the two g:o ps, they ielt therE.wlts war:-antee fl.:ther st'Jdy with a larger

number of participants.

THE SECO TI STUDYThe second st"Jdv ::wo:vec 31 foctball

players dunng :h off- season n. ey a:1

er,gaged ::-, a weight ITairur,g program: fol.:

times a weeK , ar.e :'iour oer sesion, T.'Le ath-ietes "H'rl' cil' icec r,,:-,ce ;,,:1( ::-to :wo giOUpSone :L'ce:ved Cn:': um r' ico::",,:e ",.d lhl:!', cr J plJcc o ,

;', ,

"'JS a cO\.8:e-c-ii",

C\ ::k,

..\ '

,1r": c.' :Jr, WJS ce' urr'i:w,C'c c ,1 :"C J, : c S, \ '

'" -; ,"),

' !lc';, ' 5; cC C -- '' J S

....

.. I

: ,

,Ji ;', J: l ;: '

:-,

,,'c:

..- -, - ' ~~~ - -. -

L'-H'

Page 27: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

N1JTRITION 21 , ET AL.

Complaint

EXHIBIT E

Chromium PiLofinale -The Resulls SpE'akfor Tht!1I5ei.es

lean Xxy mass. cC.-?,, eC to 39 pounds ::-those gettir,g a placebo. This 44% g ealer in.crease is stalis::.:ily L'er'f s:gruf:CJr,

BODY FA T LOSSEven mere intriguir,g was he eiiect or.

body Eat The group that had bE'fl IJkingChromium Picolin.le aycraged a fJt :os. of 7

pounds. Tht was 22%, of tneir total body fatThe other group iost at! average of 22 pO'-r. ds,only 6% of their total boy fat. T.'.is differencE"als had a very rugh statisbcai sigrUficance

The anaboiic effect of goo c.,,omium rn.ltT:-

tJOn can readily be attributed tathe ilnownani3bcIic effects of the hor.one i:1ulin. Butthe fa! bum:ng result with CvomiumPicolinate. as Gerr.onstTatro in Dr. Cilrr, ar,stud)'. is nol so :-eadily p:-eeictable

A likely possibility is U' a! C!LemJl.:m PI-colinile erJLr.ces metabolism in "Drowf'. fatTni tye of adipose tissue :s fCL.nd or. theback and near many inlemal organs, 1: is arll.vated after a CirSohydrare-ric:1 mea; b:r acNin of events :h.: H' .lires :.:.lin ac:ion ona portion of the brain' known as t:..e h:rpo-tMamus P obably Chromi'.lm PiroLr..temakes the hypothalamus more ser.sitive te in-sul.

Activated brown fat raises the metabolicrate by rapidJy tuming falty acds and gener.ating heat. Thus, Chromium Picclir, ate maypromote. fat burning while aiding the syn-

thesis aId :-e(er.t:on of protein in m'.1clE:e:-.tainy an idea: state of afiai:-s for ' ocybuiJders

HOW tT WORKSP:col;n.r aCle IS a rr. ineral binder--

cfwIJIor- Ih.1 :5 produced in the human bOv:-om prcteir. it is exceptjoni11y effecve fo

?r:J:-, ot; g :he a:;sorptlOn anc C'llular uptakeci minerais such as zinc, lron, IDnganese, andCnOfT. lum 0:-, Gar, Evan., fonnerly a re-

JfCr. SClentlS: lor :he united States ' Depart-r;,en: of Ag:-ic.llt.lre and now a chemprofessor at Bemid)i State University, Lsprimarily responsible for demonstrJting the

sLlperb nutrition.J value of mineralplrcil:L

Chromium Picol:T1te is of specal mterestrlOrganlc sources o( chromium such asc:"ro:Tlc c;'"o,ide a e very poorIy ab.srbed,cr, lv abO'J; : /" of 1 % of an oral dose- Aru:r.st. d:es ccr.ducted bv Dr, Eva"- showed thatChromium r.i:1Rt was five to :0 times bet-

ter aoso-ed QI, rctai d tIn other forms of

c:-r:lr:iur;tes tedT)ll C)vor., :um pjco!in.te r;,olecule is hig

7 stable ar.d passes ac:oss ceJl membranesr:, uc." more readdy than inorgaruc chromIumTrJs . ;:1 cor,tras; to tr.e compound of(r.ro iu.'T ar. e r..aQn wrjc. Dr. Walter yjertzhas reported to be unlabJe, AmmaJ studjesaiso show th.t Chromium Pimlinte is excep-t:ona11y safe. Fears tht Chromium PicoUnatemight prove to)':c because of an antagonimbetween r, iaen and picoliruc ac;d are ground.less- The standard daiJy dos of ChromiumPicol:nale provides orJy 14 milligrarr..s. cf?Icoiir, ic "cie- less than :/lC of the amour,p,od' Jcee in he human body evIK cay!

Weight Control Results With Chromium PicolinateThe sharp reduction ;11 bod:' fat o:ed in

:he Bernie): Slale s:udy WJS remar"Jble iJ;',unant-iopated, ane sugge5ts ::'1at Ch:or., :Uj.Picoli.'lte may have value as iJ eiet aie

fullowing outstar,ding aile unec:uiVOCJ! casere:ul:s were rC?:J:-:ed bv J'JiiJ Ross . E,ec' t:\'eDirecor of Rec er- Sy stems

q,J- :!:"r,n. :J"

obes, Si: U!:

,),,"j

50!h "'oJ;r

fe. s;,

:.' .., .., , ", :;'

I-' r,he's s

".;.., ,... !)", , '

(1) Rr/'"ri c,, :u. jlj'Jr..!.., "i"-maJ " ,J,' i"..

r:; Shr oS,

HiSh iJlciJhol and tobacco col1sumphol1 115 alT

dult. T"ese sy"'ploms worse b fC!re meals(3; SiTe h

..

Ions history of ell '" c..1 hypo-

SI'fU"IT'," w:rh a,SOCT,"! l1' .md chnHlI;!:elJdaclres, d!:::ness ,"nti SUgi/T CT,"V!rlgS. Thes,

:,'''pton,s pe's,s ed !Jen dun rrg th past rlirre:"ClU5 of 5 b,'c we'ghr loss t;'ro"gh the OUt,.,""Ins . II()II'fIJI. program) Q proteIn Qr.u

(ollly! Jidf,n: Jose of Shape-l.1p (ChrQm;um

'" a ' j ! i:" ;, J a c.' e 5 :J';. rh, rr

-,.

- s. ".l, be ,

' .

. :c

,j "''- \ -

L ...

,.:

:CiJ m,

c).. .j .;.., .'oJ,

.JLJ'-

Page 28: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

Complaint

FEDERAL TRADE COMMISSIO?\ DECISIONS

124 FTC.

EXHIBIT F

Lose The Fat; Keep The 1Iuscle'Vith Chromium Picoliate.

Herf'; \n" You '\ d C romlumPiCOllnJle

' ,

rC'

I,nj 1\'

"I'

,,' .: ,

J' " ,r,:,.: ,, 'C' ,

LOSf Fa! and Keep -'Iusclf "llhChromium Picolinal

'",

I:,,,,r.e:

, , "", '

1 Jr,

,,,,. ;';,

C'.c,

, "

" ;C C"

" '\;",,,,

Chromium Picolmale Help \IJLnl.lLr.-\ '.ormal H al!h, \lelabolism

J", -

'I,

' c., r , "r. -

,,",

"" ..0'

ChromLum' nder uppILed rn -JU"

c1f-\dull D;e\, c J.l'-" ,

:""

cc,,

) , ::.-".,,,,,,"'

,c,c,,, cc, , ' r,

'nl ' he" "'uJ '

' "'

0''',nc C,ce:

- "

,r.

I,n":,

", " :,

' r ",

CHROMIBIPICOU"ATE

Cuil Qr rile .":urlllLn..1 (,p Li fRfJbro( ure

, '

HIJdol F"I ,n r -\m,

",,''

Dit ' \Urrilion 21 1 ' rio":'"''''SrrCfi- Pp.. ,m UI" U c.-'6 i LJ \ HH ..J

Page 29: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

NUTRlTION 21 , ET AL

Complaint

EXHIBIT G

Lose the Fat; Keep the Muscleith Chromium Picolinate

j;,

'f, ?;i; t?iif.-du, ' lJ;c r

'1",,'Th' "n!O'bk, , ,.." F.

h, ("n-ump"""'

' .

";" "c ' - t: " '''' f",

.! I ",

,.-. ,-,- ",,

" F, , - I.,,.I",,, II,"h,,, ""..",,,.

'I ,,, " I(.-u I

, \,.

" t. ".

",,," .

I"c"'

,.,

Hu r"

t 1" - (h,..m,um ,' ."1,,,.

.,,

- I!.

.",

,h"" """r ,t"

. "".

,,"1' '')111

i!il" "1l1l11l111"' . "0 rl /I "'frell"U """1/" /j 1111( , Ifr, 'J,. "/.1,,,,,, "II"'

\ '"

'woi/I) /,,,,,1 . ,r"rn 'I"" ",Iall'/ ur" '('In'" ,mti

'1IP' III"T:;,

Page 30: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COM\1ISSIO'J DECISIONS

Decision and Order 124FTC

DECISION A,\TI ORDER

The Federal Trade Commission , having initiated an investigationof certain acts and practices of the respondents named in the captionhereof, and the respondents having been furnished thereafter with acopy of a draft of the complaint which the Bureau of ConsumerProtection proposed to present to the Commission for itsconsideration and which , if issued by the Commission , would chargerespondents with violation ofthe Federal Trade Commission Act; and

The respondents , their attorney, and counsel for the Commissionhaving thereafter executed an agreement containing a consent orderan admission by the respondents of aJl the jurisdictional facts set forthin the aforesaid draft of complaint, a statement that the signing of saidagreement is for settlement purposes only and does not constitute anadmission by respondents that the law has been violated as aJleged insuch complaint , or that the facts as aJleged in such complaint , otherthan the jurisdictional facts, are true, and waivers and otherprovisions as required by the Commission s Rules; and

The Commission having thereafter considered the matter andhaving detennined that it had reason to believe that the respondentshave violated the said Act , and that a complaint should issue statingits charges in that respect, and having thereupon accepted the

executed consent agreement and placed such agreement on the publicrecord for a period of sixty (60) days , and having duly considered thecomments received , now in further confonnity with the proceduredescribed in Section 2. 34 of its Rules , the Commission hereby issuesits complaint , makes the foJlowing jurisdictional findings and entersthe following order:

1.Respondent Nutrition 21 is a limited partnership organizedexisting, and doing business under and by virtue of the laws of theState of California with its offce and principal place of business at1010 Turquoise St. , Suite 335 , San Diego , CA.

Respondent Selene Systems , Inc. is a corporation organizedexisting, and doing business under and by virtue of the laws of theState of California with its office and principal place of business at1010 Turquoise St. , Suite 335 , San Diego , CA. It is a general partnerof'Jutrition 21.

Respondent Herbert H. Boynton is President of Selene SystemsInc. , a corporation. He fonnulated , directed , and controlled the acts

Page 31: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

J\1lTRlTIO"l 21 , ET AL.

Decision and Ordcr

and practices of Nutrition 21 and Selene Systems , Inc. His address isthe same as that of Nutrition 21.

The Federal Trade Commission has jurisdiction of the subjectmatter of this proceeding and ofthe respondents , and the proceedingis in the public interest.

ORDER

DEFINITO'iS

For the purposes of this order:

1. "Competent and reliable scientifc evidence sha11 mean tests

analyses , research , studies , or other evidence based on the expertiseof professionals in the relevant arca, that has been conducted andevaluated in an objective manner by persons qualified to do so , usingprocedures genera11y accepted in the profession to yield accurate andreliable results.

2. "Purchaser for resale sha11 mean any purchaser or othertransferee of Chromium PicoJinate, or of the right or Jicense to se11

Chromium PicoJinate, either as Chromium Picolinate or as aningredient of any other product, other than respondents , who se11s , orwho has sold , Chromium Picolinate , either as Chromium Picolinateor as an ingredient of any other product , to other purchasers or toconsumers.

3. Unless otherwise specified respondents sha1l mean '\utrition, a limited partnership, Selene Systems , Inc. , a corporation , their

successors and assigns and their offcers; and Herbert H. Boyntonindividua11y and as an offcer of Nutrition 21 and Selene SystemsInc. ; and each ofthe abovc s agents , representatives , and employees.

4. "Commerce sha1l mean as defined in Section 4 ofthc FederalTrade Commission Act , 15 U, c. 44.

It is ordered That respondents, directly or through anycorporation , partnership, subsidiary, division, or other device, in

cmIDcction with the manufactUling, labeling, advertising, promotionoffering for sale , sale , or distribution of Chromium Picolinate or anyfood , dietary supplement , or drug, as " food" and "drug" are definedin Section 15 of the Federal Trade Commission Act , in or affecting

Page 32: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE C:OM'vTSSION DECISIONS

Decision and Order 124 FTC

commerce, shall not make anyexpressly or by implication , that:

representation, in any manner

A. Such product reduces body fat;B. Such product causes weight loss;C. Such product causes weight loss without dieting or exercise;D. Such product causes 10ng- tenn or permanent weight loss;E, Such product increases lean body mass or builds muscle;F. Such product increases human metabolism;G. Such product controls appetite or craving for sugar;H. Such product reduces serum cholesterol;I. Such product lowers elevated blood sugar levels;.T Such product is effective in the treatment or prevention of

diabetes; orK. Ninety percent or any number or percentage of U.S. adults do

not consume diets with sufficient chromium to support normal insulinfunction , resulting in increased risk of overweight, heart diseaseelevated blood fat, high blood pressure , diabetes , or any other adverseeffect on health, unless, at the time the representation is made

respondents possess and rely upon competent and reliable scientificevidence that substantiates the representation.

II.

It is further ordered That respondents , directly or through anycorporation , partnership, subsidiary, division , or other device, in

connection with the manufacturing, labeling, advertising, promotionoffering for sale , sale, or distribution of Chromium Picolinate or anyfood , dietary supplement , or drug, as " food" and " drug" are definedin Section 15 of the Federal Trade Commission Act , in or affectingcommerce, shall not make any representation, in any mannerexpressly or by implication , regarding the benefits , perfom1anceeffcacy, or safety of such product, unless, at the time the

representation is made , respondents possess and rely upon competentand reliable scientific evidence that substantiates the representation.

It is further ordered That respondents directly or through anycorporation , partnership, subsidiary, division, or other device, in

connection with the manufacturing, labeling, advertising, promotionoffering for sale , sale , or distribution of any product or program , in or

Page 33: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

NtTRlTION 21 , ET AL.

Decision and Order

affecting commerce , shan not misrepresent, in any maner, expressJyor by implication, the existence, contents, validity, results

conclusions , or interpretations of any test , study, or research.

IV.

It is further ordered That respondents shan send by certifiedmail , return receipt requested , a copy of the attached Exhibit A to:

A. Each purchaser for resaJe of Chromium Picolinate with whomrespondents have done business since January 1 1993 , within thirty(30) days of the date this order becomes final , to the extent that suchpurchasers are known to respondents through a diligent search oftheirrecords , including but not limited to computer files , sales records , andinventory lists. The mailing shan not include any other documents;and

B. For a period ofthree (3) years fonowing service of this ordereach purchaser for resale with whom respondents do business afterthe date of service of this order who has not previously received thenotice. Such notices shan be sent no Jater than the earliest of: (1) theexecution of a sales or licensing agreement or contract betweenrespondents and the prospective purchaser for resale; (2) the receiptand deposit of payment fTom a prospective purchaser for resale of anyconsideration in connection with the sale or licensing of chromiumpicolinate; or (3) the datc on which respondents first ship chromiumpicolinate to the purchaser for resale.

It is further ordered That respondents , and their successors andassigns , shan , for five (5) years after the last date of dissemination ofany representation covcrcd by this order, maintain and upon requestmake available to thc Federal Trade Commission for inspection andcopymg:

A. An advertisements and promotionaJ materials containing therepresentation;

B. An materials that were relied upon in disseminating thcrepresentation; and

C. An tests , reports , studies , surveys , demonstrations , or otherevidence in their possession or control that contradict, qualify, or caninto question the representation , or the basis relied upon for the

Page 34: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE CO'vMISSIOJ\ DECISIOJ\S

Decision and Order 124 F. T.C.

representation, including complaints and other communications withconsumers or with governental or consumer protectionorganizations.

VI.

It is further ordered That respondents shal1 notify the FederalTrade Commission at least thirty (30) days prior to any proposedchange in the partnership or corporation(s), that may affectcompliance obligations arising under this order, including but notlimited to a dissolution , assignent, sale , merger, or other action thatwould result in the emergence of a successor corporation; the creationor dissolution of a subsidiary, parent , or affliate that engagcs in anyacts or practices subj ect to this order; the proposed fiing of abankptcy petition; or a change in the partnership or corporationnamc or address. Providcd, however, that with respect to anyproposed changc in the corporation about which respondents learnless than thirty (30) days prior to the date such action is to take placerespondents shal1 notify the Commission as soon as is practicableafter obtaining such knowledge. Al1 noticcs required by this Part shal1he sent by certified mail to the Associate Director, Division ofEnforcement , Bureau of Consumer Protection, Fcdcral Trade

Commission , Washington , D.

VII.

It is further ordered That respondents sha1l deliver a copy of thisorder to a1l current and future principals , partners , officers , directorsand managers , and to al1 current and future employees , agents , andrepresentatives having responsibilities with respect to the subjectmatter of this order, and shal1 sccure from each such person a signedand dated statement acknowledging receipt of the order. RespondentsshaH deli vcr this order to current personnel within thirty (30) daysafter the date of service ofthis order, and to future pcrsonnel withinthirty (30) days after the person assumes such position orresponsibilities.

VII

It is further ordered That respondent Herbert H. Boynton, for aperiod often (10) years after the date of issuance of this order , shaHnotify the Commission of the discontinuance of his current business

Page 35: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

N1TRITION 21 , ET AL

Decision and Order

or employment or of his affliation with any new business oremployment. The notice sha1J include respondcnt' s new businessaddress and telephone number , and a description of the nature of thebusiness or employment and his duties and responsibilities. A1Jnotices required by this Part sha1J be sent by certified mail to theAssociate Director, Division of Enforcement , Bureau of ConsumerProtection , Federal Trade Commission , Washington, D.

IX.

It is further ordered That respondents sha1J , within sixty (60)days after the date of service of this order, and at such other times asthe Federal Trade Commission may require , file with the Commissiona report , in writing, setting forth in detail the manner and fonn inwhich they have complied with this order.

This order wi1J tenninate on July 1 l , 2017 , or twenty (20) yearsfrom thc most rccent date that the United States or the Fcdcral TradcCommission files a complaint (with or without an accompanyingconsent decree) in federal court a1Jcging any violation of the orderwhichever comes later; provided , howcvcr , that the filing of such acomplaint wi1J not affect thc duration of:

A. Any Par in this order that tenninates in less than twenty (20)years;

B. This ordcr s application to any respondent that is not named asa defendant in such complaint; and

C. This order if such complaint is filed after the order hasterminatcd pursuant to this Part.

Provided further, that if such complaint is dismissed or a federal courtrules that the respondent did not violate any provision of the orderand the dismissal or ruling is cithcr not appealed or upheld on appealthen thc ordcr wi1J tenninate according to this Part as though thecomplaint was never filed , cxcept that the order wi1J not tenninatebctwecn the date such complaint is filed and thc later of the deadlinefor appealing such dismissal or ruling and the datc such dismissal orruling is upheld on appeal.

Page 36: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COM'vISSION DECISIOKS

Dccision and Order 124 r.Te.

ATTACHMENT A

(To be printed on Nutrition 21 Stationery)

BY CERTIFIED MAIL , RETUR:' RECEIPT REQUESTED

(Date)

Dear (purchaser for resale J:

This 1ctter is to inform you that Nutrition 21 recently entered into aconscnt agrcement with thc Federal Trade Commission ("FTC" ) concerningcertain c1aims we made for chromium picolinate , which the FTC hasalleged to be deceptive. Although Nutrition 21 does not admit the FTC'sallegations , we have agreed to have substantiation for any future claImsabout the effectIveness of chromium picolmate at the time we make thoseclaims , and to stop making c1aims that scicntific studies demonstrate theeffectiveness of chromium picolinate unless those c1aims are true.

As a part of our settlement with the FTC , we also agreed to send thisletter notifying our distributors , wholesalers and others to whom we sellchromium picolinatc to stop using or distributing advertisements orpromotional matcrials containing the challenged claims.

The FTC alleged that we made unsubstantiated claims relating to thccffectivencss of chromium picolinate. Specifically, the FTC alleged that wedid not have a reasonable basis for c1aims that:

ChromIUm Plcolinate signifIcantly reduces body fat;ChromIUm Picolinate causes slgmficant weIght loss;ChromIUm Picolinate causes significant weight loss without dieting orexerCIse;Chromium Picolinate causes long- term or permanent weight loss;Chromium Picolmate mcreases lean body mass and builds musc1e;Chromium Picolmate significantly incrcases human metabolism;Chromium Picolinate controls appetite and craving for sugar;Chromium Picolmate significantly reduces total and LDL serumcholesterol;ChromIUm Picolinate significantly lowers elevated blood sugar 1cvcls;Chromium Picolinate IS effective in the treatment and prevention ofdIabetes; and

-- Ninety percent of U.S. adults do not consume dicts with sufficientchromium to support normal insulin function , resulting in increasedrisk of overweight, heart disease , elevated blood fat, high bloodpressurc , and diabetes.

The FTC considers a rcasonab1c basIs for thcse types of clalms to consistof competent and reliable sCIentific evidence.

Page 37: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

NL' TRITON 21 , ET AL

Decision and Order

In addition , the FTC alleged that we falsely claimed that scientificstudies demonstrated many of the above claims about chromium picolinate.

We request your assIstance by asking you to discontinue using, relyingon or distributing any advertising or promotional materials for chromiumpieolinate that make any of the above claims unless and until you possesscompetcnt and rehable scientifIc evidence that substantiates the claims.Pleasc also notify any of your retail or wholesale customers that theyshould follow the same procedures.

Thank you very much for your assIstance.

Very truly yours

HERBERT H. BOYNTONChairman of the Board1\utntlOn 2 I

Page 38: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE CO\1MISSION DECISIO:'S

Modifying Order 124 FTC.

IN THE MA TTER OF

COLUMBIAJCA HEALTH CAR CORPORATION

MODIFYIJ'G ORDER 1'1 REGARD TO ALLEGED VIOLA TION OFSEC. 7 OF THE CLA YTON ACT AND SEC. 5 OF THE

FEDERAL TRADE COMMISSION ACT

Docket C-36I9. Consent Order. Oct. I995--Modifing Order. July 14 1997

This order reopens a 1995 consent order -- that permitted Columbia/HCA andHealthtrst , Inc. , to merge and required the divestiture of the lease agreement-- and this order modifies the consent order by terminating ColumbialHCNsobligation to divest a commercial lease (the Infusamed Lease) for office spacein a building in Utah.

ORDER REOPENING AND MODIFYING ORDER

On February 18 , 1997 , Columbia/HCA Healthcare CorporationColumbia ) filed its Petition Of Columbia/HCA Healthcare

Corporation To Reopen And Modify Order ("Petition ) pursuant toSection 5(b) of the Federal Trade Commission Act, 15 C.sc. 45(b),and Section 2. 51 of the Commission s Rules of Practice and

Procedure , 16 CFR 2. 51. Respondent asks that the Commissionreopen the proceeding in Docket No. C- 3619 and modify the order toterminate the requirement that Columbia divest the commercial leaseidentified in Item 6 of Part II of Section A of Schedule B ofthe orderthe Infusamed Lease ). The Petition was placed on the public

record for thirty days , until March 24 , 1997 , and no comments werereceived. For the reasons discussed below the Commission hasdetermined to grant Columbia s Petition.

Columbia states that this Petition is the second step of twoprocedural steps to remedy a minor error in the order. On December

1995 , Columbia filed a petition to reopen and modify the order toterminate the Utah Hold Separate requirements upon its completionofthe divestiture of the Par I assets listed on Schedule B ofthe order

the Utah hospitals themselves The Part II assets listed onSchedule B consist of certain assets and businesses that wereidentified by Columbia during consent negotiations with Commissionstaff as being related to each of the listed Utah hospitals

, I and

included the Infusamed Lease. On May 15 , 1996 , the Commission

, "

Jl1e only distinction that the order expressly makes between the Part and Part II assc s is thatthe acquirer of a divested Pan I hospital need not give t11e Commission priur nuti f ;cation of the re-sakofa Part I! asset to anyone who also owns a hospital in thcTclevant market. See on:r.r, paragraph Ivr

Page 39: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

COLlJ.\BIA/HCA HEAL THCARE CORPORA TION

Modifying Order

granted Columbia s December 5 , 1995 petition. In addition , as of May, 1996 , Columbia completed the divestitures of all of the Utah

hospitals and reJated assets and businesses required by the orderexcept for the Infusamed Lease Asset.

As explained in the Petition ' the Jeased space in question is usedby Infusamed , a home health care company providing infusion andpharmacy services that was owned by Healthtrust, Inc, when it wasacquired by Columbia. The order docs not require Columbia to divestthe Infusamed business. It also appears that the lease was not part ofthe business of Pioneer Valley Hospital , with which it was identifiedas a relevant asset. Specifically, Columbia expJains that , although theInfusamed program was located temporarily at Pioneer ValleyHospital to enable it to register with the state of Utah and securenecessary licenses , it was subsequently separately incorporated andwas not in fact part of the competitive package comprising thePioneer Valley Hospital Assets.

CoJumbia claims that the order should be reopened and modifiedon the grounds of changed conditions of fact. Specifically, Columbiaasserts that there was a mutual mistake of fact during consentnegotiations. According to Columbia , during consent negotiationsboth Columbia and the Commission were under the impression thatthe Infusamed Lease Asset was intrinsically related to Pioneer ValleyHospital , one of the Schedule B hospital assets. In reality, Columbiaclaims , the Infusamed Lease Asset was not " related" to PioneerVal1ey Hospital in any sense that is competitively meaningful interms of that hospital specifical1y or the relevant acute care inpatienthospital services market in Utah general1y. As a result ofthis mistakeCoJumbia asserts that there has been a " constructive change of fact"which warrants correction by reopening and modifying the order toeliminate the requirement that Columbia divest the Infusamed LeaseAsset

CoJumbia also asserts that reopening and modifying the order toeliminate its obligation to divest the Jnfusamed Lease Asset is in thepublic interest. Columbia states that forcing it to divest the InfusamedLease will not further the original purposes of the order. Columbiaalso states that it will be burdened by unnecessary complianceobligations that will impede its ability (0 compete in the relevant Utah

2 Petition at 3 & ExrJibit D.

. In SUPPOTt , Columbia cites the Commission s cecision in Saint-Gobain/"\orton IndustrialCeramics Corporation , Docket :\0. C-3673 , Order Reopening and Modifying Order (1' ovember 191996) (mutual mistake caused a " constructive change offac! " justifying a modification).

Page 40: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIO"lS

Modifying Ordcr 124 FTC

acute care hospital market. Further, Columbia states that a forceddivestiture will cause significant and unforesccn hann to competitionfor the provision of home health services by interfering with theongoing business of the Infusamed regional home health carecompany.

Section 5(b) of the Federal Trade Commission Act, 15 U.S.c. 45(b), provides that the Commission shall reopen an order to considerwhether it should be modified if the respondent "makes a satisfactoryshowing that changed conditions of law or fact" require suchmodification, A satisfactory showing suffcient to require reopeningis made when a request to reopen identifies significant changes incircumstances and shows that the changes eliminate the need for theorder or make continued application of it inequitable or hannful tocompetition. S. Rep. No. 96-500, 96th Cong. , 2d Scss. 9 (J 979)(significant changes or changes causing unfair disadvantage);Louisiana-Pacific Corp. , Docket No. C-2956 , Letter to John C. Hart(June 5 , 1986), at 4 (unpublished) ("Hart Letter

Section 5(b) also provides that the Commission may modify anorder when , although changed circumstances would not requirereopening, the Commission detennines that the public interest sorequires. Respondents are therefore invited in petitions to reopen toshow how the public interest warrants the requested modification.Hart Letter at 5; 16 CFR 2. 51. In such a case , the respondent mustdemonstrate as a threshold mattcr some affnnative need to modifythe order. Damon Corp. , Docket No. C-2916, Letter to Joel E.

Hoffman , Esq. (March 29, 1983), 1979-83 Transfer Bindcr , FTCComplaints and Orders , (CCH) 007 , p. 22 585 ("Damon Lctterat 2, For example, it may be in the pubhc interest to modify an orderto rchcvc any impediment to effective competition that may result

from the order. Damon Corp. Docket No. C-2916 , 101 FTC 689692 (1983). Once such a showing of need is made , the Commissionwill balance the reasons favoring the requested modification againstany rcasons not to make the modification. Damon Letter at 2. TheCommission also will consider whether the particular modificationsought is appropriate to remedy the identified hann. Damon Letter at

The language of Section 5(b) plainly anticipates that the burdenis on the petitioner to make a "satisfactory showing" of changed

See also Uniled Srnles v. l.ollisinl1a-Pacifc CUlp, 967 f. 2d 1372 , 1376- 77 (9th Cir 1992) ("decision to reopen docs not necessariiy entail a dec:sion to modify the ordcr. Reopening may OCCt.T

even where the petition itself docs not plead facts requiring modification

Page 41: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

COUiMBIA/HCA HEAL THCARE CORPORA TIm;

Modifying Order

conditions to obtain reopening of the order. The legislative historyalso makes eJear that the petitioner has the burden of showing, otherthan by conclusory statements , why an order should be modified. TheCommission "may properly decJine to reopen an order if a request ismerely conclusory or otherwise fails to set forth specific factsdemonstrating in detail the nature of the changed conditions and thereasons why these changed conditions require the requestedmodification of the order. " S. Rep. No. 96-500 , 96th Cong. , 1st Sess.

10 (1979); see also Rule 2. 51(b) (requiring affidavits in support ofpetitions to reopen and modify), If the Commission detennines thatthe petitioner has made the necessary showing, the Commission mustreopen the order to consider whether modification is required and , if

, the nature and extent of the modification. The Commission is notrequired to reopen the order, however, if the petitioner fails to meetits burden of makng the satisfactory showing required by the statute.The petitioner s burden is not a Jight one in view ofthe pubJic interestin repose and the finaJity of Commission orders. See FederatedDepartment Stores, Inc. v. Moitle 425 D, S. 394 (1981) (strong pubJicinterest considerations support repose and finality).

Columbia has not met its burden of showing that changedconditions of fact require reopening and modifying the order. Firstthe Commission disagrees with Columbia s assertion that the

mistaken inclusion of the Infusamcd Lease Asset was a mutualmistake by both parties to the consent negotiations. In deriving theJist of related assets and businesses to be divested by CoJumbia alongwith the core divestiture assets required to be included as the Part Iassets of Schedule B (i. which Utah hospitals should be divested),the Commission reJied on the reprcsentations of Columbia that eachone of the three separate lease assets identified by Columbia forinclusion on Part II , Section A , of Schedule B (i. Items 3 and 4 aswe11 as Item 6 , the Infusamed Lease Asset) was related to thebusiness of Pioneer Ya11ey Hospital. It was only when Columbianegotiated its divestiture agreement with Paracelsus HealthcareCorporation, which acquired, among other things , the Pioneer Ya11ey

and Davis hospitals in Utah , that Columbia reaJized its error and alsoascertained that Paracelsus did not want the Infusamed Lease Asset.As the Commission stated in Saint-Gobain: "Oversights madeunilatera11y by respondents do not constitute changed conditions fact within the meaning of Section 5(b) of the FTC ACT. '" The

Saint-Gobain/Norton Industrial Ceramics Corporation , Docket 1\'0. C-3673

Page 42: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Modifying Order 124 FTC.

mistake in this case was made unilaterally by Columbia and was nota mutual mistake of fact.

More significantly, however, this case does not present the kindof situation that the Commission recognized as establishing aconstructive" change of fact in Saint-Gobain. Application of theconstructive" changed facts ground for reopening a final order is

limited to situations where , as in Saint-Gobain, the ordcr misnamesmislabels or misidentifies a person , place or thing, and this errorincorporated in the order prevents the respondent from complyingwith the order as written , so that the purposes of the order cannot beachieved. In these situations , the error will typically involve a singlefact, the truth or accuracy of which is casily and objectivelyverifiable

g.,

whether an individual is or is not an offcer of a

particular corporation , or whether an asset is located at " l 05 WrightBros. Drive" or " 150 Wright Bros. Drivc. " In these circumstancesreopening and modification is necessar to allow achievement ofthcorder s remedial purposes. Unlike the situation presented inSaint-Gobain, Columbia is not prevented from complying fully withthe order as written , nor would divestiture of the Infusamed LeaseAsset ITstrate the order s purposes. Accordingly, Columbia has notdemonstrated that reopening of the order is compelled on grounds ofchanged condition of fact.

Columbia has , however , met its burden of showing that publicinterest considerations warrant reopening and modifying the order toeliminate the requirement to divest the Infusamed Lease Asset.Columbia has met its burden of showing an affnnative need toreopen thc proceeding caused by the continued operation of the order.Columbia has shown that in view of its divestiture of Pioneer ValleyHospital (the hospital with which the Infusamed Lease Asset wasidentified as a related asset), the Pioncer Valley Hospital acquirerlack of interest in the Infusamcd Lease Asset , and the lease s lack ofcompetitive significance in the relevant acute care hospital marketcontinuing to require Columbia to divest the lease is burdening it withunnecessary expense in tenns of achieving the ordcr s remedial

purposes , and is having a negative impact on its ability to compete.Columbia has also shown that requiring it to divest the InfusamedLease Asset will cause hann to competition in the market for theprovision of home hea1th services. The Commission s complaint didnot identify any competitive problems in the market for home hea1thservices and , accordingly, the Commission sought no relicf in this

Page 43: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

COLl''vBIAfHCA HEAL TlICARE CORPORA nON

ConcuTTing Statement

market. Requiring Columbia to divest the lease in Eght of a lack ofinterest by the acquirer of the othcr divested assets , and the lack ofany allegation in the complaint that a competitive problem exists inthe home health services market , would impede competition in thatmarkct.

Where the potential hann to the respondent outweighs any furtherneed for the order, the Commission may modify the order in thepublic interest to a110w the respondent to retain the relevant assetsBecause the Infusamed Lease Asset has been shown to have nocompetitive significance in the acute care hospital market in Utahthere is no need for Columbia to divest the lease. The remedialpurposes identified in the order have already been achieved by thedivestitures that have taken place. Further, requiring Columbia todivest the Inf11amed Lease Asset will cause hann to competition forthe provision of home health services. The hann and costs toColumbia associated with the continuing requirement to divest thelease appear to be significant , while there do not appear to be anybenefits associated with requiring the divestiture,

Accordingly, II is ordered That this mattcr bc , and it hereby isreopened; and

II is filrlher ordered That the ordcr in Docket No. 3619 , beand it hereby is , modified by deleting the asset identified as Schedule

, Scction A, Part II , Item 6: "Lcase of7 , 134 sq. ft. , 150 Wright Bros.Drive , Suite 540 , Salt Lake City, Utah 84116" from the Est of assetsto be divested.

Commissioner Azcuenaga and Commissioner Starek concurrng

in the result only.

COXCURRI' ,G ST A TEME'iT OF C0\1\1JSS10NER MARY L. AZCUENAGA

Today, the Commission reopens the order against ColumbialCAHealthcare Corporation under Section 5(b) of the Federal TradeCommission Act , 15 U.S.c. 45(b), to eEminate the requirement thatColumbialCA divest an ordinary commercial lease of a 7143 squarefoot offce suite on the ground that reopening and modifying the orderis in the public interest. I agree with the result but not with thercasoning of the majority.

See C. Johnson & Sons , Inc , Docket :-o. 3418 , Order Reopemng Proceeding andModifying Order C\ovember 8, 1993) (mder modified on pub!ic interest b'TOunds to eliminaterequircment to divest rcmaining intematiom.l Rcnuzit assets not in the relevant market and not wantedby the acquirer Oft!lC divested North Ar.erican Renuzit assets); T&N plc , Docket o. C-3312 , OrderReopening Proceeding and Modifying Order (1\ovember 13, 1(91) (order modified on public interestgrounds to permit respondent to retain inventory not \vantcd by the acquircr).

Page 44: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Concurrng Statement 124 FTC.

The majority is correct that a showing of affnnative need isrequired before an order wil be reopened under the public intereststandard , and only after such a showing of affnnative need does theCommission balance the public interest reasons for and against themodification, See Damon Corp. , Docket No. C-2916 , Letter to JoelE. Hoffman, Esq. (Mar. 29 1983). Commission Rule 2. 51(b), 16 CFR

51 (b), provides that the petition must be supported by affidavitscontaining " specific facts" justifYing the reopening and modificationof an order and cautions against "conclusory" justifications. BecauseColumbialHCA failed to make the requisite showing of affinnativeneed under Rule 2.51 (b), I cannot agree with the majority that thepetition should be granted under the public interest standard,

Finding affnnative need , the majority states: "continuing torequire Columbia to divest the lease is burdening it with unnecessaryexpense in tenns of achieving the order s remedial purposes , and ishaving a negative impact on its ability to compete. " Order at 5. Theaffdavit filed in support of ColumbialHCA' s petition contains thebare assertion that the expenditure of time and other resources

(presumably to find a buyer for the lease) wi11 impede its ability tocompete in the hospital market. 1 It is virtua11y always foreseeable at

the time a consent agreement is signed that a divestiture wi11 entailtime and other resources" to accomplish, An order need not bereopened and modified on the basis of a circumstance that isforeseeable at the time that a consent order is signed. SeeLouisiana-Pacific Corp. , Docket No. C-2956 , Letter to John C. Hart

(June 5 , 1986); United States v. Louisiana-Pacifc Corp. 967 F,1372 1378 (9th Cir. 1992),

ColumbialHCA does not assert , much less support , a particularcost of leaving the requirement to divest the lease in the order. Thisomission alone is suffcient ground to deny the petition under thepublic interest standard. On this point , the Commission s decision istantamount to waiving the requirements of Rule 2.51(b) that apetition must be supported with particularity. It seems to me that therequirements of Rule 2.51(b) are there for good reason , and I see noreason to waive them.

The entirc explanation provided in the supporting affdavit is as fol1ows: "ColumbialHCA willsuffer unforeseen competitive harm if it is forced to divest I11C Infusamcd Lease Asset. Columbia/! ICAis extremely unlikely to find a buyer for the lease , which will terminate in five months. \1canwhilcthe required expenditure of time and other resources will impede ColumbiaiHCA' s ability to competecffcctiveiy, particularly in the Salt Lake Area acute care r,ospital market. FinaJ1y, a forced divestiturewin interfere with the ongoing business of the Infusamcu regional home health care company.

Page 45: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

COLUMB1A1HCA HEAL THCARE CORPORA TION

Concumng Statement

The majority s substantive discussion of affnnative need iscontained in one paragraph, Order at 4-5, After stating its conclusionthat the petitioner has shown affnnative need, the majority refers inone sentence to three circumstances to bolster its conclusion: thcalready completed divestiture of Pioneer Valley Hospital , the hospitalacquirer s asserted lack of interest in the lease , and the " lack ofcompetitive significance L of the lease J in the relevant acute carehospital market." Order at 4-5. None is explained. Pioneer ValleyHospital was divested , as required by the Commission s order, toParacelsus Healthcare Corp" except for the lease in question , whichwas listed among the "Pioneer Valley Assets" to be divested. It is atbest unclear why a partial divestiture justifies elimination of theremaining divestiture obligation. Surely this is not a precedent themajority would like to establish for other cases.

Second , the majority relies on "the Pioneer Valley Hospitalacquirer s 1aek of interest" in the lease. Assuming the truth of thisconclusion, it is not at all clear why it should bc rclevant.Columbia/HCA asserts in a single scntcncc that Parace1sus did notwant the lease in question. Petition Para. 8. In the past , theCommission has been rigorous in probing assertions like this. Itsfailure to do so here is an indication that the Commission thinks thelease is competitively insignificant, which, indecd, is thc nextcircumstance to which the majority refers as a basis for granting thepetition. The majority s reliance on the " lack of competitivesignificance (ofthe lease) in the relevant acute care hospital market"amounts to a finding that the Commission made a mistake inrequiring divestiture ofthe lease. But for the assumption that the leasewas competitively significant , therc would havc becn no possiblereason to require divestiturc in the first place.

Finally, thc majority states that divestiture of the lease "will causehann to competition in the market for the provision of home healthservices. " Order at 5. This asserted harm is entirely unexplained ' nodoubt because the market for home health services was not alleged inthe complaint and is not otherwise at issue in the order thatColumbialHCA seeks to have changed. Presumably, the majority

The closest the maJority comes to an explanation is: " Requiring Columbia to divest the leasein light of a lack of interest by the acql.irer of the other divested assets, and the lack of interest by theacquirer of the other divested assets , and the lack of any allegation in the complaint that a competitiveproblem exists in the home hea1th services market , would impede competition in that market. " Orderat 5. The complaint also lacks any allegation that a competitive problem exists in the market forcommercial rea1 estate in Salt Lake Ciry, just to take one of any number of examples , but that hardlyjustifies changing an order th8.t addresses the market for acute care hospital services

Page 46: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSIOK DECISIONS

Statement 124 FTC

would not so lightly assume hann to competition in a market it hasnot studied or previously identified if the majority were decidingliability. To do so in this context undermines the Commissionanalytical standards.

The petitioner asserts that the petition should be granted on thebasis of mutual mistake offact (constructive change offact), citingSaint-GobainIorton Industrial Ceramics Corp. , Order Reopeningand Modifying Order, Docket No. C-3573 ('ovember 19 1996). Onthat ground , I concur in the result.

STATEMENT OF COYlYlISSIONER ROSCOE B. ST AREK , IICONCCRR1:\G IN THE RESULT

The order in this case requires respondent to divest assets inseveral areas of the country, as a remedy for the likelyanti competitive effects of respondent' s acquisition of Healthtrust , Inc.- The Hospital Company. One oflhe assets required to be divested isthe "Infusamed Leasc " an offce space in Salt Lake City from whichrespondcnt s Infusamed subsidiary provides infusion and phannacyservIces.

Respondent has petitioned to reopen and modify the order toeliminate the Infusamed Lease fTOm the schedule of assets to bedivested. Respondcnt claims that both parties to the consentsettlement of this matter (i. both respondent and the Commission)labored under the erroneous assumption that thc Infusamed Lease wasa vital part of Pioneer ValJey Hospital-- one of the primary assetsthat rcspondent was required to divest -- when in fact the InfusamedLease has no critical relationship to the Hospital. Arguing that thismutual error regarding the Infusamed Lease constitutes aconstructive change of fact " respondent bases its request on our

ruling last falJ in Saint- GobainJorton Industrial Ceramics COrp I --

the case in which we articulated the concept of a "constrctive changeof fact." Alternatively, rcspondent contends that the public interestrequires the deletion of the Infusamed Lease from the divestitureassets.

I rcach thc same conclusion as my colJeagues: respondent has

made the case for modifying the order. The Infusamed Lease is notcritically related to Pioneer Valley Hospital and should not have bcenincluded in the assets to be divested. I am comfortable reaching this

Docket No. C- 3673 (OracT Reopening and \Iodifying Order , Nov. 19 , 1996).

Page 47: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

COLUMBIA/HCA HEAL THCARE CORPORATION

Statement

result either on a " constructive change of fact" basis or on the groundthat it is in the public interest to grant the requested modification.

In the present order, however, the majority concludes that

respondent has not shown a " constructive change of fact" within theparameters outlined in Saint-Gobain. First, my col1eagues " disagree(Jwith Columbia s assertion that the mistaken inclusion of theInfusamed Lease Asset was a mutua1 mistake by both parties to thcconsent negotiations. '" The majority tries to b01ster this conc1usionby observing that " the Commission relied on the represcntations ofColumbia that each one of the three separate Icase assets identified byColumbia for inclusion (in the relevant schedule to the consent order was related to the business of Pioneer Val1ey Hospital. . . . Themistake in this case was made unilateral1y by Columbia and was nota mutua1 mistake of fact. ,,3

But as I understand the facts, both respondent and theCommission were under the misimpression that the Infusamed Leasewas sufficiently related to Pioncer Val1ey to require inclusion in theset of divestiture assets. That the Commission may have " relied" onrespondent' s representations to this effect changes nothing: with orwithout such reliance , the fact remains that both parties to the consentagreement -- Columbia/HCA and the Commission -- entertained anincorrect view of the Infusamed Lease. This mistake was no 1essmutual" than was the error (concerning the status of certain

Carborundum managers) at the heart of the " constructive changc offact" doctrine that we announced in Saint-Gobain

The majority s second reason for rejecting rcspondent'constructive change of fact" c1aim is even more perp1exing. The

majority states: " (TJhis case does not present the kind of situation thatthe Commission recognized as establishing a ' constructive ' change offact in Saint-Gobain. Application of the 'constructive ' changed factsground for reopening a final order is limited to situations wherc, as inSaint-Gobain, the order misnames, mislabe1s or misidentifies aperson, place or thing, and this error incorporated in the ordcr

prevents the respondent from complying with the order as written , sothat the purposes ofthe order cannot be achieved. In these situations

2 Order Reonening and \1odifyinOrder at 4 (Julv 14 , 1997)

:-OT 1 suspect , did the Commission "rely " a1'.y less or, respondent s representations in Saint-Gobain than in the present case. Indeed , if the CUIT.missio:" had done an If. dependent fact- findingconcerning the Carborundum personnel u rather than relying on responden: s rcpresentations -- it ishigr. ly likely that there never would have been an er:"or coneeming the Carborundum managers

Page 48: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSIO;- DECISIONS

Statement 124 FTC.

the eITor will typically involve a single fact , the truth or accuracy ofwhich is easily and objectively verifiable. . . ,,5

I search in vain for language in our Saint-Gobain order to supportthe gloss my colleagues have put on it here. Nothing in that orderspeaks to the singularty ofthe fact at issue or to its easy or objectiveverifiability. With regard to prevention of compliance with the orderand frustration of its purposes , the only sentence pertinent to thisissue in our Saint-Gobain order ' is hardly authority for the almostcategorical limitation that my colleagues announce today. All of themajority post hoc qualifications on the meaning of Saint-Gobainseem designed to mitigate the impact of a decision with which theymay have become uncomfortable. If that is the majority's purposehowever , it finds no source in the text of Saint-Gobain itself.

In any event , evcn if my collcagues are COITect that the kind ofmistake cognizable under the "constructive change of fact" doctrinewill typically involve a single fact , the truth or accuracy of which is

easily and objectively verifiable " why is the Infusamed Leasesituation not a suitable candidate? Although my colleagues are silenton this question , the critical facts sUITounding the Infusamed Leasedo not differ materially (in tenns of objective verifiability, etc, ) fromthe facts concerning the Carborundum managers in Saint-Gobain, andI find the present case a worthy candidate for application of the

constructive changc of fact doctrinc.Having rejected changed conditions of fact as a basis for

modifying the order, thc majority turns to respondent' s assertion thatpublic interest considerations also waITant the requested relief.Although I agree that it is in the public interest to excuse respondentfrom an obligation to divest the Infusamed Lease , I cannot agree thatrespondent has satisfied the " affnnative need" standard , which hasbecome enshrned in the Commission s public interest order

modifications despite having no rightful place in our jurisprudence, 7Indeed , were my colleagues to apply their affrmative need

criterion with any sort of rigor, respondent' s public interest argumentwould fail. For example, I would be interested to learn what evidencesupports the majority s observation that "continuing to require

Order Reopening and Modifying OnJer supra , at 4.6 "

Saint-Gobain cannot , therefore , comply \vith the term of paragraph 5. d. of the Hold Separate.In the Matter of Saint-GohainlNorton Industrial Ceramics Corp. , Order Reopening and ModifyingOrder

;,

supra n. 1 , at 4I for one directly pertinent illustration afmy oft-stated views on affrmative need

see In theMatter ofCoIumbiaJHCA Healthcare Corp. , Docket No. C-3619, Order Reopening and ModifyingOrder (May 15 , 1996) (Statement ofCommissiom:r Roscoe B. Starck , l! , Concun' ing in the Result).

Page 49: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

COLLNfBIAlHCA HEAL THCARE CORPORA TIOK

Statement

Columbia to divest the (InfusamedJ lease is burdening it withunnecessary expense in tenns of achieving the order s remedialpurposes , and is having a negative impact on its ability to compete. ,,8

Moreover , how has Columbia shown that "requiring it to divest theInfusamed Lease Asset wi1l cause hann to competition in the marketfor the provision of home health services"?' And what is in the recordto support the majority s conclusion that " (rJequiring Columbia todivest the lease in light of a lack of interest by the acquirer of theother divested assets , and the Jack of any a1legation in the complaintthat a competitive problem exists in the home health services marketwould impede competition in that market,,?lO Absent moreinformation and analysis regarding home health services in the SaltLake City area, how could the Commission possibly know thatrequiring respondent to divest the Infusamed Lease would " impedecompetition" in that "market"? Respondent' s petition furnishes littlein the way of substantiation , nor does the order issued today gobeyond the conclusory.

Nevertheless , it is clearly in the public interest to grant therequested relief. The Infusamed Lease was included among thedivestiture assets through an error, and -- entirely apart from the rolethat this error plays under the constructive change of fact doctrinc --the public interest requires that it be rectified. This conclusion isderived from a simple , straightforward balancing of the reasons todeJete this divestiture requirement against the reasons to retain it.Consideration of the " affinnative need" question simply muddles the. l'analysls, .

Order Reopenmg and \1odifying Order, supra 1'. , at 59 Id

Id.11 As I have noted elsewhere

, "

(aJ case such as tr,is one -- in which the affrmative needevidence ' is paltr, but the requested relief fairly cries out to be granted -- demonstnltcs why theCommssion should summon the will to jettison the 'affrmative need' concept and embrace explicitlya simple cost/encfit balancing approach to order modifications pursuant to the ' public intereststandard oflCommissionj Rule 2. 51, " Statement of Commissioner Roscoe E. Stan , II , Concuningin the Result supra , at 2.

Page 50: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSIO:- DECISIONS

Modifying Order 124 FTC.

!' THE MA TTER OF

CLASS RIGS , INe. , ET AL

MODlFYIJ\G ORDER IN REGARD TO ALLEGED VIOLA T10:- OFSEC. 7 OF THE CLA YT00J ACT AJ\D SEC. 5 OF THE

FEDERAL TRADE COMMISSIOJ\ ACT

Docket C-370!. Consent Order, Dec. 20. I996--Modifing Order, July 21 1997

This order reopens a 1996 consent order -- that prohibited the respondents fromhaving any interest in or assets of Gold Lance , Inc. - - and this order modifiesthe consent order by settg aside a provision prohibiting the respondents , forone year, from employing or seeking to employ any person who is or wasernpIoyed during 1996 by GoId Lance , Inc. or Town & Country Corporation.

ORDER REOPENTG ACI MODIFYING ORDER

On May 29, 1997 , respondents Commemorative Brands, Inc.

fonnerly known as Class Rings , Inc. ("Class Rings ), and CastleHarlan Partners II, L.P. (collectively "CBI") fied a Petition ofCommemorative Brands , Inc. and Castle Harlan Partners II , L.P. toReopen and Modify Order ("Petition ), pursuant to Section 5(b) ofthe Federal Trade Commission Act, 15 U.S. e. 45(b), and Scction

51 of the Commission s Rules of Practice and Procedure , 16 CFR51. In its Petition , CBJ requests that the Commission reopen thc

order in Docket o. C-3701 (" order ) to set aside paragraph V , whichprohibits CBI , for a period of one year, from employing or seeking toemploy any person who is or was employed at any time during 1996by Gold Lance, Inc. ("Gold Lance ) or by Town & Countr Corpora-tion ("Town & Country ) in any position relating to the design

manufacture , or sale of class rings (the "Employment RestrictionFor the reasons discussed below, the Commission has detennined

that CBI has demonstrated changed conditions of fact suffcient torequire the reopening and modification of the order 1

In its Petition ' CBI requests that the Commission modify theorder to set aside the Employment Restriction contained in paragraphV of the order3 The restrictions in paragraph V expire by their own

I Because the Commission has determined to gran! CBl's Petition based on change of fact , we

do not reach a determination with respect to CB1' s assertion that the provision should be set aside underthe se

rarate public interest standardIn support of its Petition , CBI provided the affdavit of Jeffrey \-1. Brennan , President and Chief

Executive Officer of Commemorative Brands, Inc. (" Brennan Affidavit3 Paragraph V provides that Castle H;Jrlan and Class Rings

shall not , for a period of one (I) year from the date this orcerbeeomes final , employ or seek to employany person who is or was emp10yed at any time during calendar year 1996 by Gole! Lance or by Town& Countr in any position relating to the design , manufacture , or sale of Class Rings

Page 51: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

CLASS RIGS , INC. , ET AL.

Modifying Order

tenns on Ianuary 9 , 1998 , one year from the date on which the orderbecame final'

CBI bases its Petition on changed conditions of fact and publicinterest considerationsS The changes of fact

a11eged by CBI include

the fact that Gold Lance is no longer a stand-alone competitor, but isnow a part of the industry s market leader, Iostens , Inc, ("IostensSince the order became final , Iostens , the largest producer of classrings in the country, purchased Gold Lance from Town & Country.CBI contends that, as a result of the acquisition , the EmploymentRestriction no longer operates to achieve the purpose for which it wasdesigned but has the unintended effect of precluding CBI fromcompeting against Iostens for Gold Lancc employees

In addition to changc of fact , CBI argues that it is in the publicinterest to grant its Petition because the Employment Rcstriction nowhas the unintended effect of preventing Gold Lance employees , manyof whom wi11 soon be out of work due to the Iostens ' acquisitionfrom obtaining employment with CBI , which desires to offer jobs toqualified individuals. The Petition asserts that such a result isinconsistent with the purpose of the order and is unduly hannfu1 tothese employees

STA'\DARD FOR REOPE:'JJG A:\D YlODlFY1NG FINAL ORDERS

Section 5(b) of the Federal Tradc Commission Act , 15 U.sC.45(b), provides that the Commission sha11 reopen an order to considerwhether it should be modified ifthe respondent "makes a satisfactoryshowing that changed conditions of law or fact" so require. Asatisfactory showing suffcient to require reopening is made when arequest to reopen identifies significant changes in circumstances andshows that the changes eliminatc the nced for the order or makecontinued application of it inequitable or hannful to competition

Section 5(b) also provides that the Commission may modify anorder when , although changed circumstances would not requirereopening, the Commission detennines that the public interest so

Order'IV5 eBl docs not assert that any c1ange of law requires reopening the order

6 Petition 'I12. Brennan Affdavit"

7 Petition ,,: 13-

S. Rep. No. 96-500 , 96th Cong. , 1st Sess 9 (1979) (significant changes or changes causingunfa:r disadvantage); Louisiana-Paciiic Corp. , Docket 1\0. C-2956, Letter to John C Hart (June 51(86), at 4 (unpublished) ("Hart Letter See also Uniled Stales v. Louisiana-Pacifc Corp- 967 F.2d

1372 1376-77 (9fh eiL 19(2) ("A decision to reopen does not necessarily entail a decision to modifythe order Reopening may occur even where the petition itse!f rioes not plcad facts requiringmodification.

Page 52: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE CO:vMISSION DECISIONS

Modifying Order 124 F.

requires. Respondents are therefore invited in petitions to reopen toshow how the pubJic interest warrants the requested modification9 In

such a case , the respondent must demonstrate as a threshold mattersome affnnative need to modify the order. 10 For example , it may bein the public interest to modify an order "to relieve any impedimentto effective competition that may result from the order. " II Once such

a showing of need is made , the Commission will balance the reasonsfavoring the requested modification against any rcasons not to makethe modification. 12 The Commission aJso will consider whether theparicular modification sought is appropriate to remedy the identifiedhann,

The language of Section 5(b) plainJy anticipates that the burdenis on the petitioner to make a "satisfactory showing" of changed

conditions to obtain reopening of the order. The legislative historyalso makes clear that the petitioner has the burden of showing, otherthan by conclusory statements , why an order should be modified. TheCommission "may properly decline to reopen an order if a request ismerely conclusory or otherwise fails to sct forth specific factsdemonstrating in detail thc nature of the changed conditions and thereasons why these changed conditions require the requestedmodification ofthe order. "J4 If the Commission dctennines that the

pctitioner has made the necessary showing, the Commission mustreopen the order to consider whether modification is required and , if

, the nature and extent of the modification. The Commission is notrequired to reopen the order , however , if the petitioner fails to meetits burden of making the satisfactory showing required by the statute.The petitioner s burden is not a light one in view of the public interestin rcpose and the finality of Commission orders,

9 Hart Leite at 5; 16 CrR 2. 51.

10 Damon Corp., Docket "\0- C-2916 , Lctter to Joel E. Hoffman , Esq. (March 29 1983), 1979-

Transfer Binder , FTC Complaints and Orders , (CCH) 007 , p. 22 585 ("Damon Letter ), at 2.11

Dallu/! Co/p. Docket 1\0. C-2916. 101 FTC 689 , 692 (1983).12 Damon Letter at 2

13 Oamon Lcttcr at 4.

14 S. Rep.:.o 96-500 , 96th Cong , 1st Sess 9. 10 (1979); see also Rule 2. 51(b) (requiring

affidavits in support of petitions to reopen and modify)15

See Federated Department Slures , Inc. v. Moilie 425 U.S. 394 (198;) (strong pt.blic interestconsiderations support repose and finality)

Page 53: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

CLASS RI1GS , INC. , ET AL.

Modifying Order

CB1 HAS DEMONSTRATED CHANGED CONDITIONS OF FACT THATREQUJRE THE REOPEJ\ING AJ\D MODI FICA '110:' OF THE ORDER

CBI's Petition demonstrates that Jostens s acquisition of GoldLance eliminates the need for the Employment Restriction containedin paragraph V of the order. Thc complaint in this matter chargcd thaton May 20 , 1996 , Class Rings , an entity controlled by Castle Harlanagreed to purchase all of the class ring assets from two companiesTown & Country and C.TC Holdings , Inc. and CJC North AmericaInc. ("CJC" 16 At the time of the proposed merger

, CJC was

manufacturing class rings. Town & Country, another leadingproducer of commemorative jewelry, manufactured class ringsthrough its class ring divisions Gold Lance and L.G. BalfourCompany, Inc. ("Balfour 17 Under the consent order, Castle Harlanin effect, was prohibited trom acquiring the Gold Lance business butpermitted to acquire the Balfour business as well as the CJC businesstrom Town & Country l' Paragraph V of the order , the subject of thePetition , was included in the order to ensure that Town & Country,through its subsidiary Gold Lance , remained a viable independentcompetitor in the manufacture and sale of class rings.

On April 21 , 1997 , Jostens , the largest producer of class rings inthe United States , announced that it had purchased Gold Lance tromTown & Country. Such a change , which was not foreseen at the timethe Commission issued the order, results in the EmploymentRestriction having the unintended effect of precluding CBT tromcompeting against the market leader Jostens for a significant numberof skilled and experienced workers in this industry.

Gold Lance is no longer in need of the protection afforded by theEmployment Restriction. Therefore , the acquisition of Gold Lance byJ ostens constitutes a change of fact that eliminates the need for theEmployment Restriction and requires the reopening and modificationof the order to set aside paragraph V.

Accordingly, It is ordered That this matter be , and it hereby isreopened and that the Commission s order be, and it hereby is

modified to set aside paragraph V as of the effective datc of thisorder.

The complaint alleged t11at the proposed merger would violate Section 7 of the Clayton Act15 L. C. 18 , and Section of the Federal Trade Commission Act 5 U. C. 45. Complaint '1'124- 25.

Com laint n )-J8 Order'l!!

19

: ,

Order II I,

Page 54: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COM\1ISSIO'l DECISIONS

Complaint 124 FTC.

IN THE \1ATTER OF

SOFTSEARCH HOLDINGS , INC. , ET AL.

CONSENT ORDER , ETC. , !J REGARD TO ALLEGED VIOLA TION OFSEC. 7 OF THE CLA YTO'i ACT AND SEC. OF THE

FEDERAL TRADE COMMISSION ACT

Docket 3759. Complaint, July I997--Declsion . July 28 1997

This consent order requires , among other things , Dwight s Energydata , a subsidiaryof Softsearch , to license a set of complete well history and production data toa Commssion-approved buyer, which then will be an independent competitor.In addition , the Commission has appointed a trustee to find a licensee and tocomplete the required divestiture.

Appearances

For the Commission: George Cmy, Frank Lipson, Philhp Broylesand William Baer.

For the respondents: Sandy Plunder, Gibson, Dunn CrutcherWashington , D. C. and Neil lnus, Vincent Elkins Washington

COMPLAINT

The Fcderal Trade Commission ("Commission ), having reasonto believe that Dwight's Energydata, Inc. ("Dwight's ), a

wholly-owned subsidiary of respondent SoftSearch Holdings , Inc. , acorporation subject to the jurisdiction of the Federal TradeCommission , has entered into an agreement to merge with PetroleumInfonnation Corporation ("PI"), a wholly-owned subsidiary ofrespondent GeoQuest International Holdings, Inc. , a corporation

subject to the jurisdiction ofthe Commission, in violation of Section7 of the Clayton Act, as amended , 15 c. , and Section 5 of theFederal Trade Commission Act ("FTC Act" ), as amended , 15 U.S.

, and it appcaring to the Commission that a proceeding in respectthereof would be in the public interest , hereby issues its complaintstating its charges as follows:

THE RESPO'iDENTS

PARAGRAPH 1. Respondent SoftSearch Holdings, Inc. , is a

corporation organized , existing, and doing business under and byvirtue of the laws of the State of Delaware , with its offces and

Page 55: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCI! HOLDINGS , I"IC , ET At.

Complaint

principal place of business located at 1202 Estates Drive , Suite AAbilene , Texas. Its whol1y-owned subsidiary, Dwight' s EnergydataInc. , is a corporation organizcd , existing, and doing business underand by virtue of the laws of the State of De law arc , with its offce andprincipal place of business located at 1633 Firman Drive , Suite 100Richardson, Texas. Dwight's Energydata , Inc. , holds a 37 percentinterest in Graphic Infonnation Technologies, Inc.

, ("

GITI") acorporation organized , existing, and doing business under and byvirtue of the laws ofthe State of Delaware.

PAR. 2. Respondent GeoQuest Intcrnational Holdings , Inc. , is acorporation organized , existing, and doing business under and byvirtue of the laws of the State of Delaware with its office andprincipal p1acc of business located at 5333 Westheimer DriveHouston , Texas. Its principal subsidiary is Petroleum InfonnationCorporation , a corporation organized , existing, and doing businessunder and by virtue of the laws of the State of Delawarc , with itsoffice and principal place of business located at 5333 WestheimerDrive , HOllston , Texas.

PAR. 3, At al1 times relevant herein , each of the respondents ortheir predecessors , has been and is now engaged in commerce, as

commerce " is defined in Section 1 of the Clayton Act, 15 U.S.c. 12and is a corporation whose business is in or affecting commerce , ascommerce" is defined in Section 4 of the Federal Trade Commission

Act , 15 u.se. 44.

THE YlERGER

PAR. 4. 1n July 1995 respondents agreed to merge the businessesof Dwight' s and PI.

THE RELEV A'iT MARKETS

PAR. 5. One relevant line of commercc in which to evaluate theeffects ofthe merger is the sale or licensing ofwel1 data. "Well datameans infornlation in any media concernng the location, pennitting,dril1ing or completion of any oil and gas wel1located in the Unit cdStates , and related infonnalion.

PAR. 6. One relevant line of commerce in which to evaluate theeffects of the merger is the sale or licensing of production data.

Production data" means information in any media concerning thelocations of, and volume of oil , gas , or water produced from any oilor gas we1110cated in the Unitcd States , and related infonnation.

Page 56: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSIO!\ DECISIONS

Complaint 124 FTC.

PAR. 7. One relevant section of the country in which to evaluatethe effects of the merger is the United States as a whole.

PAR. 8. The relevant markets set forth in paragraphs five, six , andsevcn arc highly concentrated whether measured byHerfindahl-Hirschmann Indices or two-finn and four-finnconcentration ratios, Dwight's and PI are actual competitors in therelevant markets. Dwight' s and PI are the only competitive providersof well and production data for many areas of the country. Themerged Dwight's/PI will have the largest market share in the relevantmarkets.

PAR. 9. Respondents are the only finns that have extensivemulti -state collections of historical information on oil and gasproperties. Finns lacking similar databases cannot effectivelycompete in the relevant markets. Assembling a database that matchesthe database possessed by either respondent would be very diffcultexpensive, and time consuming. This factor makes timely andeffective entry into the relevant markets difficult and unlikely.

EFFECTS OF THE MERGER

PAR. 10. The merger may substantial1y lessen competition in therelevant markets in the fol1owing ways , among others:

(a) By eliminating direct competition between Dwight' s and PI;(b) By increasing the likelihood that respondents wil1 unilateral1y

exercise market power; and(c) By increasing thc likelihood of, or facilitating, col1usion or

coordinated interaction;

cach of which increases the likelihood that thc prices of wel1 data andproduction data wil1 increase. The merger is also likely to lead toreduced service for customers. The merger may lead to a decline intechnological innovation due to loss of rivalry in making productenhancements. The merger may further lead to a deterioration in theaccuracy of the data compiled duc to loss of competition in securingand verifying data.

VIOLATIONS CHARGED

PAR. 11. The merger described in paragraph four constitutes aviolation of Section 5 of the FTC Act , 15 U.S. c. 45.

Page 57: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDIJGS , INC. , ET AL.

Decision and Order

PAR. 12. The merger described in paragraph four, ifconsummated, would constitute a violation of Section 7 of theClayton Act , 15 U. c. 45 , and Section 5 of the FTC Act , 15 U.S,

DECISION ANTI ORDER

The Federal Trade Commission ("Commission ) having initiatedan investigation ofthe proposed merger of Dwight's Energydata , Inc.

wholly-owned subsidiary of SoftSearch Holdings Inc.respondent"), and Petroleum Infonnation Corporation, a

wholly-owned subsidiary of GcoQucst International Holdings , Inc.respondent"), having been furnished with a copy of a draft

complaint that the Bureau of Competition proposed to prcsent to theCommission for its consideration, and which, if issued by theCommission, would charge respondents with violations of theClayton Act and Federal Trade Commission Act; and

Respondents , their attorneys , and counsel for the Commissionhaving thereafter executed an agreement containing a consent orderan admission by respondents of all the jurisdictional facts set forth inthe aforesaid draft of complaint , a statement that the signing of saida!,'Teemcnt is for settlement purposes only and does not constitute anadmission by respondents that the law has been violated as alleged insuch complaint, and waivers and other provisions as required by theCommission s Rules; and

The Commission having thereafter considered thc matter andhaving detennined that it had reason to believe that the respondentshave violated the said Acts , and that complaint should issue statingits charges in that respect , and having thereupon accept cd theexecuted consent agreement and placed such agreement on the publicrecord for a pcriod of sixty (60) days , and having duly considered thecomments received , now in further confonnity with the procedureprescribed in Section 2. 34 of its Rules , the Commission hereby issuesits complaint , makes the followingjurisdietionaJ findings and entersthe following order:

I. Respondent SoftSeareh Holdings, Inc. is a corporation

organized , existing, and doing business under and by virtue of thelaws of the State of Texas , with its offce and principal place ofbusiness located at Suite A , 1202 Estates Drive , Abilene , Texas. Itswholly-owned subsidiar, Dwight' s Energydata, Inc. is a corporation

Page 58: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Decision and Order 124 FTC.

organized , existing, and doing business under and by virtue of thelaws of the State of Delaware , with its office and principal place ofbusiness located at 1633 Firman Drive , Richardson , Texas. Dwight'Energydata, Inc. holds a 37 percent interest in Graphics InformationTechnologies , Inc. ("GITI"), a corporation organized , existing, anddoing business under and by virtue of the laws of the State ofDelaware. GITI has no operating assets , but since the formation ofTobin Data Graphics LLC in June 1994 , GITI has held a 50% percentinterest in Tobin Data Graphics LLC.

2. Respondent GeoQuest International Holdings, Inc. is acorporation organized , existing, and doing business under and byvirtue of the laws of the State of Delaware with its offce andprincipal place of business located at 5333 Westheimer DriveHouston , Texas. GeoQuest is a holding company and has nooperating assets. Its principal subsidiary is Petroleum InformationCorporation , a corporation organized , existing, and doing businessunder and by virtue of the laws of the State of Delaware , with itsoffice and principal place of business located at 5333 WestheimerDrive , Houston , Texas.

3. Tobin Data Graphics LLC is a Texas limited liability company,with its offce and principal place of business located at 114 CampStreet , San Antonio , Texas.

4. The Federal Trade Commission has jurisdiction ofthe subjectmatter of this proceeding and ofrespondents , and the proceeding isin the public interest.

ORDER

it is ordered That , as used in this order, the following definitionsshall apply:

A. Dwight means SoftScarch Holdings , Inc. , its directors

offcers, employees, agents and representatives, successors, andassigns; its subsidiaries , divisions , groups and affliates controlled bySoftSearch Holdings, Inc. , and the respective directors , offcersemployees, agents and representatives , successors and assigns ofeach.

E. PiC" means GeoQuest International Holdings, Inc. , its

directors , offcers , employees , agents and representatives , successors

Page 59: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , IKC. , ET AL.

Decision and Order

and assigns; its subsidiaries, divisions, groups and affliatescontrolled by GeoQuest International Holdings, Inc., and the

respective directors , offcers , employees , agents , and representativessuccessors and assigns of each.

e. TDG " means Tobin Data Graphics LLC , its directors , offcersemployees , agents and representatives , successors , and assigns; itssubsidiares , divisions , groups and affliates controlled by Tobin DataGraphics LLC, and the respective directors , offcers , employeesagents , and representatives , successors and assigns of each.

D. Graphics Information Technologies, Inc. is a corporationorganized, existing, and doing business under and by virtue of thelaws of the State of Delaware with its offce and principal place ofbusiness located at 1560 Broadway, Suite 903 , Denver, Colorado.

E. HPDI, LLC. is a Texas limited liability company with itsoffce and principal place of business located at 9300 ResearchBoulevard , Suite 306 , Austin , Texas.

F. Respondents means Dwight' s and PIe.G. The Merger means the proposed combination of the

businesses of Dwight' s Energydata, Jnc. , and Petroleum JnfoDlationCorporation.

H. Commission means the Federal Trade Commission.1. Relevant product means well data and production data.J. Well data means infoDlation in any media concerning the

location , peDlitting, drilling activity or completion of any oil or gaswell located in the Unitcd States , including U.S. terrtorial watersand related infoDlation.

K. Well header data means the following infoDlation regardingan oil , gas , or other well: API Number, Surface and Bottom HoleLocations (Township, Range , Section, Area, Block , Section , Survey,Abstract , and Footage Calls), Lease Name and ID , Well NumberPeDlit Number, Operator Name, Total Depth, Completion orPlugging Date, Final Status, Class , Field Name, Elevation, andDwights ID.

L. Production data means infoDlation in any media concerningthe identity, location and volume of fluids , including, but not limited

, oil , water, and natural gas , produced ITom or injected into any oilor natural gas well or leases located in the United States , including

S. territorial waters , and related infoDlation.M. Acquirer means the person or persons approved by the

Commission to acquire the specified data.

Page 60: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSIOK DECISIONS

Decision and Order 124 f.TC

N. Divest means to grant a perpetual , world-wide license to theAcquirer, with the right , subject to the tenns of this order, to usecombine with other infonnation, reproduce, market, assign or

otherwise transfer, and sublicense the specified data,O. Specifed data means digital well data and production data

that are included in one or more ofthe Schedule A products and thewell header data received by Dwight's from TDG under the DataExchange and Sales Representative Agreement entered into on June

1995.P. Schedule A products means those products listcd in Schedule

A ofthis order.

Q, Shared employee means any person whose salar or othercompensation for services rendered is paid , directly or indirectly, byboth TDG and Petroleum Infonnationlwight'

R. Petroleum Information/Dwight means the entity that iscreated as a resu1t of the Merger.

S. Royalty-based compensation means a payment to a vendoror licensor based , dircctly or indirectly, upon the revenue gcncratedby the sale of the vendor s or licensor s well data or production data.

II.

It is further ordered That:

A. Following completion ofthc Merger, respondents shall divestthe specified data, absolutely and in good faith , at no minimum priceconsistent with the provisions of this order, either to (1) HPDIL.L.C , pursuant to , and in accordance with the time frame set out inparagraph 2(a) of, the License Agreement for specified data entcredinto between Dwight' s and HPDI , L.L.C , dated September 18 , 1996(Exhibit A hereto); or (2) another person that receives thc priorapproval of the Commission, and only in a manner that receives theprior approval ofthc Commission. Provided , however , if, at the timethe Commission detennines to makc this order final , the Commissionnotifies respondents that HPDI , L.L.C , is not an acceptable acquirerthcn respondents shall not divest the specified data to HPDI , L.L.Cupon expiration of the divestiture period described in paragraphIILBA of thc order, respondents shall have no further obligation todivcst.

B. The purpose of the divestiture of the specified data is to ensurcthc continued use of the specified data in the same type of business

Page 61: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDlI\GS , INC. , ET AL

Decision and Order

in which the specified data is used at the time of the Merger, and toremedy any lessening of competition resulting from the Merger asalleged in the Commission s complaint.

C. After the specified data has been divested , respondents sha1lnot exercise any right they may have , whether at common law , inequity, or in bankuptcy or reorganization (including through

obtaining any equity interest in a reorganized debtor) or otherwise, totenninate the license granted under this order or to seek to have suchlicense tenninated , or to require , or seek to require , the Acquirer orits successor or assignee to return the specified data.

It is further ordered That:

A If respondents have not divested , absolutely and in good faithand with the Commission s prior approval , the specified data, theCommission may, on the date this order becomes final , or at any timethereafter, appoint either Ben C. Burkett , II , of Burkett Consulting,Dallas , Texas

, ("

Burkett") or someone else to act as trustee to divestthe specified data. In the event that the Commission or the AttorneyGeneral brings an action pursuant to Section 5(1) of the Federal TradeCommission Act, 15 U.S. c. 45(1), or any other statute enforced by theCommission , respondents shall consent to the appointment of atrustee in such action. Neither the appointment of a trustee nor adecision not to appoint a trustee under this paragraph shall precludethe Commission or the Attorney General from seeking civil penaltiesor any other relief available to it , including a court-appointed trusteepursuant to Section 5(1) of the Federal Trade Commission Act, or anyother statute enforced by the Commission , for any failure by therespondents to comply with this order.

B. If a trustee is appointed by the Commission or a court pursuantto paragraph III.A of this order, respondents shall consent to thefollowing terms and conditions regarding the trustee s powers , dutiesauthority, and responsibilities:

1. The Commission either (1) shall select Burkett to be the trusteeunder the tenns of a trustee agreement as set out in Exhibit B hereto;or (2) shall select another trustee subject to the consent ofrespondents , which consent shall not be umcasonably withheld. Thetrustee , if not Burkett, shall be a person with experience and expertise

Page 62: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Dccision and Order 124 fTC

in acquisitions and divestitures, Ifrespondents have not opposed , inwriting, including the reasons for opposing, the selection of any

proposed trustee , other than Burkett, within ten (10) days after noticeby the staff of the Commission to respondents of the identity of anyproposed trustee , respondents shal1 be deemed to have consented tothe selection of the proposed trustee.

2, Subject to the prior approval of the Commission , the trusteeshal1 have the exclusive power and authority to divest the specifieddata.

3. Within ten (10) days after appointment of the trusteerespondents shal1 execute a trust agreement that , subject to the priorapproval of the Commission , and in the case of a court -appointed

trustee, of the court , transfers to the trustee al1 rights and powersnecessary to pennit the trustee to effect the divestiture required bythis order. Such agreement may contain provisions requiring thetrustee to protect against unauthorized disclosure or use of thespecified data before the specified data is divested.

4. The trustee shal1 have twelve (12) months from the date theCommission approves the trust agreement described in paragraphII. 3 to accomplish the divestiture , which shal1 be subject to theprior approval of the Commission. If, however, at the end of thetwelve (12) month period , the trustee has submitted a plan ofdivestiture or believes that divestiture can bc achieved within areasonable time , the divestiture period may be extended by theCommission, or, in the case of a court-appointed trustee , by theCourt; provided , however, the Commission may extend this periodonly two (2) times for up to twelve (12) months each time.

5. The trustee shal1 have ful1 and complete access to the specifieddata and to the personnel , books , records and facilities related to thespecified data or to any other relevant information , as the trustee mayreasonably request. The trustee may require that a repository beestablished to al10w for examination of the specified data byprospective Acquirers. Respondents shal1 devclop such financial orother infonnation as such trustee may reasonably request and shal1

cooperate with the trustee. Respondents shal1 take no action tointerfere with or impede the trustee s accomplishment of thedivestiture. Any delays in divestiture caused by respondents shal1extend the time for divestiture under this paragraph in an amountequal to the delay, as detennined by the Commission or, for acourt-appointed trustee , by the court.

Page 63: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDIKGS INC. ET AL.

Decision and Ordcr

6. The trustee shall make reasonable efforts to negotiate the mostfavorabJe price and tenns available in each contract that is submittedto the Commission, subject to respondents' absolute andunconditional obligation to divest at no minimum price. Thedivestiture shall be made in the manner and to the Acquirer as set outin paragraphs II and II of this order, provided, however, ifthe trusteereceives bona fide offcrs from more than one acquiring entity, thetrustee shall submit all such bids to the Commission, and if the

Commission detennines to approve more than one such acquiringentity either for the whole data set or for any of the same parts of thedata set comprising the specified data, the trustee shall divest to theacquiring entity or entities selected by respondents from among thoseapproved by the Commission. The Commission may approvedivestiture of parts of the specified data to different acquiring entitiesbut in no event will there be more than onc Aequirer for either thewhole data set comprising the specified data , or any of the same partsof the data set comprising the specified data.

7. The trustee shall serve , without bond or other security, at thecost and expcnse ofrespondents , on such reasonable and customarytenns and conditions as the Commission or a court may set. Thetrustee shall have the authority to employ, at thc cost and expense ofrespondents , and at reasonable fees , such consultants , accountantsattorneys , investment bankers , business brokers , appraisers , and otherrepresentatives and assistants as are reasonably necessary to cany outthe trustee s duties and responsibilities. Thc tmstec shall account forall monics derived from the divestiture and all expenses incurred.After approval by the Commission and in the case of acourt-appointed tmstee , by the court , of the account of the tmsteeincluding fees for his or her services , all remaining monies shall bcpaid at the direction of thc respondents , and the trustee s power shallbe terminated. The trustee s compcnsation shall be based at least insignificant part on a commission arrangement contingent on thetmstee s divesting the specified data.

8. Respondents shall indemnify the trustec and hold the tmsteehannless against any losses , claims , damages , liabilities , or expensesarising out of, or in cOlmection with , the perfonnance of the tmsteeduties , including all reasonable fees of counsel and other expensesincurred in connection with the preparation for, or defense of anyclaim , whether or not resulting in any liability, except to the extentthat such liabilities , losses , damages , claims , or expenses result from

Page 64: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Decision and Order 124 FTC.

misfeasance, gross negligence, willful or wanton acts , or bad faith bythe trustee,

9. If the trustee ceases to act or fails to act diligently, a substitutetrustee shall be appointed in the same manner as provided inparagraph IILA of this order.

10. Consistent with the tenns ofthis order, the Commission or, inthe case of a court-appointed trustee , the court, may on its owninitiative or at the request of the trustee issue such additional ordersor directions as may be reasonably necessary or appropriate toaccomplish the divestiture required by this order. Notwithstandingparagraph IV.G herein, such additional orders or directions mayprovide for, among other things , giving the Acquirer the right to usethe record layouts specified in paragraph IV.A when sublicensing thespecified data, with provisions that insure against confusion of theorigin of the data.

11. The trustee shall have no obligation or authority to operate ormaintain the specified data.

12. The trustee shall report in writing to respondents and theCommission every sixty (60) days concerning the trustee s efforts toaccomplish divestiture.

IV.

It is further ordered That:

A. The specified data shall be delivered to the Acquirer inmachine-readable , usable fonn in the record layouts in Annex 1 ofthis order for well data, Annex 2A of this order for production dataAnex 2B ofthis order for the Texas oil test (WI 0) file; Anex 2C ofthis order for the Louisiana oil test (DM1R) file; and Annex 3 of thisorder for Petroleum Data System (PDS) data , which support theDwight s Petroleum Rescrvoirs CD-ROM. Respondents shall providethc Acquirer the specified data in the computcr code set in which therecords are maintained or in industry standard (8-bit) ASCII , at thc

Acquirer s option.B. Rcspondents shall provide the Acquirer with all existing

technical system documentation and user documentation rc1ating tothe specified data. Such documentation includes , but is not limited toa description of all data e1ements in Dwight' s Well Data System , a

description of thc data file in Dwight's A-File (unpacked) file; adescription of the tcst file in the Texas oil test (W10) file; a

Page 65: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , INC , ET AL.

Dccision and Order

description of thc test file in the Louisiana oil test (DM1R) filc;Dwight' s "Data Item Manual; " and the keys to all codes used byDwight' , whether maintained in machine-readable fomat , hard copy,or microfiJm,

C. Respondents shall provide Acquirer with data that is CUITent asofthe date of the divestiture for all data elements that were includedin any ScheduJe A product on the date on which the Commissionaccepts this order for comment, to the extent that data exist on anyDwight' s computer records.

D, Respondents shall make no claim to ownership, title, or

interest in any product derived from the specified data by theAcquirer.

E. Respondents are not required to provide the Acquirer the rightto sublicense well identifier codcs , field and reservoir codes , andoperator codes , to the extent that such codes are unique to Dwight'Howcver, respondents shall provide Acquirer with the right toprovide its licensccs with a cross-reference to enable a licensee toconvert fiom Dwight' s codes to the Acquircr s codes.

F. Respondents are not required to provide Acquirer (a) anylatitude or longitude data that respondents posscss solely by reasonof the Data Exchangc and Sales Representative Agreement entercdinto between Dwight' s and TDG on June 1 1995; (b) any softwareor any rights to use or subliccnsc any softare; or (c) any calcuJationof estimated future recoverable oil or gas reserves.

G, Respondents are not requircd to provide Acquirer the right touse the record layouts specified in paragraph IV.A when sublicensingthe specified data.

H. The Acquirer shall not transfer or sublicense any rights to anyspecified data in any manner that would have the effect of creatingadditional independent vendors for the whole or any part of thcspecified data. Notwithstanding the above , Acquirer shall have theright to , among other things: assign or otherwise transfer all of itsrights to and interest in all or part of the specified data to anotherperson; crcate distributorships or appoint sales agents for liccnsing ofthe specified data; or license the specified data to geologicaJ librariesfor use by their members on a read-and-print-only basis. In additionAcquirer shalJ have the right to enter into data exchange agreementswherein the recipient of the Acquircr s data has the right to marketand sublicense the specified data, provided that the recipient undersuch data exchange agreement shall not grant a license or other right

Page 66: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Decision and Order 124 FTC.

to specified data, or otherwise knowingly make the specified dataavailable , to any person unless such person has agreed not to transferor sublicense the specified data and not to make the specified datapublicly available. Respondents shall not enforce any restriction onthe Acquircr s right to transfer or sublicense the specified data in theevent that a court or an administrative agency, in a procecding

involving the respondents , issues a final order from which no appealhas been or can be taken , detennining that all or a portion of thespecified data is not protected intellectual property, Within 30 daysof the issuance of such an order, respondents shall notify theCommission and the Acquircr that restrictions on the transfer orsublicense contained in the License Agreement will not be enforcedwith respect to the portion of the specified data that was detenninedto be unprotected intellectual property.

1. Upon rcasonab1e notice to respondents from the Acquirerrespondents shall provide such assistance to the Acquirer as isreasonably necessary to ensure that the purpose of the divestiture ofthe specified data is accomplished. Such assistance shall includereasonable consu1tation with knowledgeable employees ofrespondents for a period of time suffcient to ensure that the

Acquirer s personnel are appropriately trained in the sources andprocessing of the data contained in the specified data. Respondentshowever, shall not be required to continue providing such assistancefor more than twelve (12) months from the date of the divestiture.Respondents may charge thc Acquircr at a rate no greater than theirdircct costs for providing such technical assistance. Direct costsconsist of expenses and the salary and benefits attributable torespondents ' employees actually providing assistance , for the timerequired for the provision of such technical assistance , and variableoverhead , including out-of-pocket expenses.

J. Respondents may take reasonable steps with respect to theiremployees to assure that the confidentiality of their proprietary datais not compromised, but respondents shall not imposenon-competition agreements that have the purpose or effect ofinterfcring with the ability of the Acquirer to rccruit or employrespondents ' employees.

K. Respondents , upon 24 hours advance notice by the Acquirershall provide Acquirer, at Acquirer s expense , reasonable access toand the right to copy, any data-source document or data inrespondents ' possession that was used to compile the specified datato the extent respondents have such data-source document or data at

Page 67: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , l'c. , ET AL.

Decision and Order

the time of the request. Respondents may charge the Acquirer onlyfor respondents ' direct costs in providing such access or copying,Direct costs consist of the salary and benefits attributable torespondents ' employees for the time required for the provision of suchaccess and copying, and variable ovcrhead , including out-of-pocketexpenses,

L. Within ten (10) days after divestiture of the specified dataDwight' s shall assign to the Acquirer all of its rights under andinterest in the Data Exchange Agreement of July 1 , 1993 , with TheIndependent Oil & Gas Service , Inc. ("Independent"), which relatesto well data in Kansas. IfIndependent consents to such assignmentPetroleum Informationlwight's shall promptly remove from itsproducts all data acquired from Independent under the Data ExchangeAgreement of July 1 , 1993 , and all predecessor agreements andprovide the data to the Acquirer in the record layout specified inparagraph IV. above; provided, however, that PctroleumInformation/Dwight' s shall be tYee to negotiate a new agreement withIndependent. Such new agreement may neither be exclusive norcontain a royalty-based compensation provision. If Independent doesnot consent to such assignent , Dwight's shall promptly terminatethe Data Exchange Agreement in accordance with its terms andprovide any data to which Dwight' s has an ownership right under saidAgreement to the Acquirer in the rccord layout specified in paragraphIV.A

M. Within ten (10) days after divestiture of the specified dataDwight' s shall assign to the Acquirer all of its rights under andinterest in the Joint Marketing Agreement of July 1 , 1994 , withMunger Oil Information Services , Inc. ("Munger ), which relates towell data for California, Oregon , Pacific Federal Offshore , Alaskaand Washington, If Munger consents to such assignment , PetroleumInformation/Dwight' s shall promptly remove from its products alldata acquired from Munger under the Joint Marketing Agreement ofJuly 1 , 1994 , and all predecessor agreements and provide the data tothe Acquirer in the format specified in paragraph IV.A above;provided , however, that Petroleum Informationlwight' s shall be tYeeto negotiate a new agreement with Munger. Such new agreement mayneither be exclusive nor contain a Royalty-based compensation

provision. If Munger does not consent to such assignment , Dwight'shall promptly terminate the Joint Marketing Agreement inaccordance with its terms and provide any data to which Dwight' s has

Page 68: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Decision and Order 124 f.TC.

an ownership right under said Agreement to the Acquirer in therecord layout specified in paragraph IV.

It is further ordered That respondents shaJl provide to theCommission staff or a Repository designated by the Commissionstaffa copy of the specified data that was provided to the Acquirera copy of all Schedule A products as of the date on which theCommission accepts this order for comment, and a copy of allDwight' s CD-ROM products published and offered for sale tocustomers immediately prior to the divestiture of the specified data.

VI.

It is further ordered That, for a period of ten (10) years from thedate this order becomes final , respondents shall not , without priornotification to the Commission , directly or indirectly:

A. Acquire any stock , share capital , equity, or other interest inGraphics Information Technologies , Inc. , or in any person engagedin the distribution of a relevant product at any time within the twoyears preceding such acquisition;

B. Enter into any agreements or other arrangements with any

person whose principal business is distributing a relevant product , toobtain direct or indirect ownership, management , or control of anypreexisting data bases that are or were used in such business; or

C. Acquire from anyone entity cumulatively during any periodof three consecutive calendar years (a) the exclusive ownership ofrecords containing wcll data covering morc than 75 000 wells in anyone state except Texas , or 250 000 wells in the State of Texas or (b)either the exclusive right, or a non-exclusive right with a

royalty-based compensation, to market well data covering more than000 weJls in anyone state except Texas , or 250 000 weJls in the

State of Texas. Respondents shall have the right to rcly upon thesupplying entity s best estimates, at the time of the acquisition

concerning the number and locations of the covered wells. Indetennining whether notification may be required by this provisionwell records that have becn included in a previous notification underthis provision or under 15 U.S.c. 18a shall not bc considered.

Page 69: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS ET AL

Decision and Order

VII.

It is further ordered That the prior notifications required byparagraph VI of this order shall be given on the Notification andReport Fonn set forth in the Appendix to Part 803 of Title 16 of theCode of Federal Regulations as amended (hereinafter referred to asthe Notification ), and shall be prepared and transmitted in

accordance with the requirements of that part , except that no filing feewill be required for any such notification, notification shall be filedwith the Secretary of the Commission, notification need not be madeto the United States Department of Justice, and notification isrequired only of respondents and not of any other party to thetransaction. Respondents shall provide thc Notification to theCommission at least thirty days prior to consummating any suchtransaction (hereinafter referred to as the " first waiting period"). Ifwithin the first waiting period , represcntatives of the Commissionmake a written request for additional infonnation, rcspondents shal1not consummate the transaction until twenty days after substantiallycomplying with such rcquest for additional information. Earlytennination of the waiting periods in this paragraph may be requestedand, where appropriate , granted by letter fTOm the Bureau ofCompetition.

Provided , however, that prior notification shall not be required byparagraph VI of this order for a transaction for which notification isrequired to be made , and has been made, pursuant to Section 7 A ofthe Clayton Act , 15 U. c. 18a.

VII

It is further ordered That within thirty (30) days aftcr the datethis order bccomcs final and every thirty (30) days thereaftcr untilrespondents have fully complied with the provisions of paragraphs II

, IV , and V of this order, respondents shal1 submit to theCommission a vcrified written report setting forth in detail thcmanner and fonn in which they intend to comply, are complying, orhave complied with this order. Rcspondents shal1 include in theircompliance reports , among other things that are required from timeto time , a ful1 description of the efforts being made to comply withthe order.

Page 70: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSIO'\ DECISIONS

Dccision and Order 124 FTC

IX.

It is further ordered That:

A. Within ten days of receiving notification from the Commissionstaff that the specified data has becn divested to the Acquirer, TDGshall offer to the Acquirer, its successor, assignee , agent or distributor(collectively, "Acquirer" for purposes of this paragraph), a SalesRcpresentative Agreemcnt in the fonn of Exhibit C hereto. The tennsof any sales representative agreement between TDG and the Acquirershall cover the same products and be at least as favorable to theAcquirer as the tenns agreed to from time to time between TDG andPetroleum Infonnation/wight's. The Sales RepresentativeAgreement for the Acquirer shall be non-terminable by TDG , exceptunder the following circumstances:

1. The breach of matcrial terms by the Acquirer or the Acquirerinability to pay. In the case of such a breach, the obligations of TDGshall resume upon cure of the breach. In the case of receivcrship orvoluntary or involuntary bankruptcy, or the institution of proceedingstherefor , the obligation of TDG under this paragraph may besuspended until thc appointment of a trustee or a successor to operatethe Acquirer s business or a debtor in possession; or

2. TDG no longer maintains a Sales Representative Agreementwith Petroleum 1nfonnationJDwight' s and there are no other jointselling arrangements between TDG and PetroleumInfonnationJDwight' s for a particular product.

B. TDG shall not disclose to any offcer, director, or employee ofPetroleum InfonnationJDwight s or any sharcd cmployee anyinfonnation that TDG receivcs from the Acquirer regarding (I) theAcquirer s actual or prospective customers , (2) the eontent of anycustomer proposals or offers made by the Acquirer , or (3) the tennsof any individual customer dealings with TDG or the Acquirer.

C. Within 30 days ofreceiving notification from the Commissionstaff that the specified data has heen divested to the Acquirer , TDGshall submit to the Commission a copy of the Sales RepresentativeAgreement entcred into with Petroleum InfonnationJDwight' s and

with the Acquirer. For thrce years after the datc this order becomesfinal , TDG shall submit to the Commission any revisions oramendments to such agreements within thirty (30) days of theirexecution.

Page 71: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDNGS , 1r-C. , ET AL.

Decision and Order

It is further ordered That , for the purpose of detennining orsecuring compliance with this order, and subject to any legallyrecognized privilege , upon written rcquest and reasonable noticecach respondent and TDG shall pennit any duly authorizedrepresentative of the Commission:

A. Access , during offce hours and in the presence of counsel , toinspect and copy all books, ledgcrs, accounts, correspondence

memoranda and other records and documents in the possession orunder the control of respondent relating to any matters contained inthis ordcr; and

B. Upon five (5) days ' notice to the appropriate respondent , andwithout restraint or interference , to intcrvicw offccrs , dircctors , oremployees of the respondent , who may have counsel present.

XI.

It is further ordered That respondents and TDG shall notify thcCommission at least thirt (30) days prior to any proposed change inthe corporate respondents or TDG such as dissolution , assignmentsale resulting in thc emergcnce of a successor corporation , or thecreation or dissolution of subsidiaries or any othcr change in thecorporations that may affect compliance obligations arising out of thcorder.

SCHEDULE A

1. Dwight s Production Data eD.-Rom ProductsWest Coast Area , consisting of California , Oregon , Pacific Federal OffshoreAlaskaGulf Coast Area , consisting of Arkansas , Louisiana , Mississippi , AlabamaFlorida , Federal Offshore , Coastal Counties of TexasMidContinent Area, consisting of Arkansas , Kansas , \1ichigan , Oklahoma andTexas Railroad Commission District 10.Texas Area , consisting of all of TexasRocky Mountain Area, consisting of Arizona , Colorado , Montana , New'Iexico , c-orth Dakota , South Dakota , Wyornmg, c-ebraska , c-evada , Utah

II. DWight's Discover SCOUT CD-ROM ProductsGulf Coast Area, consisting of Arkansas , Louisiana , :\ississippi , AlabamaFlorida , Federal OffshoreMidContinent Area , consistmg of :\orthern Arkansas , :\ichigan, Oklahomaand Texas Railroad Commission District 10Texas Area , consisting of alJ of Texas

Page 72: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Decision and Order 124 F.

Rocky Mountain Area, consisting of Arizona , Colorado , Montana , NewMexico, Korth Dakota , South Dakota , Wyoming, Nebraska , Nevada, UtahIdaho

II. Dwight s Discover CD-ROM ProductsOklahoma Area , consisting of OklahomaRocky Mountain Area, consisting of Arizona, Colorado , Montana, KewMexico , North Dakota , South Dakota, Wyoming, Nebraska, Nevada , UtahIdaho

IV. Dwight s Petroleum Reservoirs (DPR) With Operated Production

CD-ROM ProductsState of AlaskaState of CaliforniaPennan BasinTexas & Southeast New MexicoState of OregonGulf Coast Area, consisting of Alabama , Arkansas , Florida , Gulf of MexicoOffshore , Louisiana , Mississippi , Texas Railroad Commssion Districts 2 , 3and 4

MidContinent Area, consisting of Arkansas, Kansas, Oklahoma, Texas

Railroad Commssion District

Rocky ountain Area , consisting of Arizona, Colorado , :vontana , NorthDakota , South Dakota , Utah , Wyoming, New Mexico

Page 73: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , I='C. , ET AL.

Decision and Order

ANCEX 1

We;, 2u:i)e;c

: of 7

ord Layout ror Comma Delimited FiJe

TIe opooo. ID I:rt ""TIS in!Or:::o. i. 1

::= ~~~

!cr.1 ?r.-V.: .It:

I'Cl wr i.pcrtg "..o. irHLJ Ipn: c..

:.\

': :I::DUI e::1

!d""j".l r=r. i:1.;'.."" by =. F ue:tt 11!::Jf e A.::C-IUr:I.':c. ': double qu. :I::y 5e ..-;eal q-:tc is rod 1. l!e:i

.u:\

!'..

=IDRLI' (OO",o11ft"" J

'IJ.N"w.o A': CC,\ c:'NC:CE." wrC:OE:

c.:;E-;CN

N(1)W.::

""",

1Vc:

J. NO!tTH:SCtr.1".l::,ONC1'M:E.i"f'J, .C!:rwP'Jt

""''""''""""

OH!'

=""==.

C!rL-: . Y.w::Jrt ':,.'OC'lit rcJU

..

--I';:CNA.CCC-E

"""'

;:C:/iIU.o':':CN AC C:CE

ru r.A':J:5f"-"r.A""'::5

::':\TTCX'C; ':;rT-7:.'::rS'7!'" c."WC\CF!Cp' r-'

. . .-:: "'''"' "" , ,,"". "

,C",""1:":I '-'' '-r:. =-=v,

,. "",

Page 74: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

Dccision and Order

FEDERAL TRADE COMMISSION DECISIONS

AJ''NEX 1

Well DataAr.nex

Page 2 of 7

f"""

""""

"I(",.. If1U':-u.s"a

Pa ' CA'!.\I'K. .

"'"'''' (""

'nJ"":.1SJ::'::I'C M."I

'U':Ct'!)Jr:.. ':)Jt:.'rAIrcTKA'J 'lAla7ra'n 10'1 '\ AG

"'''

DAT'

""mro

"" "" -=-

I:CACA':ASC::':A

", ."". ""'-

\"u' ic'

":-

"'''-=''.o:t".,,

124 F.

Page 75: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , IJc. , ET AL.

,,,,,,,,""-=

':Cf1"':ro':CNNArc':.o J, c:

'=IDKEfO ': I.."" "' OC1

cr NL"11Us:':CNsz':CH':Cf'\

- l'':IL:N

""""

n...=:s;t.

':.

CN.5

':.

cs

=:::( :=."", ,,,"_.

jU":cs , n.B..o ""''I

""""""""""

1"':Cf

~~~--, --.,,.

c--

AI''NEX 1

Dccision and Order

lye II Ua;a\r.rex

Pase J 0: 7

="=

r-..

)J N., , c';"Ir-..

?.uc:J".. x. " . CC

Page 76: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

Decision and Order

FEDERAL TRADE COMMISSION DECISIONS

AN0EX 1

e!!

"-'

Cj l"

.rJ1ex 1

Pag 4 of 7

c.J.P"-"

""'"

l:'!l ftOCM""o.

'r'rc:( Ia)r.r"'-Dn'M ""aao=""J"':!irc-rOi). o:S''\TU

"!!N

==""""

IN '\'nC

'\'!

f':N.JI"P'la:s.rn:Nn.

== ""..~~~

sm-D

=, v.bC

.. .-.=,,,

4nu

--o;_ oi=.""-"

124 FTC.

Page 77: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , INC. , ET AL.

Decision and Order

ANKEX 1

\'k; I Da:a.'.r.r,

?age 0 f i

,==

F"..Ii'

.."""==""

Cts:'J':CN c:( nJ""!N':CN ;sol

fa':CNN.rcl! CN N:

SHWJV.":rE

r'..x."

""'"

I' T;a: m.'1':CN

!N':CN 'I c: I.. :11

':..=='

":CtJ.

- F"WJ'I.==a1"..H.'

""'' ("'"".

u:1tT''f=I!-._I"""1

""='""""

'C:'. 'f:v :'t,,

""""..",,"

Page 78: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

Decision and Order

FEDERAL TRADE COMMISSION DECISIONS

ANcEX 1

We : I ::':1ex 1

e 6 of 7

:N..P!1W '

WO'"'0C

tt5';::X:ENa

,..

Cf&CI.':CN c: :

=",oncc \I"Mve"t c.;:VCU;1.I:

ve"lWAw.. vc:.:.

pg.

J)IJIo;=lnlJ.)

WOID

="'

m: u;"D Ntaaf,"Z'rc:( lIJ

'M'n(

""''

rcna N.P",:J:J.c:=CO2n. ':w'E F"..C)IH:NSX:Nc.

='=

c:1.c.va1.

""'""

1fTD.."'

..""

)oCI

':..-:, ,,,..

c.:,,,,,

N(1:\

124 FTC.

Page 79: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDI'\GS , INC , ET AL.

Dccision and Order

ANNEX 1

\\ie II Ci te.A."'..ex :

7 of 7

':"'

f.u1"""NA'

'milD

tmDr

~~~

ia.rJ\? .J':c:

JJ MJS1AAA C:7r

C;' C:E:

~~~

M?""=M? "" NAC:L'1

L"',

. .'..

''"T'

":

8C "" "r.'" ::,

~~~ :"':"":" "";:

Page 80: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE CO\,\,ISSIO)! DECISIONS

-,

IT,..S

IHI gJ3li'rT

"I -iI JO.."".ft i ::

?mb I jQ' ..

." ..

a.J'"'; t: : ..no; I-!

l =1

fi

1-'" -

i 21I ;.

..c1, -

:: I:;

,.dS

,-.

. :i-

!::;; ! =

- i

Decision and Order

A!\ EX 2

Prcx JCI ur: UIJAnr.ex: 2

Pag t cf J

~~~::

:; 3 i:!

:j

:""1-

'r-' tJ .011..040 i-"'

:j = '

...,,, i= I

E'13 l:J

f-i

7""

s I I l:::

I:; l =1

1-' O1 1 O1

j j : '"

I _ 7_, J 3

, 1 I :: 1 -

I . ,

::'

1 -

! ' ~~~

i=j:

-- -

.'L."'::

!"',

,"0:" I -

..",, - '" -

124 FTC.

,."!..-" '

.c'

11

':" j

" t'

::j ,:,, ::

::oUH 11'.'

:: = ,- --

...rt.'Cf\o.

~~~~

i 3 I- 1..

.., .."'''

1 -

E 1-

.."', "" -

; :: i -

I l1'..-

" -; -= ... .' :

i ::

.. ..

: I -

::-

i -

- , -

:ij .II'"::,if.

''' -

_0'

= 1

::1t-.

S I

;-.'

w .

;1:

_..

Page 81: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , INC. , ET AL.

i ..

,., j

.3

EI

1::; =i

~~~: ="

t-l::

I ii

I =i

I j

':' :' '.= -\-.

"1 -

i :::-

i -

, -

I j

' .- .

i -i -

I ,"- -

"".

Decision and Order

AKKEX 2

~~~

..c icn Cae.'

An.rex 2 B2 of J

8! =

E.J :::I -

1-:: -

I =

, ::

I "..,

- , - j =-" -

I I:='

I :

t::1

I j tl!

LJd

-" -

f. -

r-'- I -

, -

I =f- .

I =

\-.-., =

i= 1 -

, -

I == i =

: =

:= i =

. -

I -

,..".

E,,

! ::- ='" -';

I =

- ,\:,,,; -

- I =

.. -

'- 1 =

, -

Page 82: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Decision and Order

AN)EX 2

P'oc.:ction L\Eta

An,ex 2 CPa.e J of J

:3 J;g

=1

I j q J 3

. J=1

Jg 1 ElJ

"'

I ' . 1 d g

I )3

E" 3 I::

I ,1 Enf- -

, ::

:: I ::

-, -

"',,1 -l =

I :,""''( f- '

'''1S

.. -",..

'o.,

;: = ..:: -=! =

tl3:i:;

j "

J OJ

H!3

;, mi1 E-

,,

"'-J':I.

-- ..

8. 3

I ,: fII ", I""

i =:

';;-:

1 =".s -

!::, -

I =

. -

J-.

-, -

124 F.

Page 83: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , INC. , ET AL.

Decision and Order

ANJ\EX 3

DWIGHT'S

PETROLECM DATA SYSTEM

TOTL FORMAT

DPDS/TOTL Fixed-Format Specification

Tape Strcture

A DPDSrrOTL Fixed-Format data tape contains data from the Dwight's PetrolcumData System Oil and Gas fie (TOTL) database. Tberc are three versions of theDPDS/TOTL Fixed-Format fie:

The Initial Load format will contain all information about each Field orReservoir.

The L"pdate fonnat wil contain only information that has been updated since

the previous release.. The Special format wil contain all information about each Field or Reservoir

in a custom-defined area.

There are multiple physical fies per tape. Each tape begins with a Tape HeaderFile. This file contains one record, a Tape Header Record (Record type 0000),which identifies the information present on the tape. The remaining files aredivided into TOTL Area Groups. Each TOTL Arca Group has:

File Header File. This fie contains one record , a File Header Record (RecordType 0001), which identifies the DPDS Area to which the data file applies.

Data File. This file contains the actual DPDS/TOTL data. Refer to the attachedtape specifications for the format of the data file. The last record in the Data FilewIll always be a File Total Record (Record Type 9900). The File Total Recordcontains contr01 totals which can be used to verify that the update completedsuccessfully.

The last fie on the tape is a Tape Total File. This fie contains one record, a Tape

Total Record (Record Type 9999), which contains control totals which can be usedto verify that the update completed successfully.Each file on the DPDS/TOTL Fixed-Format tape has a record length of 140. Thcrecords are blocked at 114 records per block for a blockslze of 15 960.

Tapes can be produced using either the EBCDIC or ASCII character set.Tapes can be produced at a density of 1600 or 6250 bpi.Dwight s uses industr-standard 2400 feet , 9-track tapes.

Record Type RclationsbipsEach record contains a Unique Record identifier and a Transaction Code. Theunique Record Identifier (L'NIQID) will specifically identify one , and only onefield or reservoir record in DPDS/TOTL. The Transaction Code indicates the actionto be taken to update the data associated with the TOTL field or reservoir record.There are three Transaction Types:

Page 84: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIO)!S

Decision and Order 124 FTC.

The Add Transaction Type (A) indicates that the data on the transaction recorddid not previously exist and should be added to the file. An Initial Load tape willconsist of only Add transactions. If an Add transaction is encountered on RecordType 0100 , this indicates a new field or reservOIr to be added to the file. An Addtransaction on other record types indicates that the data on that transaction recordshould be added to the field or reservoir record identified by the Unique RecordIdentifier.

The Change Transaction Type (C) indicates that one or morc data items on thetransaction record has been updated. All data items on the TOTL field or reservoirrecord should be updated with the values provided on the Change tTansaction.

The Dc1ete Transaction Type (D) indicates that all data items on thetransaction record have been deleted from the DPDS/TOTL file. If a Deletetransaction is encountered on Record Type 0100 , ths indicates that the entire fieldor reservoir record has bcen deleted from the DPDS/TOTL file. A Deletetransaction on other record tyes indicates that only those data items on thattransaction have been deleted from the field or reservoir record.

Data TypesThere arc three data types used by the DPDS/TOTL Fixed-format Specification.The Data Type is mdicated by an A , N , or L in the "Type " column of the Fixed-Format Specification that fol1ows. The three data tyes arc:

The Alpha-Numeric data type (A) indicates text data and can contain lettersnumbers , and special characters. Alpha-numerica data is left-justified.

The 1\umeric data tye (N) contains a numerica value only. The numbers areFORTRA)J-compatible. The numbers do not contain leading zeros , and have anexplicit decimal point ifnot a whole number. A numeric a specification is providedin the "Format " column. The numeric specification is given in the fonnat "where "W" is the total field width , and "D" is the number of decimal digits.

The Logical data type (L) contains either a " 1" or a blank. The !I I" indicatesa "TRUE" condition, and the blank indicates a "FALSE" condition.

EXHIBIT A

LICENSE AGREEMENT FOR SPECIFIED DATA

This Agreement is made by and between Dwight s Energydata , Inc. , a

Delaware corporation , located at 1633 Finnan Drive, Richardson, Texas 75081(hereinafter referred to as "DwIght's ), and IIPDI , L.L.c. , located at 9300 RescarchBoulevard , Suite 306 , Austin , Texas (hereinafter referred to as "Licensee ). ThisAgreement replaces and supersedes an Agreement between the partes signed as :vay 2 , 1996 , which earlier Agreement shall be null and void.

I. LICENSE A'\D DATA

(a) Dv,!ight s hereby grants to Licensee , subject to the tenns and provisions ofthis Agreement, a perpetual , worldwide , nonexclusive license (the "License ) to

use , combine with other information , reproduce and market, with the rightsprovided herein to sublicense , assign or otherwise transfer, the digital well data andthe digital production data described on Schedule A hereto (collectively the

Page 85: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDIKGS INC. ET AL.

Decision and Ordcr

Specified Data ). The License shall become effective on the Effective Date (ashereinafter defined) upon the payment by License of the initial installment of theLicense Fee (as hereinafter defined) in accordance with paragraph 3 hereof.

(b) Dwight s shall deliver the Specified Data to Licensee in machine-readablefonn in thc record layout in Annex I to Schedule A hereto (for well data), in therecord layouts in Annexes 2A , 2B and 2C to Schedule A hereto for production datathe Texas oil test (WIO) file and the Louisiana oil test (DMIR) file) and II therecord layout II Annex 3 to Schedule A hereto (for Petroleum Data System (PDS)data). The Specified Data so delivered shall be in the computer language in whichDwight s records therefor are maintained or, ifrequested in writing by the Licenseeat least ten days prior to the Effective Date , II industr standard (8-bit) ASCII , orin any other mutually agreeable fonnat. Delivery of the Specified Data shall be inaccordance with the following schedule:

(I) A copy of the well data portion of the Specified Data , cunent as of eachdate of delivery, shall be delivered (A) II a single delivery within ten days after theEffective Date L J.

(ii) A copy of the production data portion of the Specified Data for the statesof Texas , Louisiana , Oklahoma , New Mexico , Kansas and Colorado and for GuldOffshore (the "HPDI Areas ), cunent as of each date of delivery, shall be delivered(A) in a single delivery within ten days after the Effective Date L J.

(iii) A copy of the production data portion of the Specified Data for all areasother than the HPDI Areas (the "Kon-HPDI Areas ), current as of each date ofdelivery, shall be delivered (A) in a single delivery within ten days after theEffective Date L 1-

(iv) A copy of the PDS data portJOn of the Specified Data , cunent as of eaehdate of delivery, shall be delivered (A) II a single delivery within ten days after theEffective Date L J.

The Specified Data so delivered sha11 be accompanied by well identifier codesfield and reservoir codes and operator codes created by Dwight s for use byLicensee to the same extent as Dwight s has created such codes for its own use.

(c) Each portion of the Specified Data shall be cunent as of the date of itsdelivery for all data elements included in the products listed on Schedule A heretothat are part of the delivery. Dwight s shall have no obligation to provide updateswith respect to Specified Data after the date of delivery thereof L J.

(d) Notwithstanding the foregoing, and subject to paragraph 1(f) hereofLicensee shall have no right to market , sublicense , assign or otherwise transfer therecord layouts and formats set forth in Annexes 1 , 2C or 3 to Schedule Ahereto , any proprietary well identifier codes , field and reservoir codes or operatorcodes of Dwight s or any other proprietary formats of Dwight's. In no event shallLicensee acquire any right under this Agreement to (i) any latitude or longitudedata that Dwight's possesses solely by reason of the Data Exchange and SalesRepresentabve Agreement dated June I , 1995 , with Tobin Data Graphlcs LLC("TDG" ), (ii) any software (or any intellectual property or other rights in respectthereof) or (iii) any calculation of estimated future recoverable oil and gas reserves."Vithout limiting the foregoing, it is acknowledged that the Agreement ContainingConsent Order (In the Matter of SoftSearch Holdings, Inc. , and GeoQuestInternational Holdings , Inc. , File No. 951-0130) in the form executcd by DWlghtfor acceptance by the Federal Trade Commission (the "Order ), contemplates that

Page 86: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Decision and Order 124 FTC

Licensee shall be offered a Sales Representative Agreement by TDG covering thesame products and on as favorable terms as those agreed to from time to timebetween TDG and Petroleum Informationlwight' s (as hereinafter defined).

(e) At the time of delivery of each porton of the Specified Data. Dwight s shallprovide Licensee for its own use a copy of all tcchnical system documentation anduser documentation relatig to such Specified Data then in existence. With respectto the Specified Data as a whole , such documentation shall include , but is notlimited to , a description of all data elements in Dwight s Well Data System, a

description of the data file in Dwight's A- File (unpacked) fie; a description of thetest file in the Texas oil test (WID) file; a description of the test file in theLouisiana oil test (DMIR) file; Dwight s "Data Item Manual" and the keys to allcodes created by Dwightls for use by Licensee pursuant to paragraph l(b) above.

(I) On the EffectIve Date , Dwight s shall provide Licensee, in rnachine-

readable fonn as described in paragraph l(b) above, with a cross-reference to

enable License and its Sublicensees to convert from Dwight's proprietary codes tonon-proprietary codes.

2. LICENSE TERM

(a) This Agreement shall becornc effective on the 1atcst of (1) the date theassets of Dwight s are tTansferred to Petroleum Informationiwight , L.L.c.

PetToleum TnfonnatioruTIwight ) pursuant to the Formation Agreement to beentered into by Dwight s and GeoQuest International Holdmgs , Inc. , or (ii) the datethe order becomes final; or (iii) the date the Federal Trade Commission approvesdivestiture to HPDI. L.L.c. pursuant to the order , n (the latest such date being herein

refeITed to as the "Effective Date ), and shall remain in effect unless and until it isterminated in accordance with the terms hereof or applicable law. Dwight s shallhave no obligation to Licensee to effect such transfer or obtain such issuance orapproval, any of which may be abandoned at any time for any reason or no reason.:'othing contained in the immediately preceding sentence is intended to , or shallpermit Dwight s to license the Specified Data to a higher bidder pursuant to theorder while Licensee is ready, willing and able to perform its obligations under thisAgreement, if such transfer occurs and the Federal Trade Commissioncontinues to require the License as contemplated by the order.

(b) Dwight' s shall have no right, whether at common law , in equity, or inbankptcy or reorganization (including through obtaining any equity interest ina reorganized Debtor) or otherwise , to termate the License or to seek to have theLicense terminated, or to require , or seek to require , the Licensee to return theSpcCJfied Data.

(c) Licensee may terminate the License only by assignment as provided inparagraph 6 , herein.

3. LlCE:-SE FEE

(a) L1censee shall pay to Dwight s the sum of Sr J for the license grantedhereunder (the "License Fee ) io accordance with the followmg schedule: ( J. Theamount of the License .Fee remaining unpaid from time to time shall bear interestat the rate of ( J% per annum, compounded monthly, payable annually on eachanniversary of the Effective Date and on the date on which such amount matureswhether by acceleration or otherwise. Such amount shall be evidenced by a

Page 87: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , INC. , ET AL.

Decision and Order

negotiable promissory note of Licensee , payable to the order of Dwight ' , in formand substance reasonably satisfactory to Dwight , which shall be delivered byLicensee to Dwight s on the Effective Date.

(b) Licensee shall be responsible for and shall pay all sales , use , transfer orother taxes , however designated, levied or based on the License Fee, the Licenseor any other rights granted under this Agreement , exclusive of taxes based on theoverall income or capital of Dwight '

4. PROPERTY RIGHTS: CO:-FIDE'\TIALITY

(a) o title to or ownership interest in any of the Specified Data or any otherinformation provided pursuant to this Agreement is transferred to Licensee hereby.The Specified Data and all such other infonnation, regardless of the fonn, fonnatand media in which they are contained , are and remain the exclusive property andtrade secrets of Dwight s notwithstanding the license granted hereby. Dwightretains all copyright interests in the Specified Data, whether published or

unpublished , all trade secrets and all other intellectual or proprietary rights in theSpecified Data and other information provided pursuant to this Agreement.

(b) Licensee hercby acknowledges that the Specified Data and other

information provided pursuant to this Agreement contain trade secrets and otherproprietary information of Dwight

(c) Licensee shall keep the Specified Data and such other information receivedfrom Dwight s under this License confidential in accordance with this Agreement.Licensee shall take all steps necessary or reasonably requested by Dwight s to

assure that it, its sublicensees and others to whom Licensee may from time to timemake the Specified Data available in accordance with this Agreement shall avoidunauthorized publication , use or disclosure of the Specified Data, and otherwiseshall not permit the Specified Data to become publicly available.

(d) Licensee shall have no right to use the name "Dwight " or "PI" orPetroleum Information" (or any variations thereof) or any trademarks or service

marks of Dwight s or Petroleum Information s in any manner, and Licensee shallnot use the name "Dwight " or "PI" or "PetToleum Information " (or any variationsthereof) or any trademarks or service marks of Dwight s or Petroleum Informationin describing, marketing, using or sublicensing the Specified Data , or in any othermanner. The foregoing is not intended to prohibit Licensee from (i) insertingaIl0uncements in the trade press , for a period not to exceed six months from theEffective Date , that on fdateJ Licensee acquired the Specified Data from DwightEnergydata as a result of a consent order issued by the Federal Trade Commissionrelating to the merger of Dwight s and Petroleum Information Corporation or (ii)responding orally and in good faith, but not as part of any marketing effort , toinquiries concerning the source of the Specified Data.

5. UPDATES AND SUPPORT

Dwight s shall not be obligated to update or support any of the Specified Dataafter the Effective Date , except for L J the tcchnical assistance provided pursuantto paragraph 9 hereof.

Page 88: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Decision and Order 124 FTC.

6. SUBLICENSES , ASSIGNMENTS AND OTHER TRANSFERS

Licensee shall not sublicense , assign or otherwise transfer any rights to anySpecified Data in any manner that would have the effect of creating one or morevendors for the while or any part of Specified Data in addition to Licensee.Notwithstanding the foregoing. Licensee shall have the right to do the following:

(a) Sublicense all or part of the Specified Data without (i) the right to furthersublicense , or (ii) the right to disclose to the public;

(b) Assign or otherwise transfer all of its rights to and interest in all or part ofthe Specified Data to another person; provided that (i) Licensee provides Dwight'with prior WTitten notice of such assignment or other transfer, including withoutlimitation the name and address of the assignee or transferee, (ii) the assignee ortransferee agrees in writing to be bound by all of the provisions hereof applicableto the Specified Data , and (iii) Licensee shall not retain any rights to or interest inany Specified Data assigned or otherwise transferred;

(c) Create distributorships or appoint sales agents for Licensee s data productsthat include the Specified Data , under agreements appropriate for the distributionof sublicenses of such products; provided that the distributors and sales agentsagree in writing to be bound by all of the provisions hereof applicable to theSpecified Data , including without limitation the sublicensing thereof;

(d) Grant sublicenses for Licensee s data products that include the SpecifiedData to geological libraries for access through such libraries only on a read-and-print-only basis; and

(e) Enter into bona fide data exchange agreements , wherein the recipient ofrights in respect of the Specified Data has the right to market and sublicense theSpecified Data; provided that such recipient shall not grant any subbcense of anyof the Specified Data , or otherwise knowingly make any of the Specified Dataavailable , to any person unless such person has agreed in writing not to sublicensethe Specified Data and not to make the Specified Data publicly available; andprovide also that such recipient agrees in writing to be bound by all of theprovisions hereof applicable to the Specified Data.

All sublicense , assignments and other transfers permitted by this paragraph 6shall be in writing and shall expressly provide that the restrctions contemplated byparagraph 4( c) and this paragraph 6 shall be enforced by Licensee , its licensor andthe respective successors and assigns thereof. Upon Dwight's reasonable requestfrom time to time. Licensee shall provide Dwight s with the forms of agreementused by Licensee so as to verify compbance by Licensee with the requirements ofthis paragraph 6.

7. LIMITATION OF LIABILITY: INDEMNIFICAT10:'

(a) Dwight's represents and warrants that it holds such right , title and interestin the Specified Data as may be required to permit Dwight s to enter into andperform its obligations under this Agreement. THE SPECIFIED DATA AND THE MEDIA

CPON WHICH THEY ARE SUPPLIED ARE PROVIDED "AS IS. rr DWIGHT S MAKES NOOT! JER REPRESENT A nONS AND W ARR TIES , EXPRESS OR IMPLIED , INCLUDING , BUTNOT LIMITED TO , A':Y WARRANT1ES OF \:ERCHANT LIABILITY , FITNESS FOR APARTICULAR PCRPOSE OR ERROR-fREE USE ALL OF Wl-IlCJ! ARE EXPRESSLY

Page 89: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , DlC. , ET AL.

Decision and Order

DISCLAIMED. DWIGHT S .\AKES 1\0 REPRESENTATIONS AND W ARR;.' TIES THA T 1'1 IE

SPECIFIED DATA C01\TAIN O ERRORS OR OMISSIONS AND EXPRESSLY DISCLAIMS

ANY LIABILITY fOR ALL ERRORS AND OMISSIO)iS IN THE SPECIFIED DATA. Dwight

is under no obligation to continue the development of the specified data or tocorrect any error therein.

(b) m NO EVE:'T SHALL DWIGHT S BE LIABLE TO LICENSEE , ORANY END- USER

OR ANY OTHER THIRD PARTY FOR ANY LOSS OR DA:vAGE , INCLCDrXG WITHOUT

LIMITA TIO ANY LOSS OF eSE , ANY DECISI01\S MADE USING ANY or THE SPECIFIED

DATA, OR ANY LOST PROFIT, INCIDENTAL, SPECIAL AND/OR CONSEQUE';TIAL

DAMAGES , EVEN IF DWIGHT S HAS BEEN ADVISED OF THE POSSIBILITY OF SUCHDAMAGES. In the event Licensee corrects any erroneous infonnation licensed byDwight s hereunder after the delivery thereof pursuant hereto , Dwight's shall haveno interest in the correction. Dwight s shall have no obbgation to provide Licenseewith any corrections it makes in the Specified Data after the delivery thereofpursuant hereto.

(e) LICENSEE S SOLE RE'.EDY IN RESPECT OF THE SPECIfIED DATA SHALL BEREPLACEMENT OF THE DATA I'; QUESTIO';.

(d) THE LI'.ITATIONS CONTAI)iED IN THIS PARAGRAPH 7 SHALL APPLY EVEN IF

AJ'Y LlMITED REMEDY FAILS IN ITS ESSENTIAL PURPOSE.

(e) Lieensee shall indenmify, defend, and hold harmless Dwight s and itsaffiliates , employees , officers and directors from and against any and all sumscosts , damages , judgments , losses and expenses (including without limitationreasonable attorneys ' fees and disbursements) which Dwight s or any of itsaffiliates , employees , officers or directors may incur or be obligated to pay as aresult of (i) any claims for infringement of any copyrght or other proprietary rightsas to the data products marketed by Licensee (other than the Specified Datalicensed hereunder that may be incorporated therein) or resulting from or relatingto any modification, refoffatting or coding of the Specified Data or the

combination thereof with other data , or (ii) any claim or action resulting from orarising out of the sublicensing, assignment or other transfer of thc Specified Dataor the use of the Specified Data by Licensee or by any sublicensee , assignee orother transferee of Licensee (other than a breach by the sublicensee , assignee ortransferee of the terms of its sublicense , assignment or transfer that satisfy, to theextent applicable, the requirements of paragraph 4 and 6 hereof). SUCHINDEM).IFICA nON SHALL APPLY :-OTWITIISTA:-DiNG ANY :\EGLIGE:'CE (WHETHERSOLE OR co:-,rm.IBUTORY) 0:' THE PART Of ANY INDE\1NJFIED PERSO:". Licensee mayassume the defense of any matter for which indemnification under this paragraph(e) is sought with counsel reasonably acceptable to Dwight , which may beLicensee s own counsel. IfLieensee so assumes such defense , it shall take all steps,reasonably necessary in the defense or settlement of the matter at its own expense;provided that an indemnified person may participate in such defense with its owncounsel but only at such indemnified person s own expense. Licensee may notconsent to any settlement of any such matter insofar as it affects such indemnifiedperson without such person s written consent.

8. INJUCT1VE RELIEF

Licensee acknowledges and agrees that (a) the Specified Data and otherinfonnation provided pursuant to this Agreement are unique and consist ofvaluable intellectual propert that Dwight's will contmue to use in its business , (b)

Page 90: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSIO"l DECISIO"lS

Decision and Order 124 F.T.c.

the publication, disclosure or misuse of the Specified Data and other informationprovided pursuant to this Agreement by Licensee or by its sublicensees , assigneesand other transferees in violation of the restrctions provided in this Agreement willcause grave harm to Dwight s and (C) Dwight s remedy at law for a breach byLicensee of this Agreement will be inadequate. In the event of a breach or

threatened breach of this Agreement by Licensee, Dwight s shall be entitled toobtain injunctive relief, specific performance and such other equitable relief inrespect of Licensee and its sublicensees , assignees and other transferees. Theforegoing shall in no way limit any other remedies to which Dwight s may beentitled under this Agreement, at law or in equity.

9. TECHNICAL ASSISTANCE

F or up to 12 months after the Effective Date , upon reasonable notice toDwight' s from Licensees , Dwights s shall provide such technical assistance toLicensee as is reasonably necessary to enable Licensee to sublicense the SpecifiedData to end-users. Such technical assistance shall include reasonable consultationwith knowledgeable employees of Dwight s sufficient so that Licensee s personnelmay be appropriately trained in the sources and processing of the data containedin the Specified Data. Licensee shall pay Dwighes , within 30 days after eachinvoice therefor. Dwighes direct costs for providing such technical assistancetogether with all sales , service, use or similar taxes payable in respect thereof.Direct costs consist of all out-of-pocket expenses, the salary and benefitsattibutable to Dwight's employees actually providing assistance for the time

required for the provision of such assistance , and all other variable overhead. Anypast due invoiced amounts shall bear interest at the lesser of 12% per annum or thehighest rate allowed by applicable law from the date when due. Dwight s may ceasethe provision of such technical assistance if any such amounts remain unpaid for60 days.

10. VERIFICATION OF DATA

Gpon 24 hours ' advance notice to Dwight's from Licensee , Dwight's shallprovide Licensee , at Licensee s expense , reasonable access to , and the right to copy,any data-source documents or data in Dwight s possession that was used to compilethe Specified Data, to the extent that Dwight s has such data- source document ordata at the time of the request. Such documents and data may be used to verify orto COITect the information contained in the Specified Data. Licensee shall not usethe information contained therein for any other purpose and shall otherwise keepsuch inormation confidential at all times. Licensee shall pay Dwight' , within 30days after each invoice therefor , Dwight s direct costs in providing such access orcopying, together with all sales , service , use or similar taxes payable in respectthereof. Direct costs consist of all out-of-pocket expenses , the salary and benefitsattrbutable to Dwight s employees for the time required for the provision of suchaccess and copying, and all other variable overhead. Any past due invoicedamounts shall bear interest at the lesser of 12% per annum or the highest rateallowed by applicable law from the date when due. Dwight s may cease theprovision of such access and copying if any such amounts remain unpaid for 60days.

Page 91: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , INC. , ET AL.

Decision and Ordcr

11. RlGHTS U:-DER ADDITIONAL CONTRACTS

Within tcn days after the Effective Date , Dwight s shall assign to Licenseewithout any representation or waITanty of any kind and without recourse, all of itsrights under and interest in (a) thc Data Exchange Agreement of July I , 1993 , withThe Independent Oil & Gas Service , Inc. , and (b) the Joint Marketing AgreerncntofJuly 1 , 1994 , with Munger Oil Information Services , Inc. (cach an "Agreementto be Assigned"). No such assignment shall become effective until the other partiesthereto consent to such assignment. If either such other part docs not consent tosuch assignment, any well data to which Dwight s has an ownership right upontenninatJOn by Dwight s of the applicable Agreement to be Assigned (i) shall bedeemed included in the Specified Data and licensed to Licensee hereunder on allof the tenn and conditions provided herein and (ii) shall be delivered to Licenseeas soon as practicable after such tennination.

12. ATTORNEYS' FEES

Should either party institute any action or proceeding to enforce thisAgreement or any provision hereof, or for damages by reason of any alleged breachof this Agreement, or for a declaration of rights hereunder, the prevailing part any such action or proceeding shall be entitled to receive from the other part allcosts and expenses, including reasonable attorneys' fees and disbursements

incurred by the prevailing party in connection with such action or proceeding.

13. EXCUSABLE DELAYS

Neither party shall be liable or responsible for delay or failure to perform anyof such part s obligations under this Agreement (other than the payment ofmoney) occasioned by any cause beyond its reasonable control, including but notlimited to war; civil disturbance; fire; flood; earthquake; windstorm; unusuallysevere weather; acts or defaults of common carriers; accidents; strike or other labortrouble; lack of or inability to obtain materials , transportation, labor, fuel or

supplies; governental laws , acts , regulations , embargoes , or orders (whether ornot such later prove to be invalid); or any other cause, contingency or circumstancenot subject to such part s reasonable control.

14. RELATIONSHIP OF PARTIES

)Jothing contained in this Agreement shall be construed to imply a jointventure, partership, or agency relationship between Dwight s and Licensee.:-either party shall be liable for the debts , obligations , or responsibilities of theother part, and neither party shall have the right or authority to assume or createany obligation or responsibility, whether express or implied , on behalf of or in thename of the other part or to bind the other part in any manner.

15. ENTIRE AGREEMEJ\T

This Agreement embodies the entire contractual agreement of the parties inrelation to the subject matter hereunder, and there is no other oral or writtenagreement or understanding between the parties at the time of execution hereof.This Agreement cannot be modified except by the \vritten agreement of both partieshereto. ThIs Agreement is perfornmblc In and shall be governed by and constred

Page 92: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Dccision and Order 124 FTC.

and enforced in accordance with the laws of the State of Texas. This Agreementshall be binding upon and inure to the benefit of the parties hereto and theirsuccessors , assigns and transferees; provided that Licensee may not sublicenseassign or otherwise transfer the License and any other rights under this Agreementexcept to the extent penntted by, and in compliance with, paragraph 4 and 6hereof. It is hereby acknowledged and agreed that from an after the Effective Datethe obligations of Dwight's hereunder shall be perfonned solely by its successorPetroleum lnormationIwight , and Petroleum InonnatioWDwight s shall receiveall the rights and benefits contemplated under this Agreement, and Dwight s shallhave not liability therefor.

SCHEDULE A

1. Dwight s Production Data CD- Rom ProductsWest Coast Area , consisting of California , Oregon, Pacific Federal OffshoreAlaskaGulf Coast Area, consisting of Arkansas , Louisiana , Mississippi , AlabamaFlorida , Federal Offshore , Coastal Counties of TexasMidContinent Area, consisting of Arkansas , Kansas , Michigan, Oklahoma andTexas Railroad Commission District 10. Texas Area, consistig of all of TexasRocky :\ountain Area, consisting of Arizona, Colorado , Montana , NewMexico , Korth Dakota , South Dakota, Wyoming, "Iebraska , Nevada, Uah

II. Dwight's Discover SCOFr CD- ROM ProductsGulf Coast Area , consisting of Arkansas , Louisiana , Mississippi , AlabamaFlorida, Federal OffshoreMidContinent Area , consisting orthern Arkansas , Michigan , Oklahomaand Texas Railroad Commission District 10 Texas Area , consisting of al1 ofTexasRocky Mountain Area , consisting of Arizona , Colorado , Montana , NewMexico, Korth Dakota , South Dakota , Wyoming, 'Jebraska , Nevada , UtahIdaho

II. Dwight s Discover CD-ROM ProductsOklahoma Area, consisting of OklahomaRocky Mountain Area , consisting of Arizona , Colorado , Montana , NewMexico , "Iorth Dakota , South Dakota , Wyornmg, 0Iebraska , Kevada , UtahIdaho

IV. Dwight s Petroleum Rcservoirs (DPR) With Operatcd Production

CD-ROM ProductsState of AlaskaState of CaliforniaPennian Basin

Texas & Southeast Kew MexicoState of OregonGulf Coast Area , consisting of Alabama , Arkansas , Florida , Gulf of MexicoOffshore , Louisiana , Mississippi , Texas Railroad Commission Districts 2 , 3and 4

MidContinent Area, consisting of Arkansas, Kansas, Oklahoma, Texas

Railroad Commission District

Rocky Mountain Area , consisting of Arizona Colorado , Montana KorthDakota , South Dakota , Utah , Wyoming, ew Mexico

Page 93: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS, mc. ET AL.

Decision and Order

ANNEX 1

ell DataA:mex 1

?ag- : of 7

orr Layout for Comma DeIJwhtd File

The OpOO!l W r;r1 O!1:i s-:t !Cr:1 ? ..C

tU!or .:p:r..g 1.0 J:W IprrH

...

: L: c. r-:: \ pl'

E.c: Im:rdis '"tbt:c:c: r :wcJ.!lor2.:-I\HTIJuxC CCIJ

g',

y!X!G Jro \ qlj iI d.u

":.\"'-.

1t/I ("'a&'nJ,.. I71r.."l:\,..?-).;I==EAAc:c:::rN"W-""=I."""e==t

-;::N

''''

::C/N "",

v,-- ::N

~~~~~~~

).rn..F\)CE.)Dcat.,).c:F\JC

'::;=="'

'lNWr:.?':CNr:1).':ON

'==="', ..

Y-..CJiL-:L::

';'

':c"

,,

CI:O -:C.N...=:r:E

~~~

c:/"':CRT'':ON..=::rnur.). --r.-

.5''';'';::!I

"'''c.::':';P'Y:

-: :

.,=J'=Y:7 'f_"MC'

;:r:.

.! :- _

-=,o""""c, '-:l,".

.,. .=. ::"'''?''': '" ,,.,.....,,,"

Page 94: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

Decision and Order

FEDERAL TRADE COMMISSION DECISIONS

ANNEX 1

W€ll DataAr.rex 1

Pa. 2 of 7

FUIi'

""n (.._..II'5a"Z

LCi"

P'"1tN. '

R:':(""-"T9'""::aS?.l ':i!!c !-wc:_.c::.

QAn:T'!;A'I .u:x':A'I .Io:

Cl'r

1'r.A

"" ""

=c-===1.':m'Co":c:.E .ICl'=

. =.

"'W':t

'--" """"''-

""","u, .,r"

,,"

oI;:-"'"""::"";.

124F.TC.

Page 95: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , INC. , ET AL.

Decision and Order

ANNEX 1

i,' e: 1 Data.

Anex 1Page J cf 7

=-=cr..

"e", nl.)f"\':::

':CNrt':CN N.':,CA.c:

A:!' 'G-;..r.N.'

"e",Rn-I

(",

,n:..OCI1'uu

1."'cr"'I'Om."1\':CN':CN':CC':Cf

- K.'::N!1

c:cc"'-Z

""''

':I.-nJ"" I\"("I

"""'

':Cf

":.

CN c:::r. .

:""--" ""

.. II':CN':'''''' '':a:''1

N",,

==-

1'':!i1'':CfA.=';.'t

:.--:"...",...",.. - --

Page 96: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIONS

Decision and Order

ANNEX 1

E . :.!.rex

,,:a.

Pag 4 of 7

c..\

""..

""n, (a:--0CII sr"D NJ"1tH ': sa.:'re:I _Ia)'r( -CS't"\tNn.':,oN.tc':, 0I AC ccS"AT'':S

11':,Sw ",1N

':5H:NJ.':.r.H'Ar.l"..?''1.Jf1F'

n.,"SE 1" r..

~~~

=1="

==,""..,..

sv;

,..

tt4"'SJ':

''71--

124 FTC

Page 97: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS INC ET AL.

Decision and Order

ANNEX 1

Well

A'"e- 'C

?a. 5 ci 7

,=""

r-..

""'"

n: t: CI!I. c:I """"I:)

:-CN

.._.

':'=1i':::N)c

v.7:

,=""

'-L.

""'"

I-...:I" crN"v

':,

CN&a':ai C:I.._:j)

':.. .."'

':1'ra':CN,. c:

N.':'==ar..N.'

""=

rx1" 1'vr. Jac:I"" ::1TXT'I

--?"'''""''

1'':':CH

- n:: 'I, 'i'!

:'-

ol'""-",,_ro.=

Page 98: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

FEDERAL TRADE COMMISSION DECISIO!\S

Decision and Ordcr

AJ\ OIEX 1

Well Da!a.J.rex 1

Page 6 of 7

~~~

1"..1U"

""''

r.(""u.. 'D m.'MIIr:CNJiI.'1

r:c. 'M OX r n: 21':.c'lI -O'

=" '"

ccVt"Mva'1G.Vt'\'."'WA':1J1',, vct."U

':1t

1".1"s.'

.:-

t": 1.1

""''

J:'!a: st"'

': '!::

--111

'!'!(

n==-

..

J.

n.,:lH:NorSX..

==-""=""

Co vowac;t.W1'Ivaa.

-.""~~~

O'''..",

.=;'-

124 FTC.

Page 99: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , INC. , ET AL.

Decision and Order

ANNEX I

",:1 I;:",

''_

e'( 1

?9.

':'

T"""

:",

'm""

'::

",K)

~~~

':I\:r''": PCA:).

S"A':A?c:

C:.E::N.A.!'1'C:i.=I,

"'.. '

.--0

.... ,,:."" "",' ' :... ,.. "'.. '- --- :-_

x. ""

Page 100: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

100 FEDERAL TRADE COMMISSION DECISIONS

1"'""

,.: -'""..

:- i

i "0 S

I ." - r- :j

:: "" ,-,

I..",.,,: r:

:::'"

r; :: I =1

'''

" fi"r-t:

: -

to!I-'i-

: -!, -

--1-j t

,:.

r-' -

"" -

I:;

: -

:: I::0. -

' -.

.. I

1 ::21

! o.

j =

I ,."., r: i -

I ,

:,-

i- 1-i ;:

. ::

:: i-

\'HdC

I..,,,,,,;or;

Decision and Order

A!\'NEX 2

P:oc JC t i O , D: t aJ...:"'r:eX: zA

Page 1 0: 3

E I::

t=l:1

f: 13t=i :j

"" \..

r.1

I..

i: l::

P=

i: -

\- --

1-'

' ::-, -

1":' --

" ::

r- =co: :0

1-1 ::

I ::

I =

:;7

""'''J

..-,.'''''';

'C ""

,.::: -,.", -, -

'" - I -

l -t.J

Er:P11:

: "'\ ;-

I"-f- r i

'"-""

t-'..

j' --

1:0

,.., .. ,-!""",j

I::dUj,.:. i '3

i-"

='''

i oj

I s,1 I

I . I J;jr- i:o31

&!""

I J I ::

I tL-- i ::

: .! : :' ' -= - j .-" -, --- ! =-::, --:: _.: -

QI -,

;1

ri --

C ::

" jg: ;

I-

- . -i

. I 3...w

; ::

nH II..

\ """

J-,.."1""

.I 1- I =;:J

I:;

- - . . , -

" i -

-... .: '

1 =

I'.. 1-

1 .. Q ..0'1'-' -."1 -

.. .. 1-

\- --' -

i'l

:=

t i -

--"" -

i -t: '

! -

124 FTC.

.. .' -., .

i: I

I: I

;: I

,.'

c .- I

"""

:: i

E 1

;: ::! -: .

w L

) g,,-

r:i

I; I".

1 ' \ .- ::"

Page 101: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , IKC. , ET AL.

! -

Ed

i= I j

J :;

El2

I =

=:'' j

r- j

, -

?I:Jf-. -: Jj g

! j

-E

. .

1 ,

I :i l

' 3i -

t i

= 1-

' ::

.-. "pO'

o,,

ANNEX 2

Decision and Order

P:,x..::t :cn Da:a.'1ex 2 B

Pa. 2 of J

t=.;: I

t:.

::=,

t::I -I ,

:=;.

- I -"

Ei =

,..' -' -

:: 1 -

! ..,., -

I- 1--

f: -"

E12

-, -

1=1 ::

i =

,."" -

t 1 j

to' .

.. "'''

i =t:, =

l ,-" i

i -

"".-" -

iE' l =

"""

1= 1 -

::; -- ,

- I -

,;".

L--

= i -

I -

EI =

c: i -

= I -

-== -

101

Page 102: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

102 FEDERAL TRADE COMMISSION DECISIONS

tl ::

r= ::

gJ

, oi

El ::

:: i

I ::: I -

! .', .

"S

.. .,.. .-

loa',

= ' =

Decision and Order

ANNEX 2

P:::c:ic;-.A.-.r.ex 2 C

?3. J of J

. & .

I ;, El3I ,;

oj gJ

,j

j gJ

, ii r=lj E

i !

: !JJ

! (,

n.' ;d -1 "1 -,. hi:; J "1 - -

, ,,

r- I -:

;:,:

, I-I ; I fi E',

!:: "::

:: to.. I

w. k; =1

I :. :: l :: I : ::rI 3

i "

..

I '0'

....

r-,,i :1

1 =PS" -

- - ..::; -

J - i n c: I =

."' :::? =- ! -

124 F, T.e.

Page 103: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , INC , ET AL. 103

Decision and Order

ANNEX 3

DWIGHT'S

PETROLEUM DATA SYSTEM

TOTL FORMA T

DPDSITOTL Fixed-Format Specification

Tape Strcture

A DPDS/TOTL Fixed-Format data tape contains data from the Dwight's PetroleumData System Oil and Gas fie (TOTL) database. Thore are three versions of theDPDS/TOTL Fixed-Format fie:

The Initial Load fannat wil contain all information about each Field orReservoir.

The Update fonnat wil contain only information that has been updated sincethe previous release.

The Special fOITat will contain all infonnation about each Field or Reservoirin a custom-defined area.

There are multiple physical fies per tape. Each tape begins with a Tape HeaderFile. This file contains one record , a Tape Header Record (Record tye 0000),which identifies the information present on the tape. The remaining files aredivided into TOTL Area Groups. Each TOTL Area Group has:

File lIcader File. This file contains one record , a File Header Record (RecordType 0001), which identifies tbe DPDS Area 10 which the data fie applies.

Data File. This file contains the actual DPDS/TOTL data. Refer to the attachedtape specifications for the format of the data file. The last record in the Data Filewill always be a File Total Record (Record Type 9900). The File Total Recordcontains control totals which can be used to verify that the update completedsuccessfully.

The last fie on the tape is a Tape Total File. This fie contains one record , a Tape

Total Record (Record Type 9999), which contains control totals which can be usedto verify that the update completed successfully.Each file on the DPDS/TOTL Fixed-Format tape has a record length of 140. Therecords are blocked at 114 Iecords per block for a blocksize of 15 960.

Tapes can be produced using either the EBCDIC or ASCII character set.Tapes can be produced at a density of 1600 or 6250 bp1.Dwight s uses industr-standard 2400 feet , 9-track tapes.

Record Type RelationshipsEach record contains a L'nique Record identifier and a Transaction Code. TheCniquc Record Identifier (UNIQID) will specifically identify one , and only onefield or reservoir record in DPDS/TOTL. The Transaction Code indicates the actionto be taken to update the data associated with the TOTL field or reservoir record.There are three Transaction Types:

Page 104: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

104 FEDERAL TRADE COMYIISSION DECISIO:'S

Decision and Order 124 fTC.

The Add Transaction Type (A) indicates that the data on the transaction recorddid not previously exist and should be added to the file. An initial Load tape wiUconsist of only Add transactions. If an Add transaction is encountered on RecordType 0100 , this indicates a new field or reservoir to be added to the file. An Addtransaction on other record types indicates that the data on that transaction recordshould be added to the field or rescrvOlr record identified by the Unique RecordIdentifier.

The Change Transaction Type (C) indicates that one or more data items on thetransaction record has been updated. All data items on the TOTL field or reservoirrecord should be updated with the values provided on the Change transaction.

The Delete Transaction Type (D) indicates that aU data items on thetransaction record have been deleted from the DPDS/TOTL file. If a Deletetransaction is encountered on Record Type 0100, ths indicates that the entire fieldor reservoir record has been deleted from the DPDS/TOTL file. A Deletetransaction on other record tyes indicates that only those data items on thattransaction have been deleted from the field or reservoir record.

Data TypesThcre are three data types used by the DPDS/TOTL Fixed-Format Specification.The Data Type is indicated by an A , N, or L in the "Type " column of the Fixed-Format Specification that follows. The three data types are:

The Alpha-Numeric data type (A) indicates text data and can contain lettersnumbers , and special characters. Alpha-numerica data is left-justified.

The Numeric data tye (N) contains a numcrica value only. The numbers arePORTRA1\-compatible. The numbers do not contain leading zeros , and have anexplicit decimal point ifnot a whole number. A numerica specification is providedin the "Format" column. The numeric specification is given in the format "where "W" is the total field width , and "D" is the number of decimal digits.

The Logical data type (L) contains either a " I" or a blank. The " I" indicates

a "TRL EPI condition, and the blank indicates a "FALSE" condition.

EXHIBIT B

TRUSTEE A'ID MARKTI'G AGREEMENT

TRUSTEE AND MARKETI1\G AGREEMENT (this l'Agreement ), dated as ofbetween respondents (as further defincd below) and Ben C. Burkett, II ('Trustee

PRELIMINARY STATEMEI\T

On - , respondents entered into an Agreement Containing ConsentOrder, attached hereto as Exhibit A , that contemplates the issuance by the FederalTradc Commission (the FTC) of an order set forth thcrell (the " order ), whicbhas not yet been issued by the FTC or become final. The terms and provisions ofthe order shall be consIdered as If included and fully stated herein. Also , definitionsincluded in the order shall apply throughout this Agreement.

If issued by the FTC, the order (at Artcle II) requires respondents to divest theSpecified Data followllg completion of the merger. Article II of the order

provIdes that, if respondents have not so dIvested, the FTC may appollt a Trustee

Page 105: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDI , INC. , ET AL. 105

Decision and Order

and requires that, within 10 days of the FTC appointment of the Trustee , andsubject to the prior approval of the FTC. Respondents must execute a trstagreement that transfers to the Trustee all rights and powers necessary to pennt theTrustee to effect the divestiture required by the order. For this reason, the partieshave prepared this Agreement, which shall be executed if an only if the conditionsprecedent, as set forth in Article III of the order , have occurred.

The Commission may approve divestiture of parts of the Specified Data todifferent acquiring entities , but in no event wil there be more than one Acquirerfor either the whole data set comprising the Specified Data , or any of the sameparts of the data set comprising the Specified Data.

Trustee wil actively pursue an Acquirer(s) for the Specified Data.

ADDITIONAL DEF1NITO:-S

In addition to any tcnns parenthetically defined in the text of this Agreementand tenns defined in the order, the followmg defiuitions shall apply throughout:

1. "Approved Acquirer means a Prospective Acquirer that has been approvedby the FTC pursuant to Article II of the order.

2. "Divest means to grant a perpetual , worldwide , nonexclusive license to theAcquirer, with the right, subject to the tenns of the order, to use , combine withother infonnation, reproduce , market, assign or otherwise transfer, and sublicense

the Specified Data.3. Person means any individual , corporation, partership, or other business

or legal entity.4. "Prospective Acquirer means a person with a bonajide interest in acquirg

the assets to be divested.S. "ReJpondents means "Dwight's " and "PIC" as those two terms are defined

in the order.

ARTICLE I

01. Tnm"fer of Powers . Respondents hereby transfer to Trustee , in trst, andfor the duration of the trst as provided in Section 2.03 of this Agreement, andsubject to the tenns of the order , respondents ' right and power to Divest theSpecified Data.

1.02. Creation of Tmst. Trustee hereby acknowledges receipt of the authorityand power to divest the Specified Data in accordance with the tenns of the orderand to effect its purposes and agrees to hold such authority and power in trst (theTrust ) for the duration of the Trust as provided in Section 2.03 of this Agreement.

The purpose of the Trust shall be to effect the prompt divestiture to an ApprovedAcquirer.

ARTICLE II

01. Powers ofTmstee Trustee shaH have the rights , duties or powers withrespect to the divestiture as set forth in Article III of the order. Any descriptionsthereof contained in this Agreement in no way modify respondents! obligationsunder the order. Any modification of such rights, duties, and powers shall be madein accord with Section 7. 04 of this Agreement.

Page 106: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

106 FEDERAL TRADE COMMISSIO:- DECISIONS

Dccision and Order 124 FTC.

02. Trustee s Duties . Trustee s duty shall be to Divest the Specified Data toan approved Acquirer in accord with the order and this Agreement. Trustee shalluse Trustee s reasonable efforts to negotiate the most favorable price and terms forrespondents in any proposed contract that Trustee submits to the FTC for approvalsubject to respondents ' absolute and unconditional obligation to Divest at nominimum price as stated in Article III.B.6 of the order.

03. Duration of Tmstee s Authority. Trustee shall have the power andauthority to divest the Specified Data to an Approved Acquirer for a period oftwelve (12) months commencing on the latest to occur of (a) the date the assets ofDwight s are transferred to Petroleum InfonnationIwight s pursuant to the mergeragreement, dated as of _ 1996 , bctween Dwight s and PIC (the "Transfer Date(b) the date the order become fma1 and (c) the date of Trustee s appointment by theFTC. Such period may be extended pursuant to Arl1c1e II. BA of the order. Suchperiod may be terminated as provided in Section 6. 01 of this Agreement.

04. M111tip1e Offers . If Trustee receives bona fide offers from more than oneProspective Acquirer, Trustee shall submit all such bids to the FTC, and if the FTCdetennes to approve more than one such acquirg entity for either the whole dataset or for any of the same parts of the data set comprising the Specified DataTrustee shall divest to the acquiring entity of entities selected by respondents fromamong those approved by the FTC.

2.05. rontidential and Propriet,n:y lnformation . Trustee shall maintain theconfidentiality of confidential or proprietary infonnation relating to the assets tobe divested. Such infonnation may be disclosed only to:

(a) Prospective Acquirers;

(b) Prospective financiers and suppliers of Prospective Acquirers , or(c) Persons employed by Trustee under Section 3. 01 of this Agreement

Who have fIrst executed appropriate confidentiality agreements. Respondentsshall pennt Prospective Acquirers and their prospective financiers or suppliers toinspect the assets to be divested with or without Trustee being present. Trustee maydisclose to the FTC such confidential or proprietary information relating to theassets to be divested as the FTC may request , without the need for execution of aconfidentiality agreement.

06. UnaUtnOri7en Disclosurc . Trustee shall not license , divest, or otherwisedisclose to any person or use any of the Specified Data or other infonnationobtained from the respondents except as provided in this Agreement or order.

07. Re. Trustee shall submit, sixty (60) days from the date ofcommencement of the Trustee s power and authority as provided in Section 2.of this Agreement and every sixty (60) days thereafter until Trustee s appomtrnenthas been completed or this Agreement tenninates as provided in Section 6.01 ofthis Agreement, a confidential report in \Viting to respondents and the FTC , settingfroth Trustee s efforts to accomplish the dIvestiture includmg (a) a summary of alldiscussions and negotiations held with , and the identities of, all interested personsand (b) copies of offers , counteroffers and correspondence concerning theProspective Acquirer(s). Trustee shall also provide to respondents and the FTCsuch other reports of efforts to divest the assets to be divested as respondcnts or theFTC may require.

08. Access to Rel vant lnfonnation ann Fari1ities . Trustee shall have full andcomplete access to thc personnel , facilities , books and records, related assets

Page 107: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , INC. , ET AL. 107

Decision and Order

offered for divestiture or to other relevant information as Trustee may reasonablyrequest. Respondents shall develop such financial or other information as Trusteemay reasonably request and shall cooperate with any reasonable request of theTrustee. Trustee shall give respondents reasonable notice of any request for suchaccess or such infonnation; however, Trustee may have access to the assetsthemselves at any time during nonnal business hours without notice. Trustee shallattempt to schedule any other access or request for information in such a manneras will not unreasonably interfere with respondent s operations.

09. Sllhrnlssion of f:ontracts for A pprova1 . At any time during the durationof the Trust as provided in Section 2.03 of this Agreement, Trustee may submit tothe FTC for approval , in accordance with the FTC's Rules governing approval , witha copy to respondents , any contract with a Prospective Acquirer to acquire theassets to be divested. In order to assist the FTC in assessing whether anyProspective Acquirer may be deemed an Approved Acquirer. Trustee may requirethe Prospective Acquirer to summt to the FTC a verified statement setting forthfacts in support of its financial , technical, and marketing capabilities , and intent touse the assets to be divested , and to submit any business plan regarding the same.

10. Persona1 r iahihty of Tmstee Trustee shall serve without bond or othersecurity and shall use Trustee s best judgment in perfonning Trustee s duties

hereunder. With the exception of Sections 2. 05 and 2.06 of this Agreement , Trusteeshall be exempt from personal liability, to the extent permitted by law, for anyaction or decision not to act taken or made in good faith. Trustee shall be liable formisfeasance in perfonning under this Agreement or to the extent that any lossclaim , damage or liability results from Trustee s gross negligence, wilful or wantonacts , or bad faith by the Trustee or Trustee s representatives.

ARTICLE 11

01. Retention and Paymrn15s . From the date of commencementof the Trustee s power and authority as provided in Section 2.03 of this AgreementTrustee shall have authority to retain such consultants , accountants , attorneysbusiness broker, appraisers , and other representatives and assistants (collectivelyAssistants ) as Trustee determines are reasonably necessary to assist Trustee to

perfonn Trustee s duties hereunder. Retention of such Assistants shall be at the costand expense of respondents. Respondents shall be responsible for reasonable feesand expenses for Assistants retained by Trustee hereunder, and such fees andexpenses shall be billed separately from Trustee s personal expense and costs.Trustee shall note Trustee s approval of invoices for fees and expenses incurredpursuant to this Section 3. 01 and submit the same to respondents no more than five(5) days after receipt of such invoices. Respondents shall pay such invoices in theirusual course of payment, unless objected to in accordance with Section 3. 03 of thisAgreement.

02. Montn1y Payments' Success Fees Trustee shall be compensated byrespondents for Trustee s services under this Agreement as provided in this Section

02.

Ca) Respondents shall pay Trustee a retainer of Lthis Agreement by respondents and Trustee.

J on the date of execution of

Page 108: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

108 FEDERAL TRADE COMMISSION DECISIONS

Decision and Order 124 FTC.

(b) Respondents shall pay Trustee a fee (the "Monthly Payment ) of (i) ( J permonth dUIing the fIrst 12 months of the duration of the Trust as provided in Section

03 of this Agreement and (Ii) r J pcr month thereafter if the duration ofthc Trustis extended as provided in Section 2.03 of this Agreement. The first MonthlyPayment shall be rnadc on the first day of the first month that commences after thecommencement of the Trustee s power and authority as provided in Section 2.of this Agreement. Successive :vonthly Payments shall be paid at the first day ofeach month thereafter until the earlier of: (A) the date the consummation of thedivestiture contemplated hereby or (B) the date oftermmation of the Trust pursuantto Section 6. 01 of this Agreement.

(c) Respondents shall pay Trustee a success fee (the " Success fee ) if the

divestiture of the Specified Data is consummated during the duration of the Trustas provided in Section 2.03 of the Agreement. The Success Fee shall equal theproduct of (i) the amount of cash consideration (exclusive of interest on anydeferred payment obligation) provided in the definitive divestiture agreement (theCash Consideration ), time (ii) the percentage (the "Applicable Perccntagc ) set

forth below opposite the period in which the divestiture is consummated and CashConsideration is first received by respondents , as follows:

Date of Consllmma tiOJnd First ReceiptOn or before the expiration of six months after the

commencement of thc Trustee s powers and authorityas provided in Section 2. 03 of this Agreement ("FlftSix Y!onths

After the First Six Months but on or before theexpiration of 12 months after the commencement of theTrustee s power and authority as provided in Section

03 of this Agreement (" Second Six MonthsAfter Second Six Months

ApplicablePercentar:

The Success Fee shall only bc payable when , and as a_percentage of, the CashConsideration is received by respondents , and it shall not be payable if thedivestiture is not consummated or in respect of any Cash Consideration that is notreceived by respondents. 1\ otwithstanding the foregoing, if the maximum SuccessFee othenvise payable under this Section 3.02(c) would be less than the minimumamounts (each the inimum Fee ) set forth below opposite the period in whichthe divestiture is consummated and Cash Consideration is first received byrespondents , the Success Fee shall equal the lesser of: (i) such Minimum Fee and(ii) the amount of Cash Consideration provided in the definitive divestitureagreement that is actually received by respondents.

Date of Consideration and First ReceiptDuring First Six Y!onthsDuring Second SlX MonthsAfter Second Six Months

?vinimllm Fee

Ifa Mrnimurn Fee applies such fee shan be payable out of the fIrst amounts ofCash Consideration received by respondents.

Page 109: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , Thc. , ET AL. 109

Decision and Order

03. Expenses . Respondents shall reimburse Trustee s reasonable out-of-pocket expenses and costs incurred by Trustee or Trustee s Assistants in connectionwith the discharge of Trustee s duties and efforts to divest the Specified Assets tobe divested. Such expenses and costs shall include reasonable expenses of travellodging, meals, incidental items , and personal car mileage at the maximumallowable rate per mile permitted by the Internal Revenue Service.

Respondents may object to payment of any bill submitted by Trustee for thepayment of out.of-pockct expenses and costs for Trustee or Trustee s Assistants.Respondent shall make any such objection in writing within seven (7) days ofreceipt from Trustee of the bill. Payment shall be made for any portion of anamount requested which is not objected to. Any dispute under this Section 3.which the parties have not resolved within seven (7) days of any objection shall besubmitted to the FTC for detennination, which shall be binding on the parties.

04. Cost of Collection Trustee may recover Trustee s costs of collection

including reasonable attorneys I fees , if respondents fail to pay compensation orexpenses and costs not objected to or not disapproved by the FTC pursuant toSection 3. 03 of this Agreement.

ARTICLE IV

01. Binders and downpayments . Trustee shall deposit any funds paid by aprospective acquireI' as a refundable binder or downpayment in a separate interestbearing bank account with any accrued interest thereon being paid to the partyentitled to such funds.

02. T icense of Assets . If the FTC has approved a Prospective Acquirer inaccordance with Article III of the order, respondents shall execute a licenseagreement, and all related documents necessary to license the assets to be licensed;provided that the tenns of such agreement and other documents shall be consistentwith the order, shall disclaim all representations , warranties and liabilities in respectof the Specified Data by respondents and provide appropriate protection for theconfidential and proprietary infonnation of respondents , and shall contain suchother provisions as shall be appropriate to licenses of similar propert effected insimilar circumstances.

03. QQ. Trustee shall make reasonable efforts to schedule signings , andclosings for the consummation of divestitures , at a place and time determined byTrustee on dates that would provide respondents with at least thir (30) days ' priornotice. If such dates are unreasonably burdensome on the Acquirer, Trustee shallmake reasonable efforts to schedule such signings, and closings for theconsummation of divestitures, at mutually convenient times for all partiesconcerned. Trustee shall provide the FTC and respondents with an opportunity toreview any closing documents prior to the closings for the consummation ofdivestitures.

04. Fined Accmmtin,e. Upon the tennination of Trustee s duties hereunderthere shall be an accounting ("Final Accounting II) of any balance due and owing(i) for Trustee s expenses and costs (pursuant to Section 3. 03 of this Agreement),

(Ii) for Monthly Fees (pursuant to Section 3.02(b) ofthis Agreement), and (iii) asIncentive Compensation (pursuant to Scction 3.02(c) of this Agreement). Tbe FinalAccounting shall be approved by the FTC.

Page 110: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

110 FEDERAL TRADE COMMISSION DECISIONS

Decision and Order 124 FTC.

ARTICLE V

01. Respondents ' Duties . Respondents shall use all reasonable efforts to assistand cooperate with Trustee in accomplishing the divestiture as contemplated by theorder and this Agreement. Respondents shall take no action to interfere with orimpede Trustee s accomplishment of the terms of the order.

02. Respondents ' rontact with Prospective Acquirers . Respondents shallpromptly notify Trustee in wrting of any contact it may have with any persona thatmakes an offer or expresses an interest in acquiring the assets to be divested afterthe date of commencement of the Trustee s power and authority as provided inSection 2.03 of this Agreement.

03. 1ndernnity ofTmstee . With the exception of Section 2.05 and 2. 06 of thisAgreement, respondents shall indemnify Trustee and hold Trustee hanness againstany losses , claims , damages or liabilities to which Trustee may become subjectarising in any manner out of or in connection with Trustee s duties under thisAgreement and the order , unless such losses , claims , damages , or liabilities ariseout of any misfeasance) gross negligence , willful or wanton acts , or bad faith by theTrustee or its representatives.

04. Authority to Fxecu1c Respondents represent that the persons executingthis Agreement on behalf of respondents have the authority to bind respondents tothis Agreement.

ARTICLE VI

01. Tennination of Ar-reemen nd Tmst . This Agreement and the Trustestablished hereby shall tenninate upon the earliest to occur of the following: (a)the completion of the divestiture; (b) Trustee s resignation or removal by the FTCfor failure to perform Trustee s duties hereunder, (c) the tennination of thisAgreement by the FTC or (d) the expiration of Trustee s authority under Section

03 of this Agreement. Upon termination of the Trust. Respondents shall have nofurther obligation to pay compensation or expenses to Trustee hereunder , exceptto pay the compensation and reimburse Trustee for the expenses provided in ArticleIII of this Agreement that have accrued to the date oftennination. In furtheranceof the foregoing, but not by way of limitation thereof, no Success Fcc shall bepayable to Trustee in respect of a divestiture that is consummated after the date ofany tennination. Trustee s obligations under Sections 2. 05 and 2. 06 of thisAgreement and respondents ' obligations under Sections 3. , 4. 04 and 5. 03 of thisAgreement shall survive any tennination.

ARTICLE VII

01. . The FTC shall be copied on all cOlTespondencc betwcen Tmsteeand respondents. All notices and other communications required or penntted underthjs Agreement or the order sha11 be in writing and shall be deemed to have beenduly given if personally delivered, rnaJ1ed by registered or certified U. S. \'ail

return receipt requested , or delivered by overnight courier or Express Mail, ortTansmitted by facsimjle to the following addresses , or any other address that hasbeen designated in writing to the sending part:

Page 111: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , Thc. , ET AL. 111

Decision and Order

(a) To Trustee:Ben C. Burkett , IIBurket! Consulting7126 Alpha RoadDallas , Texas 75240Telecopier: 214-239-9037

(b) To respondents:Dwight s Energydata, Inc.1633 Finnan Dr.Ricbardson , Texas 75081Telccopicr: 214-783-0058Attention: President

GeoQuest International Holdings , Inc.5333 Westhelier, Suite 100Houston, Texas 77056Telecopier: 713-599-9131

(c) To FTC:Compliance DivisionFederal Trade CommissionBureau of Competition601 Pennsylvania AvenueWasbington , D.C. 20580Te1ecopier: (202) 326-2655

02. No Assignment . This Agreement shall become effective upon the dateof execution , subject to the approval of the FTC. This Agreement may not beassigned or otherwise transfencd by respondents or Trustee without the consent of

respondents and Trustee and the approval of the FTC. Any such assignment ortransfer shall be consistent with the tCITS of the order. It is hereby acknowledgedand agreed that from and after the Transfer Date, respondents' obligationshereunder shall be perfOImed solely by their successor, PetroleumInfonnationiDwight's.

03. Entire Agreement. This Agreement, and those portions of the orderincorporated herein by reference , constitute the entire agreement of the parties andsupersede any and all prior agreements and understandings between the partieswritten or oral , with respect to the subject matter hereof.

04. Modification . Ko amendment , modification , termination or waiver of anyprovision of this Agreement, nor consent to any departre therefrom by any partieshereto , shall be effective unless made in a writing signed by all parties andapproved by the FTC. Any such amendment , modification, termination or waivershall be consistent with the terms of the order.

05. Dllp1icate Ori jnals . This Agreement may be executed in severalcounterparts , each ofwhieh shall be deemed an original , but all of which togethershall constitute onc and the same document.

06. . Any heading of the sections ofthis Agreement are forconvenience only and are to be assigned no significance whatsoever as to itsinterpretation and intent.

Page 112: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

112 FEDERAL TRADE COMMISSION DECISIONS

Decision and Order 124 FTC.

07. Order Governs . The order shan govern this Agreement and anyprovisions herein which conflict or are inconsistent with it may be declared nulland void by the FTC and any provision not in conflict shall survive and remain apart of this Agreement.

08. Governin law. This Agreement shan be governed by, and constred

and enforced in accordance with , the laws of the State of Texas (excluding anypriciples of such law that would apply any other law other than applicable Federallaw) and such Federal laws as may apply.

Page 113: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS INC. ET AL 113

Decision and Order

EXHIBIT C

SALES REPRESENTATIVE AGREEMEKT

This is an agreement ("Agreement ) entered into and effective as ofEffective Date ) between TOBIN DATA GRAPHICS LLC , a Texas

limted liability company, with its principal place of business at 114 Camp StreetSan Antonio , Texas 78204 , herein referred to as "TDG " and -

_._---- _.,-----

herein referred to as " SR. " TDG and SR shall be refeITed to individually as apart, " and collectively as the "parties, " In consideration of the mutual promises

and benefits set forth, the parties agree as follows:

Recitals:TDG and SR desire that SR assist TDG in the marketing and del1very of

certain well location information owned by TDG to customers.

1.0 Definitions. The following terms shall have the definitions provided.1 "Coordinate shall mean all latitudinal and longitudinal location references

calculated or detcrmincd by TDG.1.2 "Coordinate Fees shall mean the use fees to be paid by customers for the

Coordinates as descried in Exhibit A hereto. The Coordinate Fees may be revisedunilaterally by TDG from time to time; however, such Coordinate Fees will remainequal to or less than the Coordinate fees that TDG establishes with the entitycreated by the merger of Dwight s Energydata , Inc. and Petroleum InformationCorporatiOll. SR will be given thirt days advance written notice of any such

reVISIOns.

3 "License Agreement shall mean the TDG agreement in the form attachedhereto as Exhibit B to be entered into with customers pursuant to Section 2. 1 belowwith such amendments as TDG may require from time to time in its discretion. SRwill be given thirt days advance written notice of any such amendments. TDGCustomer Agreement shall mean any agreement entered into betveen TDG andits customers for Coordinates delivered directly to such customers by TDG.

1.4 Person shall mean and include natural individuals and an entity of anytype.

0 Appointment. During the tenn of this Agreement and subject to the otherterms hereof, TDG hereby appoints SR on a nonexclusive basis, as a salesrepresentative to assist TDG in the marketing and delivery of Coordinates whichhave been correlated to SR Well Data , and to bill and collect Coordinate Fces. SRmay use its authorized sales agents to assist it provided that such agents complywith all terms and conditions imposed on SR by this Agreement , and that SR isresponsible for their actions , in their capacity as sales agents.

1 License Agreement. Prior to delivering Coordinates to a customer whois not otherwise authorized in writing by TDG to receive Coordinates. SR shallobtain from such customer a signed copy of the License Agreement as in effecthereunder at the time. Each such signed copy shall be delivered to TDG withingthirt days of receIpt by SR.

2 On- line License Agreement. Unless and until instructed otherwise byTDG in writing, SR is deemed to have obtained a valid, but limited , LicenseAgreement from on- line customers only if the following provisions have been

Page 114: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

114 FEDERAL TRADE CO:\MISSIOK DECISIOKS

Decision and Order 124 FTC.

satisfied: (i) SR shall provide a document on screen that describes the LicenseAgreement provisions for viewing or downloading TDG data , (ii) this documentmust be acceptable to TDG both as to form and content, (iii) anyon-line customersmust have previously signed a SR license agreement in which the proprietarynature of the on-line data is agreed , (iv) the License Agreement is limited only toon- line delivery ofTDG data and only for as long as this paragraph (2. 1.2) is ineffect , (v) customers are charged, and royalties are due , in accordance with TDG'sthen current Coordinate Fees schedule , and (vi) TDG is furnished a list of suchcurrent customers that have downloaded Coordinates each month.

2 Permtted Distrbution. Prior to permtting a Person access to a Coordinate

from time to time after the Effective Data , SR must be deemed to have thepermssion ofTDG as provided below (IrIDO's Permission ). SR shall be deemedto have TDG's Permssion if (i) SR has obtained from such Person a signed LicenseAgreement regarding such Coordinate which is currently effective , (ii) SR hasobtained from TDG notice that such Person otherwise has an effective TDGCustomer Agreement regarding such Coordinate , or (iii) SR has complied withSection 2. 2 above for delivery of on-line data. SR shal1 not be deemed to haveTDG' s Permission when (i) TDG provides notice to SR that any such LicenseAgreement or TDG Customer Agreement is not effective , (ii) this Agreement isterminated, or (iii) the On-line License Agreement provisions in Section 2. 2 are

no longer valid or acceptable to TDG. The parties hereby agree that all infoTIationregarding their respective customers shall be deemed Confidential InfoTIation , as

defined below, and shall not be used or disclosed for any reason other than to fulfillthe purposes of this Section 2.

3 Activities of SR. With respect to the marketing and delivery of suchCoordinates by SR tbe following shall apply:

a. SR shall represent itself to third parties only as a sales representative ofTDG.

b. SR shall not represent to customers with respect to thc Coordinates deliveredby SR that such customer is being charged less than TDG charges for Coordinatesif delivered by TDG. However, SR may at its sale discretion charge more thanTDG charges.

c. SR shall not be required to devote any particular time or resources tomarketing and delivering the Coordinates.

d. SR shall not reprcsent or warrant (i) that TDG expects to deli vcr anyparticular number of Coordinates during any future period , or (ii) that TDGotherwise wil or expects to undertake any activity not described in the LicenseAgreement or in TDG's current marketing materials in effect and delivered to SRby TDG from time to time.

e. SR shall not allow any representations to be made that it is an agent orrepresentative ofTDG capable of binding TDG in any manner.

f. SR shall make no warranties or representations to third parties as to theaccuracy, completeness or other condition of the Coordinates.

0 Coordinate Fees. SR shall bill custorncrs on behalf ofTDG not less tbanthe Coordinate Fees currently in effect from time to time. The current CoordinateFees are set forth in Exhibit A.

Page 115: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDl'GS , INC. , ET AL. 115

Decision and Order

1 Collection and Payment. SR shall bil all Coordinate Fees in accordancewith its normal procedures for billing its own or similar products. SR shall collectthe Coordinate Fees from customers and forward such funds to TDG within thirtdays of the end of the calendar month during which such Fees were collected.

2 Estiated Payments. SR may bill and collect Coordinate Fees in advanceof delivery based on SR' s estiate of the number of Coordinates to be delivered fora fixed period. Such Coordinate Fees shall be forwarded to TDG in accordancewith Section 3. 1 above provided that if the Coordinates actllally delivered for thesubject period are fewer than the estimate. TDG shall refund the excess paymentsto SR upon request. However, in accordance with SR' s normal procedures. SR maybill its CD-Rom customers at the beginning of each customer s annual licenseperiod for all Coordinates available in the area subscribed to at that time. Any newCoordinates added to the are of coverage durig the customer s annual license tennwill not be biled and Coordinate Fees wiU not be due TDG until the date of suchcustomer s annual renewal tenn.

0 Coordinates.1. Delivery and Use of Coordinates. Subject to the items of this Agreement

SR may duplicate and store thc Coordinates internaUy for the sole purpose ofdelivering them to its customers and may deliver the Coordinates as a stand aloneproduct or incorporate them as part of SR products in Sr s nonnal course ofbusiness. SR shall not deliver, copy, use or disclose to third parres the Coordinatesfor any other purpose. Notwithstanding the above, SR shall not incorporate

Coordinates into any product unless SR can limt individual customer access to theCoordinates (" Security Procedures ) in compliance with this Agreement All

Security Procedures shaU be disclosed to TDG and be reasonably acceptable toTDG.

4.2 Prohibited Transfers. SR may not offer a License Agreement or other right, or otherwise knowingly make available , any Coordinate , or any component

thercofto any of the foUowing: (i) a cornpeutor ofTDG , (ii) a government agency,(iii) an entity which might cause such information to be available in the publicdomain, or (iv) any third part to use the data for the purose of compiling, adding

, or building a data base or fie that such third person could then use , sell , licenseor lease to anyone else or for any purpose other than such third part s internal use.

0 Obligations of SR,5. I Reports. On the 30th day after each calendar month, SR wiU provide TDG

the following reports:

A Delivery Report, on a mutually agreeable form , that identifies by area andby recipient the number of Coordinates delivered by SR during the prior calendarmonth.

A Statement, on a rnutuaUy agreeable form, of aU sums biUed by SR forCoordinates during the prior calendar month.

A Trouble Report identifying any CITors in the Coordinates of which SR hasactual knowledge.

If the parties cannot agree on a form, TDG shaU provide the forms to be used.0 Marketing and Distribution. SR shall obtain in writing, prior to use

written approval from TDG of any promotional or other material which uses the

Page 116: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

116 FEDERAL TRADE COMMISSION DECISIONS

Decision and Order 124 FTC.

name , trademarks or product names of TDG. Each party shall pay its ownadvertising, marketing, and distribution expenses.

0 Warranties. Except as otherwise provided herein, TDG warrants andrepresents that it has full and umestricted right to use and to authorie others to usethe Coordinates provided to SR. TOG EXPRESSLY DISCLAIMS ALL OTHERw ARRAXTIES , EXPRESS OR IMPLIED , IXCLUDl1\G , BUT "OT LIMITED TO , TI IE I"'PLIEDWARRNTIES OF MERCHANTABILIIT A1\'O FITKESS FOR A PARTICULAR PURPOSE , ANDWARRANTIES ARlSING FROM COURSE OF CONDUCT AND CSAGE OF TRADE ALLCOORDTh' A TES AXD TI-IE MEOlA UP01\ WHICH THEY ARE SUPPLIED ARE PROVIDED "

IS. " TOG MAKES NO WARRA"TY EITHER EXPRESS OR IMPLIED AS TO THE VALIDITY

ACCURACY , OR COMPLETE:-ESS OF ANY OF SUCH COORDINATES. SR ACCEPTS TOG

COORDfNA TES "AS IS " A D WITH ALL FAULTS. TOG DISCLAIMS A Y LIABILITY FORALL, IF ANY , ERRORS AND OMISSIONS IN THE COORDI1\A TES SUPPLIED HERElT' DER.

0 General Obligations.1 Delivery. All data subject hereto shall be delivered in the delivering part

normal course of business and in its standard , electronic , machine readable formexcept as otherwise mutually agreed to by the parties. Each part shall beresponsible for the media and transportation costs of deliverig its data to the otherpart.

2 Business Practices. Each part agrees that the services to be provided byit shall be performed in a good and workmanlike manner , and that such serviceswill be perfonned in accordance with all applicable federal , state and local laws.Each party shall keep full, clear and accurate financial and other records withrespect to all data subject hereto including license and other agreements withcustomers.

3 License Enforcement. Each party agrees that it will use its best efforts innormal business prachce to ensure that its customers do not use the data subjecthereto in violation of this Agreement or the agreement entered into with thecustomer.

8.4 Inspection. TDG shall have the right at its own expense to inspect and auditthose portions of SR's books , records and all associated documents necessary toensure compliance with the terms and conditions of this Agreement. SR agrees tomaintain such books , records and associated documents for a period of two (2)years from the end of the calendar year in which such items were recorded and tomake such books , records and associated documents available to TDG at allreasonable times within such period and for so long thereafter as any disputeremains unresolved. So long as a dispute does not exits such inspections and auditsshall not be conducted more than twice per year on 30 days prior notice.

0 Confidentiality.1 Confdential Information. In the course of their mutual dealings , the parties

each have become , and will continue to become , aware of the other part s businessaffairs, propert, methods of operation, processing systems , trade secrets , datasoftware , programs , download formats and related information and technology invarious forms and formats which the other party treats for itself or others asproprietary and confidential ("Confidential Information ). Except as otherwiseprovided herein , eaeh part agrees that (i) the Confidential Information of the otherparty is the exclusive propert of the other party and such other part retains allcopyright, trade secret and trademark interests therein , whether published orunpublished, and (ii) it shall observe complete confidentiality with regard to all

Page 117: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , INC. , ET AL. 117

Decision and Order

aspects of the Confidential Information , and to insure such confidentiality, shalltake appropriate action, by instrction , agreement or otherwise, with such partyemployees, consultants, contractors, and customers permitted access to suchConfidential Infonnation so as to enable such part to satisfy its confidentialityobligations under this Agreement. Each part agrees to limit access to the otherparty s Confidential Information to those employees and consultants who in thecourse of their employment need access to such data. If either part provides accessto data or Confidential Information to individuals or entities in breach of thisAgreement , then such part agrees to indenmify and hold the other part hannlessfrom (i) any and all resulting claims of liability to third parties , and (ii) wasacquired by a part from a third part; or (iii) was know to a part prior to itsreceipt ITorn the other part; shall not be deemed Confidential Infonnation for thepurposes of this Agreement or any other agreement between the parties.

9.2 Violations. Without limitation of the foregoing, a part which learns or hasreason to believe that any person has had access to the data subject hereto or theConfidential Information , or any portion thereof, and , as a result, the terms of thisAgreement are being violated (i) shall advise the other part immediately of sucheven , and (ii) shall cooperate with the other part in seeking injunctive or otherequitable relief against any such third person. All of the undertakings andobligations relatig to confdentiality and non-disclosure , whether contained in thisparagraph or elsewhere in this Agreement, and whether of either part, shallsurvive the termination of this Agreement for whatever reason.

10.0 Proprietary Rights.10. I Infgement. Each party agrees to give prompt nollce to the other party

of any actual, threatened, or suspected infringement of proprietary, trademark orcopyright rights of ti1e other part by any enllty or third part and agrees to providereasonable assistance to the other part in the protection of those rights. Each partyalso shall give the other prompt notice of any claim that the data subject hereto mayviolate any rights of a third part.

11.0 Remedies, Limitation of Liability. The Coordinates subject hereto andthe Confidential Information are unique and each part s remedy at law for a breachof this Agreement by the other part may be rnadequate. Each part acknowledgesthat the disclosure of any aspect of the other part s Confidential Infonnation orany inormation which , at law or equity, ought to remain confidential , or the breach

of any other provision hereof, wil give rise to irreparable injury to the other partyinadequately compensable in damages. Accordingly, either part may seek orobtain injunctive relief against the breach or threatened breach to the terms of thisAgreement, in addition to any other legal remedies which may be available , andeach part hereby consents to the obtaining of such injunctive relief.

I:\ NO EVENT SJJALL TDG BE LIABLE FOR A:\Y LOST PROFIT , INCIDENTALSPECIAL, Mm/OR CO, SEQUENTIAL DAYIAGES RESULTING FROM ERRORS OROYIISSIONS IN THE COORDIKA TFS PROVIDED HEREUNDER, EVEN IF TDG lIAS BEEN

ADVISED OF THE POSSIBIl.ITY OF SUCH DAMAGES. SR S SOLE REMEDY REGARDING

DEFECTIVE COORDINATES SHALL BE REPLACEMEJ\T OF THE MEDIA AND

COORDINATES IN QUESTION PROVIDED , HOWEVER , THAT SR SHALL BE ENTITLED TO

THIS REMEDY ONLY IF TDG IS CAPABLE OF CORRECTThG THE COORDINATE I?\ TI-

j\'

ORMAL COURSE OF ITS BCSrNESS. IN KO EVENT SJIALL TOG BE LIABLE AS A RESCLI

OF DEFECTIVE , UKDELIVERED OR MISSING COORDINATES FOR A:\Y MONETARYAYIOUCiTS.

Page 118: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

118 FEDERAL TRADE COM'vISSION DECISIO:'S

Dccision and Order 124 F.

12.0 Term and Termination.12. 1. Term. This Agreement shall remain in effect for three years unless

terminated earlier as provided herein. The period from the Effective Date of thisAgreement until its tennation is referred to herein as the term of the Agreement.

12. 2 Termation Option. Each part shall have the right to terminate thisagreement at any time upon giving the other party at least one year prior writtennotice of such termination. In addition , and upon giving 90 days written notice to

, TDG shall have the right to terminate this Agreement in the event that it andlorits successor companies (i) in good faith ceases the conduct of calculating andproviding Coordinates to customers or (ii) similarly terminates all Sales

Representative Agreements that it may have with other sales representatives. Ontermation of this Agreement, TDG will not deliver additional Coordinates to SR.If this Agreement is termated by Sr, SR shall immediately return all copies of theCoordinates , and all manifestations of TDG's Confidential Information , and ceaseusing such products and information for all purposes. If this Agreement isterminated by TDG , SR will be allowed , subject to the other provisions of thisAgreement, to provide to customers Coordinates previously received , but only forthe term of each customer s then existing \\Titten agreement (excluding any renewalor extension made or attempted after such term) but not to exceed three yearsfollowing termation of this Agreement and only for the sale purpose of fu1fillingcommitments for subscription products in existence on the datc of tennination. Atthe end of such tlle , SR shall imediately return all copies of the Coordinates , andall manifestations of TDG's Confidential Information, and cease using such

products and information for all purposes.13.0 General.13. 1 Entire Agreement. This Agreement, including the exhibits hereto , all of

which arc incorporated herein by this reference , contains the full understanding ofthe parties with respect to the subject matter hereof, and no waiver, alteration , ormodification of any of the provisions hereof shall binding unless in writing andsigned by duly authorized representatives of each part. either the course ofconduct between the parties nor trade usage shall act to modify or alter theprovisions of this Agreement. If this Agreement is executed in counterparts , eachshall be deemed an original , but all together shall constitute but one and the sameagreement.

13.2 Assignment. This entire Agreement shall be binding upon and shall inureto the benefit of the successors and assigns of the parties and shall be fully

assignable by either part.

13.3 Force Majeure. Neither party shall be liable to the other for delay in theperformance of its obligations hereunder to the extent that such delay is due tocauses beyond its reasonable control.

13.4 Attorney s Fees. Should any part institute any action or proceeding toenforce this Agreement or any provision hereof, or for damages , by reason of anyalleged breach, or for a declaration of rights hereunder , the prevailing part in anysuch action or proceeding shall be entitled to receive from the other part all costsand expenses, including attomeis fees and disbursements, incurred by the

prevailing part in such action or proceeding.

13. 5 Authority. Each of the undersigned mdivldua1s executig on behalf of therespective signatories hereto warrants and represents to each of the parties heretothat he is duly authorized by such entity on whose behalf he is executing this

Page 119: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDI1GS , INC. , ET AL. 119

Dccision and Order

Agreement and that he has full power and authority to bind such entity by affxingthis signature hereto.

13.6 State Law. This Agreement shall be constred il accordance with , and therights and obligations of the parties hereunder shall be detcnnined in accordancewith , the laws of the State of Texas.

13.7. Kotices. Any notice required or pennitted hereunder shall beconclusively deemed properly given upon delivery of the same , in writing, inperson or by mailing the same by certified mail to the party to be notified at suchparty s address as set forth in the preamble to this Agreement, or to such otheraddress as may be specified in a notice delivered pursuant hereto

13. 8 Severability and Waiver. If any provision of this Agreement is declaredby a court of competent jurisdiction to be invalid or unenforceable, or if any

provision hereof is or becomes impracticable , the remaining provisions and theAgreement as a whole shall nevertheless continue in full force and effect withoutbeing impaired or invalidated in any way, and the parties shall replace the invalidunenforceable or impracticable provision with a valid , enforceable or practicalprovision which shall meet the economic aims of the invalid , unenforceable orimpracticable provision as closely as possible. No delay in exercising, no courseof dealing with respect to , and no partal exercise of any right or remedy hereundershall constitute a waiver of any other right or remedy, or future exercise thereof.With respect to any continuing or persistent default hereunder, no delay inexercising, no course of dealing with respect to , and no partial exercise of any rightor remedy shall constitute a waiver thereof.

13.9 Construction. Headings used throughout this Agreement are foradministrative convenience only and shall be disregarded for the purpose orconstring and enforcing this Agreement. The language in all parts of thisAgreement shall in all cases be constred simply, according to its fair meaning, andshall not be construed strictly for or against either of the parties.

13. 10 Other Business. Except as otherwise provided herein , each party shallbe allowed to solicit any type customer in any geographic area and enter intosoftware, hardware, data delivery, development, license, and maintenanceagreements therewith. The provisions of this Agreement do not grant either partany rights or obligations to act on behalf of the other party regarding any otherproducts or services not specifically mentioned.

13. 11 Relationship of Parties. Nothing contained in this Agreement shall beconstrued to imply a joint venture , partnership, or agency relationship betweenruG and SR or any of their employees. Except as specifically set forth herein , nopart shall be liable for the debts , obligations , or responsibilities of another part,and no part shall have the right or authority to assume or create any obligation orresponsibility, whether express or implied, on behalf of or in the name of anotherparty or to bind another part in any manner.

Page 120: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

120 FEDERAL TRADE COMMISSION DECISIO:-S

:,:::-

CCG,C, ;c:e ,

€-,=

2s\.:iE

i. e:;. H:.;;j L:CZ"S2 ;: ees

Fcr Fe.':-:

:,::'

:es

. , ..- ': --'-'-,;,',: " :"'( :';

,'e!!

:;:;,

a:es

!:-- :-' ,.":

C'::C-'

. c c : c::::c:c

-- -,,- '-'

or::

;;::'

II. mite:: ;er:- ' :1:::1'52 , e""s :~,"':ll.al:

,,, - ' ---

II " C:'

!I:. Stc :=2

, .";,

:":;::IE' ::::e.s

' - ' -- -'--

;;!i ' ''CI C:.

1'1:: '5'::"1" fees

~~~- ..

Decision and Order

EXHIBIT A

CXiiicit /-,

=::

Ie .

~~~

::e.':;;se .', ;;;;r,5-"-

;'11 c!, e: areas

':

e !!e

.;;,:;.

Q -\

C=.

;:. - ;; ::-

C3:0: '

124 FTC.

5,": S2 L

:". ;;,",_.,

Gcil:e:

-- -:

Page 121: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLD!1GS , INC. , ET AL. 121

EXHIBIT B

Decision and Order

:; ""

:c:- .scleExh i b it B (\I rs;cr, . af;; , ;:er:;," L;21 :ce'lSE

:;;::E:i::':se;' ;d;,VE; A:;re=.

"",

:r::

DATA LjCE. ;S:: AGR.:::/, 'rT

'" !'_""c

, :,'

c, ""d."'"",

""... '."

'" "',," .0' ' '0 '.Mr or,o ", :.a G",

" '

' 7.,.. ",.,.. ;",,,"" '"'''o'"y.o,c;

,..",,,

, :,ec= 0"'" 'n ","n'c , "'HI 78;:' oc= OC

" ","",

1 . G. . '""'" 400","0.0 "0"'''''"'00 u" o,': o'"O'" ".u,-

... '. "'

'00 "". .,. .uo,O'1 '. !I.

. '

clio.....; '."" '"0 0="0.

'''.

'0 no cM.M'" 10 .r-"" , OOl,,,"""':t C!c.... .., .'0"" :.",,,

Prcdu s. ,..

. ' .",. .

PrOO\JCi, " cud ,n tho ,1;,..",.01-c,.", ,0" :'" "'0'1 "oc, r..:", "'0''''''' '00 "";"; So.'.O","'

. ".. '

'0

'"''' , ,

no,"d",. .11 III

, "" ".

'''T'' .o.

".,.,

,,,,IA"'" '"c'

"..

.,,,,;.n.M "":O ",..,,.I;.n ,no ,.c nolo n 'ny ' c'"'0,," ; 10 "."... ,y "on ."4:' 0' -:::C; ae'nn. ,

. ,,,,,.

0.':, ',";'''0''"' "'o.....,

.",,

P,""uo,, ,n'"M' :.'uo, n.'eo, co" G "''' ". '0""" 'Y iO'M" ,,,'''OW'O' 10 In."",,:.n 0' ,,'"~ ","."'onl ",=n ." I i"': '0 , 110'''''' w"n.n'0" , ",..,.n'

Pricirrlj 5chedwie. "'o"""' ?',c:ngSonoe.. 'I..

..,,,

o"".on'OI,,o"OO,",".n" p'ooo,",. o,o...,,,n,,.cOl:,.c.,," " 0' or, .,' o :C '0'" omo , I"'.. o " ."InO'"'' :'-::C .n. ''':0'''. 10 '-' Oln". 10 OliO"' ""'

''''.

.' I O "". u",,", r:G,...", 0 '0''''1") 'no 'OO

'::

, :.tm 0' 'M ' "on" In . '0'"

,-,

.,.el '0 O. ..: Iy ,o.",... '" 01 "

,,.

" .,. "'c r;o,."o no..:n :y"" '"...nc' '0. ' ""d. .".I "'.. " ,.."'.n:

Gr;nt 01 Lic.nS8. Tr:C; ..nJl 10 l,,",, , .u:...' '0.,,,,,.,"n'O/I1"";,,o.,on' ,nonO'"'"".' oonllo,""o:,'Ie "'''0'' '" 0."'" ,no "u "'0.. o",o ::s '0' .."",n e":,,on.

11 ,." ''' , .. 10.. .., .. r' !I. '00''''.''

p""",

ono"""'"n ,".oc,...n" 0' l'''

'''

1 o..n 'V1." 'co " 'C: C. ..11" ,.

,'.

';".",.nL :G In," n'L . uo";"U!o ' OO'Y ,a '-,on... ",a,. L, "orou :.,.,n 01 ..c 01 !I. P,o.

' :,

;'Od

", " "'..

"."",,0 . or '", "'"0 a. "","n..., I "a"'C.", n' ""Y D. a.,.",oe

"'''

=-G a, o . c

", '....

'.0,... ..1i,.. Io, 'no co'"~ : ' n ool,n,occ "O"

. .

...C':o "'u, "o"'.r.

'",

o ,"". 01 , . roOw

ljC811S Rmslnc:ions . L".n... IQ'''' ,. u.. 'n.o ' ,:c ,,, on" ...," I n... , o..n . II,"" - '.e. n... '". .11 noL (,) ;. "",'0. ',

".,.. ,.

oro... """"0 010... ICC... o 0' .. ol

"",

'''0:' ,- . """'''''''v n' \:"0 D.." . I') .. 'no o. oo,, ," '" ,u

""".

", """"=c""" ":'ov'o,u"", ,c",.;"",,,u c""'"'

" ",""" '

.."".n' 0' ,,1 OC"""O"" . o'n"'''. ''"' "n........,-.". .n.,o... 1M '.od

C': S. l".n..."'"y 00' cOoy in. P""' c:o .,0.0' """':0;-/ ,n" ""y o "'... "', I"n"., ; ou.. . P'oo

"",

I .

,,,,

.on ..n , ',n .. "'.""'' "',,!:n.. ,,,on...' 0'" .....'"

.",,, ,",

., ;O".,n. ,I o """00'" ""y D' "'0. 11.""" '" 0:0., ""

""',' "'

II oo., l""n..., "''' ' c:n"." '. .."0'"

''''''

'''' ,ne '"""" . o" ",0,"""0'. "00"", o....,.m.,,,u

'" .."" '''..

. 0' 0"",,,,- .. "'o c'" "', '! 0"" 'nw"": .''' '00'" ,

""" '.

0 d C'O:' "". :. "'a:. "" ' . ,:on... , n ,.,.,., "u

"-- . -

,.. co,... 'o. "",:. "o""o

.. "", ,,. .". , ,

I "

: 0"". C " ,"..J'" 'o "" 0' , ,,:on.... ,..,,,... ,nO 'or .

'" ....::,.,

' ,,,,,..."' "",."",,,,,n,, \Jm...nc. .I' c.",' ' ,,,n

,- '. '" '"': ,

:,1 ",n... "

"" ,,,

n.' .."',"0 , ","".o, " ".",..- n c.

, :",., ,

:o.." " . ::: '" "n:r. ". "'''0," "".. ' .' Iu'.

;'" '.

c. : . ,.': ::0' 11 '0 '

- :. ,., ,,: "- .",, .. " ;.''-:' *" . , ' ;"""""

, ,e: .

.. . '" ,",.

,,,c-

':- ': ",..', ,- ,""",:- '

: '"c. *,

,""," ..:..,.,; - ;.'

0:.

':'-""--':",

' :c-

, ' '''' ',.

e'."

- ,-

.nsl Fils. ",,' n. 1;"10 :" I, :c " "

,"'

0"'.' ..1.. ..o....n..,;.. .'0' ,d C""," ",:' .'n.

'" '.

o:"c",.,..e 10 L:anu.", ""'",noo w', '"","11o Occ:n. so."W'"

,n....li ,nlll D. D.,Uft ,n 1 1 "" d 1 '''oc' nlS OO"'O

'" .

O'" ,."LI OW' .. :/. I...., 0' . n'..n .."'In' I' ..: 0' i

. """." ""

.,,,..'0 "I.... In " ::o.o:o tn. 0.0&.-" olh""... :,

,:.. "'.

no"l:"n... .CI D. '..o.n" " Ie' .no "y,":a, " O""'" "'."'''',".,.d 01 to... o 'r;" ,""0. n""t'" ";,..",.n, . "o,

."."

.'., ..... on l

. .

"" ,".o"'o al-::G :, .ny .".. " 1 n.,'L

;..."' '"

". no! :II :aiO in '1.'1: "' 'n 'M'1 r-

... ,

., I".1' . "'.n w"n.c" ';"''''",n 01 on, oLn.. ""'101.. I, n"n:. 7:::

"," ""'

, TCG "'., " .. dl.o:"'.n 'M .."no ' 0'''' , o.: ";o 10l..''" ,., ,.,"'",." n"

,.."'."'

i.rm nd Termin;ti n.

"..

\",,,,".n, '00" :.""'.."."". 00 l. Oli. W"".. U"c'" ii 'e.

' ,

..I ,..,.." on . n.ounW .f "Ie

, ",," "" ,".

,"IIIHn n, ,.

""'

".,,n, ."'ol . In ..,,,'" ...

" ,

."'''n 'o ' IO"":i;. ..

. '

''1.".''""1 01 ,o,

y ",

':' 0'O",,,,,"0. pro'''od ''",,.,,.. .n,Un..o ih"'fC:! )O'"g'''' 10' :oy""n.. uO"o"I.. abo.. oo, no"'o 'yTCC" ,n,i'''' """ I."",nldon \:, '"y "'''0" 01 i, A9'''O'oo. .. W.. ... ,oa;w'''''' I'C;d.y'''!\.,, '07~ ''L..n"" ",oon.. "" 0'0"00'-... "coP,..ln...o' """o"''''.Y ,.'10",""0'" ono,.,....n"Uon'ol'MP,e'"o," .."..."07C'", ,""",II,,,n, ,n . if", " 01 l".n... ,t,,1 I o ."'."c'" ".. '0., ..r. m., I

':0'" " ... 10'", ""'11'" U":y.d .M In. " ol'r.. P.

'" '"

D.'" ',"onO.C'

," "",;,,,;,,,,,,",,,

i",."n.1od fo'

''y .

.a,o'''''''. " "y I'.. e" 'I ,. :' no . I ,I;; ...', '" n. 1'" coo' , In. :. - .

., -

:C ,c,.,1 , ..,.. n, ....,r, " .

. : , '

"'c,,, ....,,, r.

" "

.n""d 10'01"" ,,",,"'. p",o..,.. .n,,'no, " 00,,,.', 0 ,ny'''0 " "vi I.' , .,n., " ",. 0' "-

..'" ,\..,

.n' no,.

F'rccrill!::r:/Righls- T... :,.",",,o;,,""""",:C; o . LI'. '0 'no", .....",. n 7r:c So"'" c' ', I 01 '"" 0.

,",,",."',

0, h do.,

.... '

0 _,e,"""''''".''''. no' ,n,o;,."o " "",o'n., ' ,"'-""'n '"", no.;v ".o '" 0-"" '0.

' '''''' '''

''0 " ..'.."'""Un,.,... 01 :C o""n",no", ; ,nv Ie''-, .

"".,.,,.

0 ,..,,,,or.'",o ' o

...

.. CCO no '''0'''' . 0 ,no '0 'no "POn. c:, ". ,,,

,.",.",

, .0.. ono ""..,,,, o'oo.""ol-::C 1!1..'i'H" ,. .10.. .M ''''"JOo," o;nto n In. uc" """0,";. w n.", ' ''"''''''0r;.-.

:'

o",n

...

",,., on. ,..a '''''''''

''''''' . :"'

1'",., ,'" "coo. 1"0 ,co.n " '."" .no ;r ..",.,n In. '''00''' - -

"CnO 'M" ". 'VI ,

'" - . ,

. 0' ;n' .'." 'c '"0

" ,,' :. . "" . " -

:I O.,. on. =. '" "0;0: '

" '".." .

0 "" .., '''o"" " ,'0010'

C " n I: C to n lj I ! n C IT. a I C "" c.," I

.." .""" '::"'"'""

'OO"''', ''''''''''C o"',o,o;".e.,,,..,,,'c,-: 0 , 1.0 . c '

. "', ,"'

'''''' '0"

"" , '. . ": ", "". ,,,,,,,, " - :::=""'

no ,.,,,e '

" ' "'''

''' 0 , ,., 'cO , ,c" '

,-.

r ",,0 '

,,- .., '-

0 " '''''0.". '"

: ,;,-" "" - , - - ..

::c ' .e' TC, .

,. . ':'-

" ,." 1.

' ,." ,.' . ,: '"

,C.r".

" - .., ,."". , . - -

'J-

, '- ," ,,,.., - ".',. - ,.;"-",.

, IC":-

.,- ." .; ..".:,""-""':-

Page 122: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

122 FEDERAL TRADE COMMISSION DECISIONS

EXHIBIT B

Decision and Order 124 FTC.

,or,,,, ""n..., :onll", '"" .",..",", voo" u-I, 'G"'''''ar... ';1.., 10 "',,' ",... ,. I

. p,.,

c,. ,. Ino.. ,""'H'"'00. 0.==",".."..-. "'o.,o.._oll"""''''''''''onl"'''

""",:.

'0 "00"::' L. .,n.', .".in.'..",... '''''"0'0''-'',",

'";,

0''''

:::.,.

,. u... 'U'n'n" .. m.y ,.

"... '. .... ..

ion.. on ,,,.,:c,,, Lc.n... InU Imm........ ,uon Ie v:, an; ""

"r" u,"",r la 'oJU ",a,.,,o.... or",. .,".ue:lIt l it.dWlrr l1ry; L.lmi1ti.nofli..bilil:i, -::C

..''"",,,

1'1 l"1! ,.. "'. IW"'.", ". 1I."..!1. .'oou'" '. L".e...'co II '".pod y f!A. :101 . mU.. on ""''" t:1 ?"'"UC:o .,.,.".",.0 ir I'

.'" "

oll" !'!.""lono """". In.",, unc.rn."".'uu 'O"""odOf"""""IKIUYllrm....."I1C Uc.n....

OT...5 P"CVIC IN EO"'E INC S NT:-ThE 01l00W0'75 M.O ,. ! IoEOIA UPON WI"flCN THEY ,o5'- LIEO "'RE PRev:CEO ""'5 . rDG !):P" .5" 'I '='SCl..iIOSALL CTHER WAlUUN":ES, ! PR!SS OR lioPLIEO, IIH:LUCIN"BU, "0" LIIO,.(O "0, ""E I'-PLI!:; W,o""",,,,.1!5 C."'E r.H" "'BILI' IThESS FOR A P..R'TICULAR PURPCSCCL'RSE OF CCNCUC7 .."0 US",C! OF 'I""Of. rr ISL'NCfil5'COC '11-"'T T OIlT"""S O/.TA INCLUCfC IN 'TE

CCUC7 F"O" T'IIIC PARTlES. I"CLUOING COVERI"Cr"'CIES , "'NO T"..T TQ IS lINOER f.O Ce-WaHICN TOC::"'TINU! ""E CEVELOPI..Ef. CF AN'IOF,.! PRcour:TS ellTO CCRR!CT ANY ERRCR , C" SIC" CR J,ULFU"CTICNE"E;" N(ITN!::: TDC "011 .0"'1 CF irS SA'

RE5E HT;YES SH"LL E O UC"'l'P TO UPO",H eRP"'RT '"i"! P'ICCL'ers

TDC OISC I"S "NY ' IIILrr F::R ALL, iF "'IY"IRCR5 ANO 0,,15S,O"5 It; 7i"E PAOOI:::":5. IN NO VEf.

SH"lL TOG BE L!. LE FOR .0"'1 LCST PRCFIT . INC,OENT"'S"(::I"'L Pl,iNITIV! ),l/O,oR CC"'5l0U!NT L O.."'AGESW"ETH!" ARISING RC'" ::0",'''::'' OR "EQL:GENCE, EVEN I'TCG OR ITS SAL!! RE:?RESEI("'1" 11.A Sf!N ",DVI!!D OF

.:.:'IIIL CF :iUC :"'W"'GES LIC! S SC\.Rc"'o::"" I!G...lCING OIlF! ! P OOI.!CTS 5"..a liEREP""CEIoEI1T CF ",f IoIICI. ANO P COliCrs I C;.ESTICN..;":1- TCC' "'OST SIIoILAII CUII EI( C

;=::

I"C: I'" NO EVE..s""'L:' T liE LI,oIIL! FCIt ANY "'J,CL.N", IN OC SS C""OU"':5 PAI e" lie::..!!! c: CR FOR TOC 'JR5L'''N""'S "'C E!Mr,"T

"HE PAIt !S AC..CW- I!:XE AT E..o; OF .P;;::V!S;c,"S CF TI;15 "'CR ;.\fN". :"Clur,mc W,ThCL'T

"" ':"'TlCN ""E H'E"7 ::VIS:'::NS "E.;;EO . WE.a';;': O"T"E "Cv'S;C. ":;::FrHIS "NCT,."T

P..R'! n'L 'I liNCE..S":''N06 A"O Ae:EI'TS T",:SLr:"'T 5""CL'''IT''":;C''S:ESC.lII!EOIN '''S

'C" S"'''lL Sul!VIVE ': E n.IoI""T1C" , FCII AN"" SC":0 IS "G;;::E""!

Ramedlos. ".. ""'"-"0," a.

,.,",.. ",.

P""C' OI' ".u""....M "C,,', ""'''' ""w ' 0" to;.

",-", ,:. , ,".

... -u

, '

"'CC

''' -- ,-". .., .' .

u"'" "'.,10 '0"'" '0 11. '"'''' . nQ '0 ". "'0 01 ;: . ..' II or, or.

:.

:C;

" "

,nl,loa :0 a "'." "'O ."""O ,,,"-I, 71" S":,,n ,"" i" '0 ..,. """, , .n,01"", ""'..'" 10 TOC "'ay" "".. .., II".,.r ,..0 'to."y (jo.

...

II cc,non -""o'.' "a ""'u",oe;. LI.'I'''' to "''''' ''' ."0 '0" TD 0"""':0. ""'" : Ir, 'N ",'IIY"":;C",,,.,I ..,,,IIof":t:G:O;r'OI'''' loc:,,.nyo,",,""'"i" '::G m.y , .o,

'"y ."

I' '.i" LIg 1M i,,,-", an' , co,"1'.,."'g;a ''''I.''"II''OI'''.'''r""na''"y. ,

..,., ...,,'"

.II " U :" ID 011"

"".,"\.

Gtntr,1 Provisions.

;..

,.. "'"0"".." an.,;".,11" "'... g"'O"'."' , :Dg.,.",..t. 'w ""'0. .,,;ng s".."..,"1I,oomp""O'''UO'"''o''I.''.n'oIIlO'g''.''."I'.''o' I"'oro..

, ..

' ,..u'..u ",,, "'.". .il

"'

'UD'." .'D''''

,".

unl."""I' I o 01 011.' .g'''''.nl. , O I 01 """

, .."''''

.. ,.l.un; 10 11. O b;.o: :,.,01.. ".,.al, "'y .o"

,,"

r",....,ny our.,... Dro.. or Olho, obm"'U"",I"" L,"M" i, ...roU;1"jooIU. a.lo. 1..,...r,IOu.. ., ,t:O; .. 0"'01 "..O" k.. ar.

lImy '0 ."'0'0 '"y WllTn" 0' 1' '''."I''' 10 ,,,anw. or '.1I",,0"" '010 "'. '''~I'OI, 00",...10"." or '''.T'O".'''o. ol.o,tI. .",ow," , to moOl1y IM.I..;,..",_", '"

"""

:o ,.. m. ",,"... u. .o;.a""n o'r".O "b"", " ..o,, o'

""" ,"'.....

. 0"

'.""

of":t:Ji , 0'" 0110"". ,... TOG.. ony """ ". L.o ". '"a'"0' ...", 01 0"'''''''. Inn.I., "'. "'O o. OT 11" "'0"."'."1 '",nyo , "","d"'Q O

y ","

I. o .iOlary. . tI'u "(I "' \kilo ..,.'J''' 01" al!!t ..i. DI aI.,)"1 .O"" 01 il bU.;,.., . 0' ota a"' to10', "'''O'T

"""""'

lO" ' ""'Q' ".I""

. """

I TeC". ,,,,

...,:"..

, E.'u""" TCCm'1 ""'"l'i1 "UI. a''''''M 'or."''';SO".oylo

, "".....

. ""odill'Don ' of O.. "", ",. Pf.OU''' "'""'O'."1noo, .'.".0"'0", I

-;".' , '''.''''."

,I ""O.,ro.",'o.iL 0"001 ""0 nOI O .I''OIl. "', "u mu. il ""'''i '0.

0"" 1i90" , H"" uan..o .n. TD;. No '0"'1 " no ..'I. '"oOIl'uol.ujnwill''Uo:!C lnd"Op'oil"""""OrloY"iolor"."U Mo"o"".' oNl a.r\10 . ""...r .I.., h "' I 0' ,."'..".,Iny..'''' "I'- or '."'..y, .' 1\11" o""'to, 11.'.01. rra"" "'.....,'."ot", ..y..., iI "" ""0 "'''...10 o G.. I y '.oOc"" 'LlM..,'01..11." 1"11'0.1"'."'1000.""'''.'''1''" na,.... ."..,.1:h. ""..",om

'"

I .... .", .nOo",u... 10 \. mn""u", ."001

""...... ':. "".."";"".

,,,..iduo' ""1""'1 ,,,,, "oro,,,.,, ..",,1.1 Lioo"'.. "p,...Ma .ro ""rT 1. 10 TOG 1..1 . 0' .

. ;, .

"0,"0"'.. : ,..,"I. 1/. ";".m. ' 0" "",II.I '..'"Wt. 'o1... "'g'''",.ol "' LI.

. ....

''''"Q ,n, 'n'a"'.. . "'0:.'''0 ,rL,."... '" -o,"Uoco U lorm.. !h" "'.,.....n' or""I...,n..

. "" "''''

. 0"'.' IO I! tn.",. 01 ".. "''''. 01 ,," S"... ,I

.... "",y"...

'.roor 000'."'1, Ia" ,II po';.... '"0 I. Ii... ",..,,,

,,"

\ ;o" 'a 10 "'.,un,,","O" .IIM OD'J'" "10,' Sill' 01'1'1' '0;':0 10 ,". "'. ."'o"I"g 10 11. '"'O '."'"'" or .",."."'.0. 1 01 "..

IIO"" I. ."" ..".. .,\ .'''000" . "'0:. '1 01"'.""'" "'... ""

'",

OU"-, I.",,, '" ". IO".o",,,a " M.,..

To.

",",

.. "'0"". "'.....; 0' '" '" 0.0,,1 0 Li'."'., "'al Lie,",.. .., ro aJ ,nO .".' """ "". 10.. ","."" ", ., ,.00..,. '.,1 "0'''.C' .''. ;0"".."""" ID' . a"'o 1:, ;.o"..a .;'...:a a . ,". ,I" '.""a In "

... "",,,,,,

, 11'0 ..;,.....

, '

.. "IO

.."--'-.'

-'__M '---" ,-

(1yO' .'oc

,.., ",,,.,

1"""",,..,,:;".,"

,",

;,,,."""'00'''''1

:"c

Page 123: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , INC. , ET AL 123

Decision and Order

APPENDIX I

ASSET MAINTENA:-CE AGREEMENT

This Asset Maintenance Agreement (the "Agreement" ) is by andbetween SoftSearch Holdings , Inc, (" SoftSearch"), a corporationorganized under the laws of the State of Texas , with its principaloffces located at Abilene , Tcxas , and the Federal Trade Commission(the " Commission ), an indcpendent agency of the United StatesGovemment, established under the Fcderal Trade Commission Act of1914 15 U. c. 41 et seq. (collectively, the "Parties

PRE\1ISES

Whereas SoftSearch and GeoQuest International Holdings , Inc.entered into an agrccment, dated -' pursuant to whichSoftSearch' s wholly-owned subsidiary Dwight's Energydata, Inc,

Dwights ) and GeoQuest's wholly-owned subsidiary PetroleumInformation Corporation will merge their assets (the "Acquisitionand

Whereas the Commission is now investigating the Acquisition todetermine whcther it would violate any of the statutes enforced by theCommission; and

Whereas The Commission has reason to believe that theagrcement would violatc Section 5 of the Federal Trade CommissionAct , and that, if consummated , would violate Section 7 of the ClaytonAct and Section 5 of the Fcderal Trade Commission Act , statutesenforced by the Commission; and

Whereas if the Commission accepts the attached AgreementContaining Consent Order ("Consent Order ), the Commission mustplace it on the public record for a period of at least sixty days andmay subsequently withdraw such acccptance pursuant to theprovisions of Section 2. 34 of the Commission s Rules; and

Whereas the Commission is concerned that if an agreement is notrcached preserving the Specified Data (as defined in the AgreementContaining Consent Order) during the period prior to the time that theConscnt Order becomes final , divestiture of said data to an possiblein any proceeding challenging the legality of the Acquisition in theevent that the Consent Ordcr does not become final; and

Whereas the action of Soft Search in entering into this Ab'Teement

shall in no way be construed as an admission by SoftSearch that the

Page 124: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

124 FEDERAL TRADE COM'vISSIO"l DECISIONS

Decision and Order 124 FTC.

Acquisition violates the statutes as alleged in the draft complaintattached hereto; and

Whereas SoftSearch understands that no act or transactioncontemplated by this Agreement shall be deemed immune or exemptfrom the provisions of the antitrust laws or the Federal TradeCommission Act by reason of anything contained in this Agreement.

Now therefore in consideration of the Commission s agreementthat , unless it determines to reject the Consent Order, it wil not seekfurther relief from thc Parties with respect to the Acquisition , exceptthat the Commission may exercise any and all rights to enforce thisAgreement and the Consent Order annexed hereto , and to seek thedivestiture of such assets to be preserved under this Agreement asmay be required to maintain the level of competition that existed priorto the Acquisition , the Parties agree as follows:

1. SoftSearch agrees to execute , and upon its issuance to be boundby, the attached Consent Order.

2. SoftSearch agrees that from the date this Agreement is acceptedby the Commission until the earliest of the dates listed insubparagraphs (a) and (b) it will comply with the provisions of thisAgreement.

(a) The date the Consent Order becomes final; or(b) Three business days after the Commission withdraws its

acceptance ofthe Consent Order pursuant to the provisions of Section34 of the Commission s rules.

3. SoftSearch shall maintain and update the Specified Data;

preserve its viability and marketability, and prevent its destructionremoval , wasting, deterioration or impairment of any kind.

4, If the Commission seeks in any proceeding with respect to theAcquisition to obtain injunctive or equitable relief, SoftSearch shallnot raise an objection based upon the fact that the Commission haspermitted the Acquisition to be consummated. SoftSearch also waivesall rights to contest the validity of this Agreement.

5. For the purpose of determining or securing compliance withthis Agreement, subject to any legally recognized privilege , and uponwritten request with reasonable notice to SoftSearch madc to itsprincipal offce, SoftSearch shall permit any duly authorizedrepresentative of the Commission:

Page 125: , ET AL....KUTRITJON 21, ET AL Complaint The changes in the placebo group were negligible. But the Chromium Picolinate group, on average, lost over 4 pounds of fat while gaining nearly

SOFTSEARCH HOLDINGS , INC. , ET AL 125

Dccision and Order

(a) Access during the offce hours of SoftSearch or Dwights , inthe presence of counsel , to inspect and copy all books, ledgersaccounts, correspondence, memoranda and other records anddocuments in possession or under the control of SoftSearch relatingto compliance with the Agreement; and

(b) Upon five (5) days ' written notice to SoftSearch or Dwightsand without restraint or interference from it, to interview offcers oremployees of SoftScarch or Dwights, who may have counsel presentregarding any such matters.

6, The Agreement shall not be binding until approved by theCommission.